UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

 

 QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2024

 

 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ____________ to ____________

  

Commission file number 000-55648

 

INNOVATIVE PAYMENT SOLUTIONS, INC.
(Exact name of registrant as specified in its charter)

 

Nevada   33-1230229
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer
Identification No.)

 

56B 5th AvenueLot 1 #ATCarmel By The SeaCA   93921
(Address of Principal Executive Office)   (Zip Code)

 

(866) 477-4729
(Registrant’s telephone number, including area code)

 

n/a
(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act: None

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  No 

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files.) Yes  No 

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

  Large accelerated filer ☐  Accelerated filer ☐ 
  Non-accelerated filer ☒  Smaller reporting company  
    Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  No 

 

As of May 13, 2024, there were 13,819,889 shares of the Company’s Common Stock issued and outstanding.

 

 

 

 

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

 

Form 10-Q

For the Quarter Ended March 31, 2024

 

Index

 

    Page No.
     
Cautionary Note Regarding Forward-Looking Statements ii
     
Part I. Financial Information 1
     
Item 1. Financial Statements (Unaudited) 1
     
  Condensed Consolidated Balance Sheets as of March 31, 2024 (Unaudited) and December 31, 2023 1
     
  Condensed Consolidated Statements of Operations for the three months ended March 31, 2024 and 2023 (Unaudited) 2
     
  Condensed Consolidated Statements of Changes in Stockholders’ Equity for the three months ended March 31, 2024 and 2023 (Unaudited) 3
     
  Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2024 and 2023 (Unaudited) 4
     
  Notes to the Condensed Consolidated Financial Statements (Unaudited) 5
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 27
     
Item 3. Quantitative and Qualitative Disclosures About Market Risk 31
     
Item 4. Controls and Procedures 31
     
Part II. Other Information 33
     
Item 1. Legal Proceedings 33
     
Item 1A. Risk Factors 34
     
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 35
     
Item 3. Defaults Upon Senior Securities 35
     
Item 4. Mine Safety Disclosures 35
     
Item 5. Other Information 35
     
Item 6. Exhibits 36
     
Signatures 37

 

i

 

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This Quarterly Report on Form 10-Q (this “Report”) contains “forward-looking statements” (as defined in Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) that reflect our current expectations and views of future events. The forward-looking statements are contained principally in the section of this Report entitled “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Readers are cautioned that significant known and unknown risks, uncertainties and other important factors (including those over which we may have no control and others listed in this Report and in the “Risk Factors” section of our Annual Report on Form 10-K for the year ended December 31, 2023 (the “2023 Form 10-K”)) may cause our actual results, performance or achievements to be materially different from those expressed or implied by the forward-looking statements. You can identify some of these forward-looking statements by words or phrases such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “is/are likely to,” “potential,” “continue” or other similar expressions. We have based these forward-looking statements largely on our current expectations and projections about future events that we believe may affect our financial condition, results of operations, business strategy and financial needs. These forward-looking statements include statements relating to:

  

  our ability to implement our business plan, including our ability to launch and generate revenue from our IPSIPay Express joint venture or other digital payment solutions we may seek to develop or commercialize in the future;

 

  acceptance by the marketplace of our products and services, notably IPSIPay Express;

 

  our ability to formulate, implement and modify as necessary effective sales, marketing, and strategic initiatives to drive revenue growth;

 

  the viability of our current intellectual property and intellectual property created in the future;

 

  our ability to comply with currently applicable laws and government regulations and those that may be applicable in the future;

 

  our ability to retain key employees and third-party service providers;

 

  adverse changes in general market conditions for payment solutions such as IPSIPay Express and other products and services we offer;

 

  our ability to generate cash flow and profitability and continue as a going concern;

 

  our future financing plans and ability to repay outstanding indebtedness; and

 

  our ability to adapt to changes in market conditions which could impair our operations and financial performance.

 

These forward-looking statements involve numerous and significant risks and uncertainties. Although we believe that our expectations expressed in these forward-looking statements are reasonable, our expectations may later be found to be incorrect. Our actual results of operations or the results of other matters that we anticipate herein could be materially different from our expectations. Important risks and factors that could cause our actual results to be materially different from our expectations are generally set forth in the “Management’s Discussion and Analysis of Financial Condition and Results of Operation,” section contain in this Report and in the “Business,” “Risk Factors” and other sections of the 2023 Form 10-K. You should thoroughly read this Report and the documents that we refer to with the understanding that our actual future results may be materially different from, and worse than, what we expect. We qualify all of our forward-looking statements by these cautionary statements.

 

The forward-looking statements made in this Report relate only to events or information as of the date of this Report. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. You should read this Report completely and with the understanding that our actual future results may be materially different from what we expect.

 

ii

 

 

PART I - FINANCIAL INFORMATION

 

Item 1. Financial Statements.

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Condensed Consolidated Balance Sheets

 

   March 31,   December 31, 
   2024   2023 
Assets  (Unaudited)     
         
Current Assets        
Cash  $6,875   $50,433 
Other current assets   12,597    38,818 
Total Current Assets   19,472    89,251 
           
Non-current assets          
Plant and equipment   6,484    7,027 
Notes receivable   161,615    - 
Security deposit   5,000    5,000 
Equity method investment   703,954    703,938 
Total Non-Current Assets   877,053    715,965 
Total Assets  $896,525   $805,216 
           
Liabilities and Equity (Deficit)          
           
Current Liabilities          
Accounts payable  $2,307,053   $2,023,375 
Federal relief loans – current portion   9,309    9,369 
Notes payable   1,086,374    1,062,007 
Convertible debt, net of unamortized discount of $432,702 and $687,503, respectively   4,393,479    3,704,280 
Derivative liability   618,255    1,434,196 
Total Current Liabilities   8,414,470    8,233,227 
           
Non-Current Liabilities          
Federal relief loans   150,000    150,000 
Total Non-Current Liabilities   150,000    150,000 
           
Total Liabilities   8,564,470    8,383,227 
           
Equity (Deficit)          
Preferred stock, $0.0001 par value, 25,000,000 shares authorized, and 0 shares issued and outstanding as of March 31, 2024 and December 31, 2023.   
-
    
-
 
Common stock, $0.0001 par value; 750,000,000 shares authorized, 13,819,889 issued and outstanding as of March 31, 2024 and December 31, 2023.   1,382    1,382 
Additional paid-in-capital   50,897,756    50,656,225 
Accumulated deficit   (58,567,083)   (58,235,618)
Total Equity (Deficit)   (7,667,945)   (7,578,011)
Total Liabilities and Equity (Deficit)  $896,525   $805,216 

 

See accompanying notes to the unaudited condensed consolidated financial statements.

 

1

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Condensed Consolidated Statements of Operations

(Unaudited)

 

  

Three months ended

   Three months ended 
   March 31,   March 31, 
   2024   2023 
         
Net Revenue  $
-
   $433 
           
Cost of Goods Sold   
-
    2,085 
           
Gross loss   
-
    (1,652)
           
General and administrative   626,797    949,947 
Depreciation and amortization   542    140,690 
Total Expense   627,339    1,090,637 
           
Loss from Operations   (627,339)   (1,092,289)
           
Deemed Interest income   3,282    
-
 
Loss on convertible notes   (66,047)   
-
 
Interest expense   (136,919)   (85,221)
Amortization of debt discount   (319,899)   (22,967)
Derivative liability movements   815,941    940,750 
Loss before Income Taxes   (330,981)   (259,727)
           
Income Taxes   
-
    
-
 
Net Loss after income taxes   (330,981)   (259,727)
           
Net loss from equity method investments   (484)   - 
Net loss from continuing operations   (331,465)   (259,727)
           
Discontinued operations          
Net loss from discontinued operations   
-
    (15,260)
    
-
    (15,260)
Net loss   (331,465)   (274,987)
           
Net loss attributable to non-controlling interest   
-
    1,597 
Net loss attributable to Innovative Payment Solutions, Inc. stockholders  $(331,465)  $(273,390)
           
Basic and diluted loss per share*          
Continuing operations*
   (0.02)   (0.02)
Discontinued operations*
   
-
    (0.00)
 
  $(0.02)  $(0.02)
           
Weighted Average Number of Shares Outstanding – Basic and diluted
   13,819,889    12,563,389 

 

* After giving effect to a 1 for 30 reverse stock split on August 30, 2023.

 

See accompanying notes to the unaudited condensed consolidated financial statements.

 

2

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Condensed Consolidated Statements of Changes in Stockholders’ Equity (Deficit)

(Unaudited)

 

   Preferred
Stock
Shares
   Amount   Common
Stock
Shares*
   Amount*   Additional
Paid-in
Capital*
   Accumulated
Deficit
   Non-controlling
shareholders
interest
   Total
Stockholders’
Equity (Deficit)
 
Balance at December 31, 2023   
         -
   $
          -
    13,819,889   $1,382   $50,656,225   $(58,235,618)  $
-
   $(7,578,011)
Fair value of warrants issued to convertible debt holders   -    
-
    -    
-
    44,813    
-
    
-
    44,813 
Fair value of warrants issued on debt extinguishment   

-

    

-

    

-

    

-

    

66,047

    

-

    

-

    

66,047

 
Fair value of warrants issued for services   -    
-
    -    
-
    36,207    
-
    
-
    36,207 
Stock based compensation   -    
-
    -    
-
    94,464    
-
    
-
    94,464 
Net loss   -    
-
    -    
-
    
-
    (331,465)   
-
    (331,465)
Balance at March 31, 2024   
-
   $
-
    13,819,889   $1,382   $50,897,756   $(58,567,083)  $
-
   $(7,667,945)

 

   Preferred
Stock
Shares
   Amount   Common
Stock
Shares*
   Amount*   Additional
Paid-in
Capital*
   Accumulated
Deficit
   Non-controlling
shareholders
interest
   Total
Stockholders’
Equity (Deficit)
 
Balance at December 31, 2022   
       -
   $
         -
    12,563,426   $1,256   $48,442,355   $(52,399,858)  $1,597   $(3,954,650)
Fair value of warrants issued to convertible debt holders   -    
-
    -    
-
    251,856    
-
    
-
    251,856 
Fair value of warrants issued for services   -    -    -    -    36,207    -    -    

36,207

 
Stock based compensation   -    
-
    -    
-
    94,464    
-
    
-
    94,464 
Net loss   -    
-
    -    
-
    
-
    (273,390)   (1,597)   (274,987)
Balance at March 31, 2023   
-
   $
-
    12,563,426   $1,256   $48,824,882   $(52,673,248)  $
-
   $(3,847,110)

 

* After giving effect to a 1 for 30 reverse stock split on August 30, 2023.

 

See accompanying notes to condensed consolidated financial statements.

 

3

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

 

   Three months ended   Three months ended 
   March 31,   March 31, 
   2024   2023 
CASH FLOWS FROM OPERATING ACTIVITIES:        
Net loss  $(331,465)  $(274,987)
Net loss from discontinued operations   
-
    15,260 
Net loss from continuing operations   (331,465)   (259,727)
Adjustments to reconcile net loss to net cash used in operating activities:          
Derivative liability movements   (815,941)   (940,750)
Depreciation   542    140,690 
Amortization of debt discount   319,899    22,967 
Loss on convertible notes   66,047    
-
 
Deemed interest income   (3,282)   
-
 
Unrealized loss on equity method investments   484    
-
 
Warrants issued for services   36,207    36,207 
Stock based compensation   94,464    94,464 
Changes in Assets and Liabilities          
Other current assets   26,221    21,957 
Accounts payable and accrued expenses   283,679    76,420 
Interest accruals   120,396    83,837 
Cash used in operating activities – continuing operations   (202,749)   (723,935)
Cash provided by operating activities – discontinued operations   
-
    35,631 
CASH USED IN OPERATING ACTIVITIES   (202,749)   (688,304)
           
CASH FLOWS FROM INVESTING ACTIVITIES:          
Investment in intangibles   
-
    (28,893)
Investment in notes receivable   (158,333)   
-
 
Investment in equity method investment   (500)   - 
Net cash used in investing activities – continuing operations   (158,833)   (28,893)
Net cash used in investing activities – discontinued operations   
-
    (35,890)
CASH USED IN INVESTING ACTIVITIES   (158,833)   (64,783)
           
CASH FLOWS FROM FINANCING ACTIVITIES:          
Proceeds from convertible notes   402,335    535,000 
Repayment of convertible notes   (84,311)   
-
 
Repayment of federal relief loans   
-
    (809)
NET CASH PROVIDED BY FINANCING ACTIVITIES   318,024    534,191 
           
NET DECREASE IN CASH   (43,558)   (218,896)
Cash and cash included in assets held for sale at the beginning of the period   50,433    374,765 
CASH AT END OF PERIOD  $6,875   $155,869 
RECONCILIATION OF OPENING CASH WITHIN THE BALANCE SHEET TO THE STATEMENT OF CASH FLOWS          
Cash  $50,433   $373,822 
Cash included in assets held for sale   
-
    943 
CASH AT THE BEGINNING OF THE PERIOD  $50,433   $374,765 
RECONCILIATION OF CLOSING CASH WITHIN THE BALANCE SHEET TO THE STATEMENT OF CASH FLOWS          
Cash  $6,875   $155,185 
Cash included in assets held for sale   
-
    684 
CASH AT THE END OF THE PERIOD  $6,875   $155,869 
CASH PAID FOR INTEREST AND TAXES:          
Cash paid for income taxes  $
-
   $
-
 
Cash paid for interest  $16,522   $1,384 
NON CASH INVESTING AND FINANCING ACTIVITIES          
Fair value of warrants issued with convertible notes  $44,813   $251,856 

 

See notes to the unaudited condensed financial statements.

 

4

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

1 ORGANIZATION AND DESCRIPTION OF BUSINESS

 

a)Organizational History

 

On May 12, 2016, Innovative Payment Solutions, Inc., a Nevada corporation (“IPSI” or the “Company”) (originally formed on September 23, 2013 under the name “Asiya Pearls, Inc.”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Qpagos Corporation, a Delaware corporation (“Qpagos Corporation”), and Qpagos Merge, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“Merger Sub”). Pursuant to the Merger Agreement, on May 12, 2016, the merger was consummated, and Qpagos Corporation and Merger Sub merged (the “Merger”), with Qpagos Corporation continuing as the surviving corporation of the Merger. On May 27, 2016, the Company’s name was changed from “Asiya Pearls, Inc.” to “QPAGOS”.

 

Pursuant to the Merger Agreement, upon consummation of the Merger, each share of Qpagos Corporation’s capital stock issued and outstanding immediately prior to the Merger was converted into the right to receive two shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”). Additionally, pursuant to the Merger Agreement, upon consummation of the Merger, the Company assumed all of Qpagos Corporation’s warrants issued and outstanding immediately prior to the Merger, which were exercisable for an aggregate of approximately 621,920 shares of Common Stock as of the date of the Merger. Prior to and as a condition to the closing of the Merger, a then-current holder of 500,000 shares of Common Stock agreed to return 497,500 shares of Common Stock held by such holder to the Company and such holder retained an aggregate of 2,500 shares of Common Stock. The other then stockholders of the Company retained 500,000 shares of Common Stock. Therefore, immediately following the Merger, Qpagos Corporation’s former stockholders held 4,992,900 shares of Common Stock which represented approximately 91% of the outstanding Common Stock.

 

The Merger was treated as a reverse acquisition of the Company, then a public shell company, for financial accounting and reporting purposes. As such, Qpagos Corporation was treated as the acquirer for accounting and financial reporting purposes while the Company was treated as the acquired entity for accounting and financial reporting purposes.

 

Qpagos Corporation was incorporated on May 1, 2015 under the laws of the state of Delaware to effectuate a reverse merger transaction with Qpagos, S.A.P.I. de C.V. (“Qpagos Mexico”) and Redpag Electrónicos S.A.P.I. de C.V. (“Redpag”). Each of the entities were incorporated in November 2013 in Mexico. Qpagos Mexico was formed to process payment transactions for service providers it contracts with, and Redpag was formed to deploy and operate kiosks as a distributor. 

 

On June 1, 2016, the board of directors of the Company (the “Board”) changed the Company’s fiscal year end from October 31 to December 31.

 

On November 1, 2019, the Company changed its corporate name from “QPAGOS” to “Innovative Payment Solutions, Inc.” Additionally, and immediately following the name change, the Company filed a Certificate of Change with the Secretary of State of the State of Nevada to effect a reverse split of the then outstanding Common Stock at a ratio of 1-for-10, effective on November 1, 2019 (the “Reverse Stock Split”). As a result of the Reverse Stock Split, each ten pre-split shares of Common Stock outstanding automatically combined into one new share of Common Stock without any further action on the part of the holders, and the number of outstanding shares of Common Stock was reduced from 320,477,867 shares to 32,047,817 after rounding for fractional shares.

 

On December 31, 2019, the Company consummated the disposal of Qpagos Corporation, Qpagos Mexico and Redpag in exchange for 2,250,000 shares (the “Vivi Shares”) of common stock of Vivi Holdings, Inc. (“Vivi. or “Vivi Holdings”) pursuant to a Stock Purchase Agreement dated August 5, 2019 (the “SPA”). Of the 2,250,000 shares of Vivi, nine percent (9%) was allocated as follows: Gaston Pereira (5%), Andrey Novikov (2.5%), and Joseph Abrams (1.5%). The transactions contemplated by the SPA closed on December 31, 2019 after the satisfaction of customary conditions, the receipt of a final fairness opinion and the approval of the Company’s shareholders. As a result, the Company no longer has any business operations in Mexico and has retained its U.S. operations, currently based in Carmel By The Sea, California.

  

On June 21, 2021. the Company acquired a 10% strategic interest in Frictionless Financial Technologies, Inc. (“Frictionless”). Frictionless agreed to deliver to the Company, a live fully compliant financial payment Software as a Service solution for use by the Company as a digital payment platform (which was subsequently branded as IPSIPay) that enables payments within the United States and abroad, including Mexico, together with a service agreement providing a full suite of product services to facilitate the Company’s anticipated product offerings. The Company had an irrevocable right to acquire up to an additional 41% of the outstanding common stock of Frictionless at a purchase price of $300,000 for each 1% acquired.

 

On August 26, 2021, the Company formed a new subsidiary, Beyond Fintech, Inc. (“Beyond Fintech”), in which it owns a 51% stake, with Frictionless owning the remaining 49%. Beyond Fintech acquired an exclusive license to a product known as Beyond Wallet, to further its objective of providing virtual payment services allowing U.S. persons to transfer funds to Mexico and other countries.

 

5

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

  

1 ORGANIZATION AND DESCRIPTION OF BUSINESS (continued)

 

a)Organizational History (continued)

 

On May 12, 2023, the Company entered into an Agreement with Frictionless (the “May 2023 Frictionless Agreement”) to unwind the equity ownership stakes that the Company and Frictionless have in each other and in Beyond Fintech. Pursuant to the May 2023 Frictionless Agreement: (i) the Company assigned to Frictionless all common stock of Frictionless owned by the Company; (ii) the warrant to purchase 1,000,000 shares of Common Stock previously issued by the Company to Frictionless as of December 30, 2022 was cancelled; (iii) the Company assigned to Frictionless all shares of common stock of Beyond Fintech owned by the Company (the “Beyond Fintech Shares”); and (iv) the rights previously granted to the Company to (a) acquire additional equity interests in Frictionless, (b) participate in future financings of Frictionless and (c) appoint a board member of Frictionless, were terminated. The consideration to the Company for the assignment of the Beyond Fintech Shares to Frictionless was a credit against potential future services to be provided by Frictionless to the Company in an amount up to $250,000. As a result of the novation agreement with Frictionless discussed below, the Company no longer utilizes, and does not expect to utilize, the services of Frictionless for the foreseeable future. The collectability of the remaining credit receivable of $231,431 has been impaired.

 

On August 30, 2023, the Company implemented a 1 for 30 reverse stock split of its Common Stock. Unless the context expressly requires otherwise, as used in this Report, all share and per share numbers reflect such reverse stock split.

 

On September 5, 2023, the Company’s entered into a novation agreement whereby it assigned all its rights and interest in its e-wallet product, IPSIPay, and its receivables and payables due from and to Frictionless, related to IPSIPay, to a third party in order to concentrate all of its efforts on the IPSIPay Express LLC (“IPSIPay Express”) joint venture. See note 1(b) for further information.

 

b)Description of current business

 

The Company is currently a fintech provider of digital payment solutions presently focused on, through its participation in IPSIPay Express, developing a new account-to-account payment application called Instant Settlement in RealTime as well as traditional credit card processing services. The Company has in the past (under the name IPSIPay) and may in the future develop and operate “e-wallets” that enable consumers to deposit cash, convert it into a digital form and remit funds quickly and securely.

 

IPSIPay Express

 

On April 28, 2023, the Company formed a new company called IPSIPay Express. This entity was formed as a Delaware limited liability company joint venture with OpenPath, Inc. (“OpenPath”) and EfinityPay, LLC (“EfinityPay”, and the Company, collectively with OpenPath and EfinityPay, the “Members”) to develop and market a proprietary consumer to merchant real-time payment platform initially focused on the fast-growing online gaming and entertainment sectors.

 

On June 19, 2023, the Company entered into a Limited Liability Company Operating Agreement (the “Operating Agreement”) with OpenPath and EfinityPay to jointly provide for the governance of and rights of the Members with respect to IPSIPay Express. The effective date of the Operating Agreement is April 28, 2023.

 

IPSIPay Express was formed by the Members with the initial business purposes of providing credit card processing solutions and also a proprietary solution for real time bank-to-bank payment transactions in a manner that provides seamless and frictionless consumer and merchant experiences, with an initial focus on merchants operating in gaming and entertainment sectors. Such solutions are collectively referred to herein as “IPEX.”

 

Pursuant to the Operating Agreement, the Company agreed to contribute cash to or on behalf IPSIPay Express to be used for the IPEX business in the aggregate amount of up to $1,500,000 (the “IPSI Capital Contribution”). The Company is required to make the IPSIPay Capital Contribution in three tranches of $500,000 (each, a “Tranche”), or such lesser amounts as may be unanimously approved by the Board of Managers of IPSIPay Express. With the full funding of each Tranche, the Company will automatically receive an 11.11% membership interest in IPSIPay Express (or a pro rata portion thereof if less than a full Tranche is funded), and OpenPath and EfinityPay’s percentage interest in IPSIPay Express will be reduced pro rata accordingly. Should the Company contribute the full IPSI Capital Contribution, the Members will each own one-third (1/3) of the membership interests in IPSIPay Express. The IPSI Capital Contribution has been or will be made by the following dates and in the following amounts: (i) $200,000 of the initial Tranche was paid by the Company on June 21, 2023; (ii) the $300,000 balance of the initial Tranche was paid on August 4, 2023; (iii) the second $500,000 Tranche was paid in September 2023 and (iv) the third $500,000 Tranche was expected to be paid on or before November 30, 2023. In late 2023, the Company agreed with its joint venture partners that such investment was not required as the joint venture is not operational as yet. The need for any additional advances will be addressed with the joint venture partners once IPEX becomes operational and begins generating revenue, our current shareholding in the joint venture remains at 22%.

 

6

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

1 ORGANIZATION AND DESCRIPTION OF BUSINESS (continued)

 

b)Description of current business (continued)

 

Simultaneously with the funding of the initial Tranche, the Company issued to each of OpenPath and EfinityPay a five-year Common Stock purchase warrant (the “IPEX Warrant”) to purchase 133,334 shares of Common Stock with an exercise price of $0.45 per share. We are still obligated to issue to each of OpenPath and EfinityPay an additional IPEX Warrant to purchase 199,999 shares of Common Stock with an exercise price equal to the average public closing price of the Common Stock for the three trading days immediately prior to the funding of the initial Tranche. Simultaneously with the funding of the second Tranche, we are obligated to issue to each of OpenPath and EfinityPay an additional IPEX Warrant to purchase 166,667 shares of Common Stock with an exercise price equal to the average public closing price of the Common Stock for the three trading days immediately prior to the funding of the second Tranche. Should we decide to fund a third Tranche, we will be obligated to issue to each of OpenPath and EfinityPay an additional IPEX Warrant to purchase 166,667 shares of Common Stock with an exercise price equal to the average public closing price of the Common Stock for the three trading days immediately prior to the funding of the third Tranche. If the full IPSI Capital Contribution is funded, OpenPath and EfinityPay will receive IPEX Warrants to purchase an aggregate of 1,333,334 shares of Common Stock.

  

2 ACCOUNTING POLICIES AND ESTIMATES

 

a)Basis of Presentation

 

The accompanying unaudited condensed financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X. Accordingly, these unaudited condensed financial statements do not include all of the information and disclosures required by U.S. GAAP for complete financial statements. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments (consisting only of normal recurring adjustments), which the Company considers necessary, for a fair presentation of those financial statements. The results of operations and cash flows for the three months ended March 31, 2024 may not necessarily be indicative of results that may be expected for any succeeding quarter or for the entire fiscal year. The information contained in this Report should be read in conjunction with the audited financial statements of IPSI for the year ended December 31, 2023, included in the Company’s Annual Report on Form 10-K as filed with the Securities and Exchange Commission (the “SEC”) on March 29, 2024 and amended on April 17, 2024.

 

All amounts referred to in the notes to the unaudited condensed consolidated financial statements are in United States Dollars ($) unless stated otherwise.

  

b)Principles of Consolidation

 

The unaudited condensed consolidated financial statements as of March 31, 2024, include the financial statements of the Company. The unaudited condensed consolidated financial statements as of March 31, 2023, include the financial statements of the Company and its subsidiary in which it has a majority voting interest, until May 12, 2023, the date of disposal of its Beyond Fintech subsidiary. Pursuant to the May 2023 Frictionless Agreement, the Company disposed of its 51% interest in Beyond Fintech. Therefore the Company currently has no subsidiaries.

 

All significant inter-company accounts and transactions have been eliminated in the unaudited condensed consolidated financial statements.

 

The accompanying consolidated financial statements have been prepared in accordance with U.S. GAAP.

 

All amounts referred to in the notes to the consolidated financial statements are in United States Dollars ($) unless stated otherwise.

 

c)Use of Estimates

 

The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions, which are evaluated on an ongoing basis, that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the amounts of revenues and expenses that are not readily apparent from other sources. Actual results could differ from those estimates and judgments. In particular, significant estimates and judgments include those related to, the estimated useful lives for plant and equipment, the fair value of long-lived investments, the fair value of warrants and stock options granted for services or compensation, convertible notes and amendments thereto, derivative liabilities, the valuation allowance for deferred tax assets due to continuing operating losses and the allowance for doubtful accounts.

 

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from our estimates.

 

7

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

2 ACCOUNTING POLICIES AND ESTIMATES (continued)

 

d)Contingencies

 

Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company, but which will only be resolved when one or more future events occur or fail to occur.

 

The Company’s management assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment.

 

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s unaudited condensed consolidated financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material would be disclosed. Loss contingencies considered to be remote by management are generally not disclosed unless they involve guarantees, in which case the guarantee would be disclosed.

 

e)Fair Value of Financial Instruments

 

The Company adopted the guidance of Accounting Standards Codification (“ASC”) 820 for fair value measurements which clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:

 

Level 1 - Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date.

 

Level 2 - Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated by observable market data.

 

Level 3 - Inputs are unobservable inputs which reflect the reporting entity’s own assumptions on what assumptions the market participants would use in pricing the asset or liability based on the best available information.

 

The carrying amounts reported in the balance sheets for cash, accounts receivable, other current assets, other assets, accounts payable, accrued liabilities, and notes payable, approximate fair value due to the relatively short period to maturity for these instruments. The Company has identified the short-term convertible notes and certain warrants attached to certain of the notes that are required to be presented on the balance sheets at fair value in accordance with the accounting guidance.

 

ASC 825-10 “Financial Instruments” allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (fair value option). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable unless a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent reporting date. We evaluate the fair value of variably priced derivative liabilities on a quarterly basis and report any movements thereon in earnings.

 

f)Risks and Uncertainties

 

The Company’s operations and prospects are and will be subject to significant risks and uncertainties including financial, operational, regulatory, and other risks, including the potential risk of business failure. The recent wars in Ukraine and Israel and the global inflationary environment which has resulted in significant interest rate increases in the U.S and abroad has resulted in a general tightening in the credit markets, lower levels of liquidity, increases in the rates of default and bankruptcy, and extreme volatility in credit, equity and fixed income markets. These conditions may not only limit the Company’s access to capital, but also make it difficult for its customers, vendors and the Company to accurately forecast and plan future business activities, which may have an adverse impact on its business and financial condition and may hamper the Company’s ability to generate revenue and access usual sources of liquidity on reasonable terms.

 

The Company’s results may be adversely affected by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, and rates and methods of taxation, among other things.

 

8

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

2 ACCOUNTING POLICIES AND ESTIMATES (continued)

 

g)Recent accounting pronouncements

 

The Financial Accounting Standards Board (“FASB”) issued additional updates during the quarter ended March 31, 2024. None of these standards are either applicable to the Company or require adoption at a future date and none are expected to have a material impact on the Company’s unaudited condensed consolidated financial statements upon adoption.

 

h)Reporting by Segment

 

No segmental information is required as the Company has only one operating segment.

 

i)Cash and Cash Equivalents

 

The Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents. At March 31, 2024 and December 31, 2023, respectively, the Company had no cash equivalents.

 

The Company minimizes credit risk associated with cash by periodically evaluating the credit quality of its primary financial institution in the United States. The balance at times may exceed federally insured limits. At March 31, 2024 and December 31, 2023, the balance did not exceed federally insured limits.

 

j)Accounts Receivable and Allowance for Doubtful Accounts

 

Accounts receivable are reported at realizable value, net of allowances for doubtful accounts, which is estimated and recorded in the period the related revenue is recorded. The Company has a standardized approach to estimate and review the collectability of its receivables based on a number of factors, including the period they have been outstanding. Historical collection and payer reimbursement experience is an integral part of the estimation process related to allowances for doubtful accounts. In addition, the Company regularly assesses the state of its billing operations in order to identify issues, which may impact the collectability of these receivables or reserve estimates. Revisions to the allowance for doubtful accounts estimates are recorded as an adjustment to bad debt expense. Receivables deemed uncollectible are charged against the allowance for doubtful accounts at the time such receivables are written-off. Recoveries of receivables previously written-off are recorded as credits to the allowance for doubtful accounts. There were no recoveries during the period ended March 31, 2024 and 2023.

 

k)Investments

 

The Company’s non-marketable equity securities are investments in privately held companies without readily determinable market values. The carrying value of our non-marketable equity securities is adjusted to fair value for observable transactions for identical or similar investments of the same issuer or impairment (referred to as the measurement alternative). All gains and losses on non-marketable equity securities, realized and unrealized, are recognized in other income (expense), net. Non-marketable equity securities that have been remeasured during the period are classified within Level 3 in the fair value hierarchy because the Company estimates the value based on valuation methods using the observable transaction price at the transaction date and other unobservable inputs including volatility, rights, and obligations of the securities the Company holds. The cost method is used when the Company has a passive, long-term investment that doesn’t result in influence over the Company. The cost method is used when the investment results in an ownership stake of less than 20%, and there is no substantial influence. Under the cost method, the stock purchased is recorded on a balance sheet as a non-current asset at the historical acquisition/purchase price, and is not modified unless shares are sold, additional shares are purchased or there is evidence of the fair market value of the investment declining below carrying value. Any dividends received are recorded as income.

 

9

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

2 ACCOUNTING POLICIES AND ESTIMATES (continued)

 

l)Plant and Equipment

 

Plant and equipment is stated at cost, less accumulated depreciation. Plant and equipment with costs greater than $1,000 are capitalized and depreciated. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The estimated useful lives of the assets are as follows:

 

Description  Estimated Useful Life
    
Computer equipment  3 years
    
Office equipment  10 years

 

The cost of repairs and maintenance is expensed as incurred. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gains or losses are included in income in the year of disposition.

 

m)Long-Term Assets

 

Assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets.

 

n)Revenue Recognition

 

The Company’s revenue recognition policy is consistent with the requirements of FASB ASC 606, Revenue.

 

The Company’s revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those services. The Company derives its revenues from the sale of its services, as defined below. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its revenue transactions:

 

i.identify the contract with a customer;

 

ii.identify the performance obligations in the contract;

 

iii.determine the transaction price;

 

iv.allocate the transaction price to performance obligations in the contract; and

 

v.recognize revenue as the performance obligation is satisfied.

 

The Company had minimal revenues of $0 and $433 for the three months ended March 31, 2024 and 2023, respectively. 

 

10

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

2 ACCOUNTING POLICIES AND ESTIMATES (continued)

 

o)Share-Based Payment Arrangements

 

Generally, all forms of share-based payments, including stock option grants, restricted stock grants and stock appreciation rights are measured at their fair value on the awards’ grant date, based on the estimated number of awards that are ultimately expected to vest. Share-based compensation awards issued to non-employees for services rendered are recorded at either the fair value of the services rendered or the fair value of the share-based payment, whichever is more readily determinable. The expense resulting from share-based payments is recorded in operating expenses in the consolidated statement of operations.

 

Prior to the Company’s reverse merger which took place on May 12, 2016, all share-based payments were based on management’s estimate of market value of the Company’s equity. The factors considered in determining managements estimate of market value includes, assumptions of future revenues, expected cash flows, market acceptability of our technology and the current market conditions. These assumptions are complex and highly subjective, compounded by the business being in its early stage of development in a new market with limited data available.

 

Where equity transactions with arms-length third parties, who had applied their own assumptions and estimates in determining the market value of our equity, had taken place prior to and within a reasonable time frame of any share-based payments, the value of those share transactions have been used as the fair value for any share-based equity payments.

 

Where equity transactions with arms-length third parties, included both shares and warrants, the value of the warrants have been eliminated from the unit price of the securities using a Black-Scholes valuation model to determine the value of the warrants. The assumptions used in the Black Scholes valuation model includes market related interest rates for risk-free government issued treasury securities with similar maturities; the expected volatility of the Common Stock based on companies operating in similar industries and markets; the estimated stock price of the Company; the expected dividend yield of the Company and; the expected life of the warrants being valued.

 

Subsequent to the Company’s reverse merger which took place on May 12, 2016, the Company has utilized the market value of its Common Stock as quoted on the OTCQB, as an indicator of the fair value of its Common Stock in determining share- based payment arrangements.

 

p)Derivative Liabilities

 

ASC 815 generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re- measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional, as described.

 

q)Income Taxes

 

The Company is based in the U.S. and currently enacted U.S. tax laws are used in the calculation of income taxes.

 

Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A full valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized. It is the Company’s policy to classify interest and penalties on income taxes as interest expense or penalties expense. As of March 31, 2024 and December 31, 2023, there have been no interest or penalties incurred on income taxes.

 

11

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

2 ACCOUNTING POLICIES AND ESTIMATES (continued)

 

r)Comprehensive income

 

Comprehensive income is defined as the change in equity of a company during a period from transactions and other events and circumstances excluding transactions resulting from investments from owners and distributions to owners. The Company does not have any comprehensive income (loss) for the periods presented.

 

s)Reclassification of prior year presentation

 

Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations.

 

3 LIQUIDITY MATTERS AND GOING CONCERN

 

The Company’s financial statements are prepared using U.S. GAAP applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has incurred net losses since its inception and anticipates net losses and negative operating cash flows for the near future. For and as of the three months ended March 31, 2024, the Company had a net loss of $331,465 In connection with preparing the unaudited condensed consolidated financial statements for the three months ended March 31, 2024, management evaluated the risks described in Note 2(f) above on the Company’s business and its future liquidity for the next twelve months from the date of issuance of these financial statements.

 

The accompanying financial statements for the period ended March 31, 2024 have been prepared assuming the Company will continue as a going concern, but the ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it establishes a revenue stream and becomes profitable. Management’s plans to continue as a going concern include raising additional capital through sales of equity securities and borrowing. However, management cannot provide any assurances that the Company will be successful in accomplishing any of its plans. If the Company is not able to obtain the necessary additional financing on a timely basis, the Company will be required to delay, and reduce the scope of the Company’s development and operations. Continuing as a going concern is dependent upon its ability to successfully secure other sources of financing and attain profitable operations. The accompanying unaudited condensed consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

 

The Company has determined that there is substantial doubt about their ability to continue as a going concern.

 

4 DISCONTINUED OPERATIONS

 

In the prior year, effective May 12, 2023, the Company disposed of its investment in Beyond Fintech.

 

The statement of operations from discontinued operations is as follows:

 

   Three months ended 
   March 31 
   2023 
     
Net Revenue  $
-
 
Cost of Goods Sold   
-
 
Gross loss   
-
 
      
General and administrative   15,260 
Depreciation and amortization   
-
 
Total Expense   15,260 
      
Loss from operations before income taxes   (15,260)
Income Taxes   
-
 
Loss from discontinued operations, net of taxation  $(15,260)

 

12

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

5 LOANS RECEIVABLE

 

On February 22, 2024, the Company (utilizing a portion of the proceeds from the issuance of convertible notes) loaned funds to Business Warrior Corporation (“BZWR”) in the principal amount of $226,190, which includes an original issue discount equal to $67,857, for net proceeds of $158,333. The loan is memorialized by a secured promissory note (the “BZWR Note”). The BZWR Note does not accrued interest, except in the case of an event of default, which case interest accrues at 15% per annum. The BZWR Note matures on the earlier to occur of December 31, 2025 and the date that BZWR’s securities are listed on a national securities exchange. The BZWR Note may be prepaid at any time for an amount equal to 110% of the then principal and accrued interest. IPSI shall have the right to exchange the BZWR Note for securities issued by BZWR in any subsequent private placement by BZWR. The principal and accrued interest under BZWR Note is convertible into common stock of BZWR at a price equal to $0.0036 per share, subject to certain adjustments and potential resets. BZWR’s obligations under the BZWR Note are guaranteed by BZWR’s subsidiaries and secured by a lien on BZWR’s accounts receivable.

 

The debt discount on the BZWR note is amortized as income utilizing the effective interest rate method.

 

Loans receivable consists of the following:

 

Description  Interest
Rate
   Maturity
date
  Principal   Unamortized discount  

March 31,

2024 Amount, net

 
Business Warrior Corporation   0%  December 31, 2025   226,190    (64,575)   161,615 

 

Discount amortized to income as deemed interest during the three months ended March 31, 2024 was $3,282.

 

6 INTANGIBLES

 

On August 26, 2021, the Company formed Beyond Fintech to acquire a product known as Beyond Wallet from a third party for gross proceeds of $250,000, together with the logo, use of name and implementation of the product into the Company’s technology. The Company owned 51% of Beyond Fintech with the other 49% owned by Frictionless. Prior to the disposal of Beyond Fintech to Frictionless the Company spent an additional 77,211 on the software to further enhance the Beyond Wallet product offering.  On May 12, 2023, Beyond Fintech was sold to Frictionless.

 

During the year ended December 31, 2021, the Company paid gross proceeds of $375,000 to Frictionless for the development of the IPSIPay wallet, prior to the novation of the rights and obligation to a third party, the company spent an additional $1,171,805 to facilitate the functioning of the IPSIPay software in the cloud environment. On September 5, 2023, the Company novated all its rights and obligations to its IPSIPay wallet to a third party.

 

Amortization expense was $0 and $125,856 for the three months ended March 31, 2024 and 2023, respectively.

 

7 EQUITY METHOD INVESTMENT

 

On April 28, 2023, the Company formed IPSIPay Express with OpenPath and EFinityPay. As described in note 1(b), the Company has agreed to make the IPSI Capital Contributions to IPSIPay Express. As of March 31, 2024, the initial Tranche of $500,000 and the second Tranche of $500,000 of capital contributions was paid by the Company to or on behalf of IPSIPay Express.

 

The Company accounts for its investment in IPSIPay Express in accordance with ASC 323, Investments – Equity Method and Joint Ventures, the movement in equity method investments related to IPSIPay Express for the period ended March 31, 2024 and December 31, 2023 is as follows:

 

  

March 31,
2024

   December 31,
2023
 
Cash contribution to IPSIPay Express  $999,500   $999,000 
Fair value of warrants issued to third party joint venture partners   108,220    108,220 
    1,107,720    1,107,220 
Prior period equity loss from joint venture   (403,282)   (403,282)
Current period equity income (loss) from joint venture   (484)   
-
 
   $703,954   $703,938 

    

13

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

8 LEASES

 

On March 22, 2021, the Company entered into a real property lease for an office located at 56B 5th Street, Lot 1, #AT, Carmel By The Sea, California. The lease commenced on April 1, 2021 and is for a twelve month period, terminating on April 1, 2022. Following the expiry of the lease term, the landlord has agreed to continue the lease on a month-to-month basis at $4,800 per month. On January 1, 2023, the Company entered into a new month-to-month lease, with a 90 day termination clause, for a monthly rental of $5,088. The lease was terminated effective August 31, 2023.

 

The Company applied the practical expedient whereby operating leases with a duration of twelve months or less are expensed as incurred.

 

Total Lease Cost

 

Individual components of the total lease cost incurred by the Company is as follows:

 

   Three
months
ended
March 31,
2024
   Three
months
ended
March 31,
2023
 
Operating lease expense  $          -   $15,264 

 

Other lease information:

 

   Three
months
ended
March 31,
2024
   Three
months
ended
March 31,
2023
 
Cash paid for amounts included in the measurement of lease liabilities        
Operating cash flows from operating leases  $
     -
   $(15,264)
           
Remaining lease term – operating lease   -    Monthly 

 

9 FEDERAL RELIEF LOANS

 

Small Business Administration Disaster Relief loan

 

On July 7, 2020, the Company received a Small Business Economic Injury Disaster loan amounting to $150,000, bearing interest at 3.75% per annum and repayable in monthly installments of $731 commencing twelve months after inception with the balance of interest and principal repayable on July 7, 2050. The loan is secured by all tangible and intangible assets of the Company. The proceeds are to be used for working capital purposes to alleviate economic injury caused by the COVID-19 pandemic.

 

The company has accrued interest of $9,309 and $9,369 on this loan as of March 31, 2024 and December 31, 2023, respectively.

 

14

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

10 NOTES PAYABLE

 

On February 16, 2021, the Company entered into separate Securities Purchase Agreements (the “SPAs”), with each of Cavalry Fund I LP (“Cavalry”) and Mercer Street Global Opportunity Fund, LLC (“Mercer”), pursuant to which the Company received $500,500 and $500,500 from Cavalry and Mercer, respectively, in exchange for the issuance of: (i) Original Issue Discount 12.5% Convertible Notes (the “Notes” and each a “Note”) in the principal amount of $572,000 to each of Cavalry and Mercer; and (ii) five-year warrants (the “Original Warrants”) issued to each of Cavalry and Mercer to purchase 2,486,957 shares of Common Stock at an exercise price of $0.24 per share.

 

In terms of the December 30, 2022 Note Amendment Transaction, described in more detail in Note 9 below, the Original Warrants issued on February 16, 2021 were irrevocably exchanged for 12-month non-convertible promissory notes in the amount of $482,000 (the “Exchange Notes”) to each of Cavalry and Mercer. This exchange caused the cancellation of the Original Warrants for all purposes. The Company accounted for the aggregate value of the notes issued of $964,000, less the fair value of the warrants exchanged for these notes of $43,608, totaling $920,392 as a component of the loss on convertible debt.

 

The Exchange Notes have a maturity date of December 30, 2023 and carry an interest rate of ten percent (10%). The Company shall have the right, but not the obligation, in lieu of a cash payment upon maturity of the Exchange Notes, to issue 51,901,711 shares of Common Stock, as adjusted for any stock splits, dividends or other similar corporate events, in full satisfaction of its obligations under each of the Exchange Notes (or any pro rata portion of such number of shares in partial satisfaction of such obligations). The Company is under no legal obligation to reserve such number of shares for future issuance.

 

On February 27, 2024, the maturity date of the notes was extended to April 30, 2024 with an automatic one month extension each month until such time as the note is declared to be in default, all other terms remain the same as the previous notes. The Company performed an analysis in terms of ASC 470 and it was determined that the extension was a debt modification, in addition, no additional consideration was paid for the maturity date extension.

 

Notes payable consists of the following: 

 

Description  Interest
Rate
   Maturity
date
  Principal   Accrued
Interest
   March 31, 2024 Amount, net  

December 31,
2023
Amount, net

 
Cavalry Fund I LP   10%  April 30, 2024   482,000    61,187    543,187    531,004 
Mercer Street Global Opportunity Fund, LLC   10%  April 30, 2024   482,000    61,187    543,187    531,003 
Total convertible notes payable          $964,000   $122,374   $1,086,374   $1,062,007 

    

Interest expense totaled $24,368 and $24,100 for the three months ended March 31, 2024 and 2023, respectively.

 

15

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

11 CONVERTIBLE NOTES PAYABLE

 

December 2022 Note Amendment Transaction

 

The Company twice extended its indebtedness to each Cavalry and Mercer. On February 3, 2022, the Company agreed to extend the maturity date of the Cavalry/Mercer Notes to August 16, 2022. Additionally, on August 30, 2022, the Company entered agreements for an additional maturity date extension to November 16, 2022. In consideration for the second extension, the Company agreed to (i) increase the principal amount outstanding and due to Cavalry and Mercer under the Cavalry/Mercer Notes by twenty percent (20%) and (ii) issue to each of Cavalry and Mercer a new five-year warrant (each, an “Extension Warrant”) to purchase an additional 100,000 shares of Common Stock at an exercise price of $4.50 per share. The Extension Warrant contains the same terms and provisions in all material respects as the Original Warrants, except for difference in exercise price.

 

On December 30, 2022, the Company again extended the maturity dates of each of the Cavalry/Mercer Notes to December 30, 2023. Each of Cavalry and Mercer entered into Note Amendment Letter Agreement with the Company (the “Note Amendment”) pursuant to which the parties agreed to the following:

 

(1)The conversion price of the Cavalry/Mercer Notes was reduced from $4.50 to $0.345 per share (such reduced conversion price being the current conversion price of the Notes give the passage of the November 16, 2022 maturity date of the Cavalry/Mercer Notes). As a result of this change in conversion price, under the existing terms of the Cavalry/Mercer Notes, the 100,000 shares of Common Stock underlying the Extension Warrants was increased to 1,304,348 shares;

 

(2)The Original Warrants issued on February 16, 2021 were irrevocably exchanged for 12-month non-convertible promissory notes in the amount of $482,000 (the “Exchange Notes”). This exchange caused the cancellation of the Original Warrants for all purposes. The Exchange Notes have a maturity date of December 30, 2023 and carry an interest rate of ten percent (10%). The Company shall have the right, but not the obligation, in lieu of a cash payment upon maturity of the Exchange Notes, to issue 1,730,057 shares of Common Stock, as adjusted for any stock splits, dividends or other similar corporate events, in full satisfaction of its obligations under each of the Exchange Notes (or any pro rata portion of such number of shares in partial satisfaction of such obligations). The Company is under no legal obligation to reserve such number of shares for future issuance;

 

(3)Each of Cavalry and Mercer agreed (i) not to convert all or any portion of the Cavalry/Mercer Notes until after March 30, 2023 and (ii) waive any events of default under the Cavalry/Mercer Notes and the Cavalry/Mercer SPAs;

 

(4)Certain other warrants held by Cavalry and Mercer which contain a mandatory exercise provision allowing us to force exercise of such warrants if the price of the Common Stock is $1.80 per share or above were amended effective December 30, 2022 to reduce such forced exercise price to $1.20 per share; and

 

(5)The Company was obligated to register the shares of Common Stock underlying the Cavalry/Mercer Notes and the shares underlying all warrants held by Cavalry and Mercer for resale with the Securities and Exchange Commission and the Company filed the registration statement to satisfy such registration obligation.

 

The parties also acknowledged that the principal and accrued interest under the Cavalry/Mercer Notes as of December 28, 2022 is equal to an aggregate of $2,264,784, or $1,132,392 for each of Cavalry and Mercer. In addition, as a result of the reduction in the conversion price of the Cavalry/Mercer Notes, certain other warrants held by third parties have their exercise price of such warrants reduced to $0.345 per share. All of the shares of our Common Stock underlying the Cavalry/Mercer Notes as amended and all warrants held by Cavalry and Mercer as adjusted were registered for resale pursuant to a registration statement that was declared effective on February 6, 2023.

 

The amendments to the Cavalry/Mercer Notes were evaluated in terms of ASC 470, Debt, to determine if the amendments to the Cavalry/Mercer Notes were considered a modification of the debt or an extinguishment of the debt. Based on the penalty interest incurred on the convertible notes of $836,414, the reduction in the conversion price of the Cavalry/Mercer Notes from $4.50 to $0.345 per share, which was valued at $1,499,577 using a Black-Scholes valuation model, the issuance of additional warrants to the Cavalry and Mercer valued at $238,182 using a Black-Scholes valuation model and the conversion of certain warrants held by Cavalry and Mercer to notes payable, resulting in an additional charge of $920,392, consisting of a mark-to-market warrant cost of $43,608 and the value of the notes of $964,000 (see note 11 above) and the value of full rachet provisions of certain of the warrants issued to the Cavalry and Mercer amounting to $841,003 (see note 14 below), the amendment of the Cavalry/Mercer Notes was determined to be a debt extinguishment.

 

Effective December 30, 2023, on February 27, 2024, the Company again extended the maturity dates of each of the Cavalry/Mercer Notes to April 30, 2024, with an automatic one month extension each month until such time as the note is declared to be in default, other than the maturity date all other terms remained the same. The Company performed an analysis in terms of ASC 470 and it was determined that the extension was a debt modification, in addition, no additional consideration was paid for the maturity date extension.

 

16

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

11 CONVERTIBLE NOTES PAYABLE (continued)

 

December 2022 Note Amendment Transaction (continued)

 

Convertible notes payable consists of the following:

 

Description  Interest
Rate
   Maturity
date
  Principal   Accrued
Interest
   Unamortized
debt discount
   March 31,
2024
Amount, net
   December 31,
2023
Amount, net
 
Cavalry Fund I LP   10.00 %  April 30, 2024  $898,980   $32,963   $
-
   $931,943   $909,218 
Mercer Street Global  Opportunity Fund, LLC   10.00 %  April 30, 2024   991,754    173,079    
-
    1,164,833    1,139,764 
Red Road Holdings Corporation*   
29.32
%  June 15, 2024   52,691    722    (14,457)   38,956    41,771 
    27.77 %  July 30, 2024   43,385    880    (18,419)   25,846    18,683 
    32.04 %  September 30, 2024   51,148    1,209    (32,843)   19,514    3,109 
Quick Capital, LLC*   11.12 %  September 30, 2024   114,286    2,348    (52,602)   64,032    
-
 
2023 and 2024 convertible notes    8.00 to 12.00 %  May 22, 2024 to February 21, 2025   2,335,001    127,735    (314,381)   2,148,355    1,591,735 
Total convertible notes payable           $4,487,245   $338,936   $(432,702)  $4,393,479   $3,704,280 

  

*The Red Road Holdings Corporation and Quick Capital LLC, interest rates are an effective interest rate as these convertible notes have a fixed interest charge which is earned on the issuance date, regardless of when payments are made.

 

Interest expense totaled $110,769 and $59,737 for the three months ended March 31, 2024 and 2023, respectively.

 

Amortization of debt discount totaled $319,899 and $22,967 for the three months ended March 31, 2024 and 2023, respectively.

 

The Cavalry, Mercer and Red Road Holdings convertible notes have variable conversion prices based on a discount to market price of trading activity over a specified period of time. The variable conversion features were valued using a Black Scholes valuation model. The difference between the fair market value of the Common Stock and the calculated conversion price on the issuance date was recorded as a debt discount with a corresponding credit to derivative financial liability.

 

17

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

11 CONVERTIBLE NOTES PAYABLE (continued)

 

Cavalry Fund LP

 

On February 16, 2021, the Company closed a transaction with Cavalry pursuant to which the Company received net proceeds of $500,500, after an original issue discount of $71,500 in exchange for the issuance of a $572,000 Senior Secured Convertible Note, bearing interest at 10% per annum and maturing on February 16, 2022. The Note was convertible into shares of Common Stock at an initial conversion price of $0.23 per share, in addition, the Company issued a warrant exercisable for 82,899 shares of Common Stock at an initial exercise price of $7.20 per share.

 

As described more fully above, the maturity date of the note was extended to August 16, 2022, additionally to November 16, 2022 and again to December 30, 2023. In consideration for the November 16, 2022 extension, the Company agreed to (i) increase the principal amount outstanding and due to Cavalry by twenty percent (20%) and (ii) issue a new five-year warrant to purchase an additional 100,000 shares of Common Stock at an exercise price of $4.50 per share. In consideration of the December 30, 2022 extension, the Company agreed to the following terms; (i) the conversion price of the Note was reduced from $4.50 to $0.345 per share; (ii) Cavalry agreed (a) not to convert all or any portion of the Notes until after March 30, 2023 and (b) waive any events of default under the Note and the SPA; (iii) the Company agreed to and registered the shares of Common Stock underlying the Note and the shares underlying all warrants held by Cavalry for resale with the Securities and Exchange Commission and filed the registration statement to satisfy the Company’s registration obligation.  

 

Between August 24, 2023 and November 20, 2023, Cavalry converted $139,726 of interest and $192,774 of interest into 963,769 shares of Common Stock at a conversion price of $0.345 per share realizing a loss on conversion of $42,210.

 

On February 27, 2024, the maturity date of the notes was extended to April 30, 2024, , with an automatic one month extension each month until such time as the note is declared to be in default, all other terms remain the same as the previous notes. Based on an analysis performed in terms of ASC470, the amendment to the agreement was determined to be a debt modification, there were no expenses incurred on the amendment and interest will be accrued at the effective interest rate.

 

The balance of the Cavalry Note plus accrued interest at March 31, 2024 was $931,943.

 

Mercer Street Global Opportunity Fund, LLC

 

On February 16, 2021, the Company closed a transaction with Mercer, pursuant to which the Company received net proceeds of $500,500, after an original issue discount of $71,500 in exchange for the issuance of a $572,000 Senior Secured Convertible Note, bearing interest at 10% per annum and maturing on February 16, 2022. The Note is convertible into shares of Common Stock at an initial conversion price of $6.90 per share, in addition, the Company issued a warrant exercisable for 82,899 shares of Common Stock at an initial exercise price of $7.20 per share.

 

As described more fully above, the maturity date of the note was extended to August 16, 2022, additionally to November 16, 2022 and again to December 30, 2023. In consideration for the November 16, 2022 extension, the Company agreed to (i) increase the principal amount outstanding and due to Mercer by twenty percent (20%) and (ii) issue a new five-year warrant to purchase an additional 100,000 shares of Common Stock at an exercise price of $4.50 per share. In consideration of the December 30, 2022 extension, the Company agreed to the following terms; (i) the conversion price of the Note was reduced from $4.50 to $0.345 per share; (ii) Mercer agreed (a) not to convert all or any portion of the Notes until after March 30, 2023 and (b) waive any events of default under the Note and the SPA; (iii) the Company agreed to and registered the shares of Common Stock underlying the Note and the shares underlying all warrants held by Mercer for resale with the Securities and Exchange Commission and filed the registration statement to satisfy the Company’s registration obligation.

 

Between May 19, 2023 and August 30, 2023, Mercer converted an aggregate of $100,000 into 289,856 shares of Common Stock at a conversion price of $0.345 per share, realizing a loss on conversion of $48,551.

 

On February 27, 2024, Cavalry entered into a note amendment with the company extending the maturity date of the convertible note to April 30, 2024. with an automatic one month extension each month until such time as the note is declared to be in default, all other terms remain the same as the previous notes. Based on an analysis performed in terms of ASC 470, the amendment to the agreement was determined to be a debt modification, there were no expenses incurred on the amendment and interest will be accrued at the effective interest rate.

 

The balance of the Mercer Note plus accrued interest at March 31, 2024 was $1,164,833.

 

18

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

11 CONVERTIBLE NOTES PAYABLE (continued)

 

Red Road Holdings Corporation

 

 

On September 9, 2023, the Company closed a transaction with Red Road Holdings Corporation (“RRH”) pursuant to which the Company received net proceeds of $125,000, after an original issue discount and fees of $21,900 in exchange for the issuance of a $146,900 Convertible Note (“RRH Note 1”), bearing interest at 13%, which interest is earned on issuance of the note, an effective interest rate of 29.3%, and maturing on June 15, 2024. The RRH Note 1 has mandatory monthly repayments of $18,444 which commenced on October 14, 2023. The RRH Note 1 is convertible into shares of Common Stock at a variable conversion rate of 60% of the lowest trading price twenty trading days before conversion.

 

The balance of the RRH Note 1 plus accrued interest at March 31, 2024 was $38,956, net of unamortized debt discount of $14,457.

     
 

On October 19, 2023, the Company closed a transaction with RRH pursuant to which the Company received net proceeds of $60,000, after an original issue discount and fees of $13,450 in exchange for the issuance of a $73,450 Convertible Note (“RRH Note 2”), bearing interest at 13%, which interest is earned on issuance of the note, an effective interest rate of 27.8%, and maturing on July 30, 2024. The RRH Note 2 has mandatory monthly repayments of $9,222 which commenced on November 30, 2023. The RRH Note 2 is convertible into shares of Common Stock at a variable conversion rate of 60% of the lowest trading price twenty trading days before conversion.

 

The balance of the RRH Note 2 plus accrued interest at March 31, 2024 was $25,846, net of unamortized debt discount of $18,419.

     
 

On December 20, 2023, the Company closed a transaction with RRH pursuant to which the Company received net proceeds of $50,000, after an original issue discount and fees of $13,250 in exchange for the issuance of a $63,250 Convertible Note (“RRH Note 3”), bearing interest at 15%, which interest is earned on issuance of the note, an effective interest rate of 32.0%, and maturing on September 30, 2024. The RRH Note 3 has mandatory monthly repayments of $8,082. The RRH Note 3 is convertible into shares of Common Stock at a variable conversion rate of 60% of the lowest trading price twenty trading days before conversion.

 

The balance of the RRH Note 3 plus accrued interest at March 31, 2024 was $19,514, net of unamortized debt discount of $32,842.

 

Quick Capital, LLC

 

On March 4, 2024, the Company closed a transaction with Quick Capital, LLC pursuant to which the Company received net proceeds of $94,000, after an original issue discount and fees of $20,286 in exchange for the issuance of a $114,286 Convertible Note, bearing interest at an effective interest rate of 11.12% per annum, which interest is earned on issuance of the note, and maturing on September 4, 2024. The Note is convertible into shares of Common Stock at an initial conversion price of $0.345 per share, in addition, the Company issued a warrant exercisable for 357,764 shares of Common Stock at an initial exercise price of $0.345 per share.

 

The balance of the Quick Capital note plus accrued interest at March 31, 2024 was $64,032, net of unamortized debt discount of $52,602.

 

2023 and 2024 Convertible Notes

 

Between February 13, 2023 and November 27, 2023, the Company entered into Securities Purchase Agreements with 30 accredited investors (the “2023 Notes”), and between February 6, 2024 and February 21, 2024 (the “2024 Notes”), the Company entered into Securities Purchase Agreements with 4 accredited investors, pursuant to which the Company received an aggregate of $2,026,666 from the 2023 Notes and $308,335 from the 2024 Notes,  in gross proceeds in private placements through the issuance of:

 

  Convertible Promissory Notes (the “2023 Notes and 2024 Notes”); and

 

  five-year warrants to purchase an aggregate 5,696,586 shares of Common Stock (the “2023 Warrants”), at an exercise price of $0.345 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events).

 

19

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

11 CONVERTIBLE NOTES PAYABLE (continued)

 

2023 and 2024 Convertible Notes (continued)

 

The 2023 Notes and the 2024 Notes mature between 3.5 months and 12 months, bear interest at rates between 8% and 12% per annum, and are convertible into shares of Common Stock at a conversion price of $0.345 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events). The 2023 Notes and 2024 Notes may be prepaid at any time without penalty. The Company is under no obligation to register the shares of Common Stock underlying the 2023 Notes and the 2024 Notes or the 2023 Warrants for public resale.

 

The 2023 Notes, the 2024 Notes and the 2023 Warrants contain conversion limitations providing that a holder thereof may not convert the 2023 Notes or exercise the 2023 Warrants to the extent that, if after giving effect to such conversion, the holder or any of its affiliates would beneficially own in excess of 4.99% (the “Maximum Percentage”) of the outstanding shares of the Common Stock immediately after giving effect to such conversion or exercise. A holder may increase or decrease its beneficial ownership limitation upon notice to the Company provided that in no event such limitation exceeds 9.99%, and that any increase shall not be effective until the 61st day after such notice.

 

On December 14, 2023, two notes totaling $225,000 which matured on December 31, 2023 were rolled over for an additional 3 months to March 30, 2024. In exchange for the roll-over, the Company issued the note holders warrants exercisable for 292,463 shares of Common Stock at an exercise price of $0.345 per share. On May 4, 2024, the maturity date of the $200,000 note was further extended to June 14, 2024, and the maturity date of the $25,000 note was further extended to June 30, 2024. In exchange for the maturity date extension, the Company issued to note holders warrants exercisable for 292,463 shares of Common Stock at an exercise price of $0.345 per share.

 

On March 14, 2024, the Company extended the maturity date of 11 convertible notes maturing between February 13, 2024 and February 23, 2024 by an additional six months and as compensation for the extension, the note holders were issued warrants exercisable for 387,673 shares of Common Stock at an exercise price of $0.345 per share. The modification was assessed in terms of ASC 470 and determined to be a debt extinguishment, resulting in the warrant value of $66,047 being expensed as a loss on convertible notes.

 

The balance of the 2023 Notes and the 2024 Notes plus accrued interest at March 31, 2024 was $2,148,355, net of unamortized debt discount of $314,381.

 

12 DERIVATIVE LIABILITY

 

The convertible notes and warrants issued by the Company to Cavalry, Mercer and RRH as described herein have variable priced conversion rights with no fixed floor price and will re-price dependent on the share price performance over varying periods of time and certain notes and warrants have fundamental transaction clauses which might result in cash settlement, due to these factors, all convertible notes and any warrants attached thereto are valued and give rise to a derivative financial liability, which was initially valued at inception of the convertible notes using a Black-Scholes valuation model.

 

Between September 12, 2023 and December 20, 2023, the Company entered into a convertible note agreement with RRH which have variable priced conversion rights with no fixed floor price and will re-price dependent on the share price performance over varying periods of time, which gave rise to a derivative financial liability, which was initially valued at inception of the convertible notes at $416,317 but limited to the cash value of the convertible notes of $235,000, using a Black-Scholes valuation model.

 

The net movement on the derivative liability for the three months ended March 31, 2024 was a net mark-to-market credit of $815,941 determined by using a Black-Scholes valuation model.

 

The following assumptions were used in the Black-Scholes valuation model:

 

   Three months
ended
March 31,
2024
   Year ended
December 31,
2023
 
Conversion price   0.0684 to $0.345     $ 0.104 to $0.345  
Risk free interest rate   4.40 to 5.49 %    3.60 to 5.55 %
Expected life of derivative liability   1 to 41 months      3.5 to 47 months  
Expected volatility of underlying stock   157.83 to 201.11 %     158.72 to 217.01 %
Expected dividend rate   0%   0%

 

20

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

12 DERIVATIVE LIABILITY (continued)

 

The movement in derivative liability is as follows:

 

   March 31,
2024
   December 31,
2023
 
Opening balance  $1,434,196   $2,550,642 
Derivative financial liability arising from convertible note and warrants   
-
    385,000 
Fair value adjustment to derivative liability   (815,941)   (1,501,446)
   $618,255   $1,434,196 

 

13 STOCKHOLDERS’ EQUITY

 

  a. Common Stock

 

The Company has total authorized Common Stock of 750,000,000 shares with a par value of $0.0001 each. The Company had 13,819,889 shares of Common Stock issued and outstanding as of March 31, 2024 and December 31, 2023.

 

On May 19, 2023, in terms of a conversion notice received from a convertible note holder, the Company issued 72,464 shares of Common Stock for the conversion of $25,000 of convertible debt, refer Note 11 above.

 

On August 16, 2023, in terms of a conversion notice received from a convertible note holder, the Company issued 72,464 shares of Common Stock for the conversion of $25,000 of convertible debt, refer Note 11 above.

 

On August 24, 2023, in terms of a conversion notice received from a convertible note holder, the Company issued 173,914 shares of Common Stock for the conversion of $60,000 of interest on convertible debt, refer Note 11 above.

 

On August 30, 2023, the Company effectuated a 1 for 30 reverse stock split, resulting in the issuance of an additional 2,838 shares to existing stockholders due to rounding of existing shareholdings. All share amounts disclosed in the unaudited condensed consolidated financial statements have been adjusted to reflect the Company’s 1 for 30 reverse stock split effectuated on August 30, 2023.

 

On August 31, 2023, in terms of a conversion notice received from a convertible note holder, the Company issued 144,928 shares of Common Stock for the conversion of $50,000 of convertible debt, refer note 11 above.

 

On November 8, 2023, in terms of a conversion notice received from a convertible note holder, the Company issued 289,855 shares of Common Stock for the conversion of $100,000 of convertible debt, refer note 11 above.

 

On November 20, 2023, in terms of a conversion notice received from a convertible note holder, the Company issued 500,000 shares of Common Stock for the conversion of $172,500 of convertible debt, refer note 11 above.

 

  b. Restricted stock awards

 

A summary of restricted stock activity during the period January 1, 2023 to March 31, 2024 is as follows:

 

   Total
restricted
shares*
   Weighted
average
fair market
value per
share*
   Total
unvested
restricted
shares*
   Weighted
average
fair market
value per
share*
   Total vested
restricted
shares*
   Weighted
average
fair market
value per share*
 
Outstanding January 1, 2023   783,167   $1.50    170,792   $1.47    612,375   $1.50 
Granted and issued   
-
    
-
    
-
    
-
    
-
    
-
 
Forfeited/Cancelled   
-
    
-
    
-
    
-
    
-
    
-
 
Vested   
-
    
-
    (170,792)   (1.47)   170,792    1.47 
Outstanding December 31, 2023   783,167   $1.50    
-
   $
-
    783,167   $1.50 
Granted and issued   
-
    
-
    
-
    
-
    
-
    
-
 
Forfeited/Cancelled   
-
    
-
    
-
    
-
    
-
    
-
 
Vested   
-
    
-
    
-
    
-
    
-
    
-
 
Outstanding March 31, 2024   783,167   $1.50    
-
   $
-
    783,167   $1.50 

 

*After giving effect to a 1 for 30 reverse stock split on August 30, 2023.

 

21

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

13 STOCKHOLDERS’ EQUITY (continued)

  

  b. Restricted stock awards (continued)

 

The restricted stock granted, issued and exercisable at March 31, 2024 is as follows:

 

    Restricted Stock
Granted and
Vested
 
Grant date Price   Number Granted*   Weighted Average Fair Value per Share* 
$1.47    683,167   $1.47 
$1.50    33,333    1.50 
$1.65    66,667    1.65 
      783,167   $1.50 

 

*After giving effect to a 1 for 30 reverse stock split on August 30, 2023.

 

The Company has recorded an expense of $0  for the three months ended March 31, 2024 and 2023. 

 

c.Preferred Stock

 

The Company has authorized 25,000,000 shares of preferred stock with a par value of $0.0001 authorized. No preferred stock was issued and outstanding as of March 31, 2024 and December 31, 2023.

 

  d. Warrants

 

Between February 13, 2023 and November 27, 2023, the Company entered into Securities Purchase Agreements with 30 accredited investors, as disclosed in note 11 above. In terms of these Securities Purchase Agreements, the Company issued five-year warrants to purchase an aggregate 5,696,586 shares of the Common Stock at an exercise price of $0.345 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events). The Company is under no obligation to register the shares of Common Stock underlying the 2023 Notes or the 2023 Warrants for public resale.

 

On August 11, 2023, the company issued an investor a five-year replacement warrant for a warrant that had expired on February 13, 2023 exercisable for 33,334 shares of Common Stock at an exercise price of $1.50 per share.

 

In connection with the formation of IPSIPay Express, the Company issued to each of the other venture partners, OpenPath and EfinityPay, IPEX Warrants to purchase an aggregate of 133,334 shares of Common Stock with an exercise of $0.45 per share. The Company is obligated to issue each of OpenPath and EfinityPay additional IPEX Warrants to purchase 199,999 shares of Common Stock at a price equal to the average public closing price of the Common Stock for the three trading days immediately prior to the funding of the remaining initial Tranche. Simultaneously with the funding of the second Tranche in September 2023, the Company became obligated to issue to each of OpenPath and EfinityPay an additional IPEX Warrant to purchase 166,667 shares of Common Stock with an exercise price equal to the average public closing price of the Common Stock for the three trading days immediately prior to the funding of the second Tranche. Simultaneously with the funding of the third Tranche, the Company will issue to each of OpenPath and EfinityPay an additional IPEX warrant to purchase 166,667 shares of Common Stock with an exercise price equal to the average public closing price of the Common Stock for the three trading days immediately prior to the funding of the third Tranche. If the full IPSI Capital Contribution is funded, OpenPath and EfinityPay will receive IPEX Warrants to purchase an aggregate of 1,333,334 shares of Common Stock. See note 1(b) above.

 

On December 14, 2023, the maturity date of two notes totaling $225,000 which matured on December 31, 2023 were extended for an additional 3 months to March 30, 2024. In exchange for the maturity date extension, the Company issued the note holders five-year warrants exercisable for 292,463 shares of Common Stock at an exercise price of $0.345 per share. On May 4, 2024, the maturity date of the $200,000 note was further extended to June 14, 2024, and the maturity date of the $25,000 note was further extended to June 30, 2024. In exchange for the maturity date extension, the Company issued to note holders warrants exercisable for 292,463 shares of Common Stock at an exercise price of $0.345 per share.

  

During 2023, warrants exercisable for 33,334 shares expired as unexercised and an additional warrant exercisable for 1,000,000 shares of Common Stock was forfeited on the disposal of Frictionless and Beyond Fintech.

 

22

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

13STOCKHOLDERS’ EQUITY (continued)

 

  d. Warrants (continued)

 

On March 4, 2024, the Company entered into a Securities Purchase Agreement with an accredited investor, as disclosed in note 11 above. In terms of the Securities Purchase Agreement, the Company issued a five-year warrant to purchase an aggregate of 357,764 shares of the Common Stock at an exercise price of $0.345 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events). The Company is under no obligation to register the shares of Common Stock underlying the Note or the Warrant, for public resale.

 

On March 14, 2024, the Company extended the maturity date of 11 convertible notes maturing between February 13, 2024 and February 23, 2024 by an additional six months and as compensation for the extension, the note holders were issued warrants exercisable for 387,673 shares of Common Stock at an exercise price of $0.345 per share.

 

The 2023 and 2024 Warrants contain conversion limitations providing that a holder thereof may not exercise the Warrants to the extent that, if after giving effect to such exercise, the holder or any of its affiliates would beneficially own in excess of 4.99% (the “Maximum Percentage”) of the outstanding shares of the Common Stock immediately after giving effect to such exercise. A holder may increase or decrease its beneficial ownership limitation upon notice to the Company provided that in no event such limitation exceeds 9.99%, and that any increase shall not be effective until the 61st day after such notice.

  

The fair value of the warrants granted and issued, as described above, were determined by using a Black Scholes valuation model using the following assumptions:

 

   Three months ended
March 31,
2024
 
Exercise price  $0.345 
Risk free interest rate   4.15 to 4.21%
Expected life    5 years 
Expected volatility of underlying stock    190.72 to 191.17%
Expected dividend rate   0%

 

A summary of warrant activity during the period January 1, 2023 to March 31, 2024 is as follows:

 

   Shares
Underlying
Warrants*
   Exercise
price per
share*
   Weighted
average
exercise
price*
 
Outstanding January 1, 2023   5,186,376   $0.345 – 5.625   $0.9000 
Granted   6,289,051     0.345 – 1.50    0.3556 
Forfeited   (33,334)   1.50    1.5000 
Cancelled on disposal of investment in Frictionless and Beyond Fintech   (1,000,000)   0.345    0.3450 
Exercised   
-
    
-
    
-
 
Outstanding December 31, 2023   10,442,093   $0.345 – 5.625   $0.6265 
Granted   745,437    0.345    0.345 
Forfeited   
-
    
-
    
-
 
Cancelled on disposal of investment in Frictionless and Beyond Fintech   
-
    
-
    
-
 
Exercised   -    
-
    
-
 
Outstanding March 31, 2024   11,187,530   $0.345 – 5.625   $0.6077 

 

*After giving effect to a 1 for 30 reverse stock split on August 30, 2023.

 

23

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

13STOCKHOLDERS’ EQUITY (continued)

 

d.Warrants (continued)

 

The warrants outstanding and exercisable at March 31, 2024 are as follows:

 

    Warrants Outstanding*   Warrants Exercisable* 
Exercise Price*   Number
Outstanding*
   Weighted
Average
Remaining
Contractual
life in years
   Weighted
Average
Exercise
Price*
   Number
Exercisable*
   Weighted
Average
Exercise
Price*
   Weighted
Average
Remaining
Contractual
life in years
 
$0.345    9,801,079    3.99         9,801,079         3.99 
$0.450    266,668    4.23         266,668         4.23 
$1.035    500,000    1.27         468,750         1.27 
$1.500    33,334    4.37         33,334         4.37 
$4.50    505,560    1.96         505,560         1.96 
$5.625    80,889    1.96         80,889         1.96 
      11,187,530    3.77   $0.6077    11,156,280   $0.6065    3.78 

 

*After giving effect to a 1 for 30 reverse stock split on August 30, 2023.

 

The warrants outstanding have an intrinsic value of $0 as of March 31, 2024 and 2023.

 

e.Stock options

 

On June 18, 2018, the Company established its 2018 Stock Incentive Plan (the “Plan”). The purpose of the Plan is to promote the interests of the Company and the stockholders of the Company by providing directors, officers, employees and consultants of the Company with appropriate incentives and rewards to encourage them to enter into and continue in the employ or service of the Company, to acquire a proprietary interest in the long-term success of the Company and to reward the performance of individuals in fulfilling long-term corporate objectives. The Plan terminates after a period of ten years in June 2028.

 

The Plan is administered by the Board or a committee appointed by the Board, who have the authority to administer the Plan and to exercise all the powers and authorities specifically granted to it under the Plan.

 

The maximum number of securities available under the Plan is 26,667 shares of Common Stock. The maximum number of shares of Common Stock awarded to any individual during any fiscal year may not exceed 100,000 shares of Common Stock.

 

On October 22, 2021, the Company established its 2021 Stock Incentive Plan (“2021 Plan”). The purpose of the Plan is to promote the interests of the Company and the stockholders of the Company by providing directors, officers, employees and consultants, advisors and service providers of the Company with appropriate incentives and rewards to encourage them to enter into and continue in the employ or service of the Company, to acquire a proprietary interest in the long-term success of the Company and to reward the performance of individuals in fulfilling long-term corporate objectives. The Plan terminates after a period of ten years in August 2031.

 

The 2021 Plan is administered by the Board or a Compensation Committee appointed by the Board, who have the authority to administer the Plan and to exercise all the powers and authorities specifically granted to it under the Plan.

 

The maximum number of securities available under the 2021 Plan is 1,766,667 shares of Common Stock.

 

Under the 2021 Plan the Company may award the following: (i) non-qualified stock options; (ii)) incentive stock options; (iii) stock appreciation rights; (iv) restricted stock; (v) restricted stock unit; and (vi) other stock-based awards.

  

During 2023, the Company cancelled options exercisable for 23,891 shares of Common Stock due to the previous resignation or termination of employees and officers whose stock options were not exercised in accordance with the terms allowed under the plan and were therefore canceled.

 

24

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

13STOCKHOLDERS’ EQUITY (continued)

 

e.Stock options (continued)

 

A summary of option activity during the period January 1, 2023 to March 31, 2024 is as follows:

 

    Shares
Underlying
options*
    Exercise
price per
share*
    Weighted
average
exercise
price*
 
Outstanding January 1, 2023     1,543,891     $ 1.20 to 12.00     $ 4.47  
Granted    
-
     
-
     
-
 
Forfeited/Cancelled     (23,889 )   $
1.20 to 12.00
      5.41  
Exercised    
-
     
-
     
-
 
Outstanding December 31, 2023     1,520,002     $ 1.20 to 12.00     $ 4.46  
Granted    
-
     
-
     
-
 
Forfeited/Cancelled    
-
     
-
     
-
 
Exercised    
-
     
-
     
-
 
Outstanding March 31, 2024     1,520,002     $ 1.20 to 12.00     $ 4.46  

 

*After giving effect to a 1 for 30 reverse stock split on August 30, 2023.

 

The options outstanding and exercisable at March 31, 2024 are as follows:

 

    Options Outstanding*   Options Exercisable* 
Exercise Price*   Number
Outstanding*
   Weighted
Average
Remaining
Contractual
life in years
   Weighted
Average
Exercise
Price*
   Number
Exercisable*
   Weighted
Average
Exercise
Price*
   Weighted
Average
Remaining
Contractual
life in years
 
$1.20    20,001    5.61         20,001         5.61 
$4.50    1,500,001    7.69                      1,430,557                           7.71 
      1,520,002    7.66   $4.46    1,450,558   $4.45    7.68 

 

The options outstanding have an intrinsic value of $0 as of March 31, 2024 and 2023.

 

The option expense was $94,464 and $94,464 for the three months ended March 31, 2024 and 2023, respectively.

 

14LOSS ON CONVERTIBLE NOTES

 

The loss on convertible notes consists of the following:

 

  

Three months ended

March 31,
2024

  

Three months ended

March 31,
2023

 
Expense on extension of maturity date of convertible notes   66,047    
-
 

 

On March 14, 2024, the Company extended the maturity date of 11 convertible notes which matured between February 13, 2024 and February 23, 2024 by six months and issued the note holders additional warrants exercisable for 387,673 shares of Common Stock, the modification of the terms and the issue of the new warrants was assessed as a debt extinguishment, resulting in a charge of $66,047 for the three months ended March 31, 2024.

 

25

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

15NET LOSS PER SHARE

 

Basic loss per share is based on the weighted-average number of Common Stock outstanding during each period. Diluted loss per share is based on basic shares as determined above plus Common Stock equivalents. The computation of diluted net loss per share does not assume the issuance of Common Stock that have an anti-dilutive effect on net loss per share. For the three months ended March 31, 2024 and 2023 all warrants options and convertible debt securities were excluded from the computation of diluted net loss per share.

 

Dilutive shares which could exist pursuant to the exercise of outstanding stock instruments and which were not included in the calculation because their affect would have been anti-dilutive for the three months ended March 31, 2024 and 2023 are as follows:

 

  

Three months ended
March 31,
2024

(Shares)

   Three months ended
March 31, 
2023
(Shares)
 
Convertible debt   15,232,285    8,293,738 
Stock options   1,520,002    1,543,891 
Warrants to purchase shares of Common Stock   11,187,530    6,703,760 
    27,939,817    16,541,389 

 

16RELATED PARTY TRANSACTIONS

 

The following transactions were entered into with related parties during the quarter ended March 31, 2024:

 

William Corbett

 

An option expense for options still vesting for Mr. Corbett was $66,587 for each of the three months ended March 31, 2024 and 2023.

 

Richard Rosenblum

 

An option expense for options still vesting for Mr. Rosenblum was $27,877 for each of the three months ended March 31, 2024 and 2023.

 

17COMMITMENTS AND CONTINGENCIES

 

The Company has notes payable and convertible notes payable, disclosed under notes 10 and 11 above, which have maturity dates between March 30, 2024 and February 21,2025. The Company may settle the notes payable, at its option by the issue of common shares and should the convertible notes not be converted to Common Stock prior to their maturity dates, the Company may need to repay the principal and interest outstanding on these notes.

 

18SUBSEQUENT EVENTS

 

Convertible note funding

  

On April 1, 2024, the Company received gross proceeds of $70,000 for a Securities Purchase Agreement entered into on March 26, 2024, pursuant to which the Company issued convertible promissory notes to one accredited investment entity for a principal amount outstanding of $88,500. The Note is unsecured, matures on December 30,2024 and has a one-time interest charge of 15% totaling $13,275. The note is convertible into Common Stock upon an event of default at a variable conversion price of 65% of the lowest trading price for the 10 days immediately prior to conversion. The note may be prepaid at a discount to the full amount outstanding, including once-off interest of 96%.

  

On April 12, 2024 and May 3, 2024, the Company entered into Securities Purchase Agreements with 3 accredited investors pursuant to which the Company received an aggregate of $100,000 in gross proceeds in private placements through the issuance of convertible promissory notes and five-year warrants to purchase an aggregate 289,856 shares of Common Stock at an exercise price of $0.345 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events). The notes are unsecured, may be converted into Common Stock at a conversion price of $0.345 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events), mature 12 months from the date of issuance and bear interest at 8% per annum, based on a 360-day year, and may be prepaid at any time without penalty.

 

On May 4, 2024, the maturity date of two notes totaling $225,000 which originally matured on December 31, 2023 and which maturity dates were extended to March 30, 2024, on May 4, 2024, the maturity date of the $200,000 note was further extended to June 14, 2024, and the maturity date of the $25,000 note was further extended to June 30, 2024. In exchange for the maturity date extension, the Company issued to note holders warrants exercisable for 292,463 shares of Common Stock at an exercise price of $0.345 per share.

 

Other than the above, the Company has evaluated subsequent events through the date the financial statements were issued and did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.

 

26

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

All references to “we,” “us,” “our” and the “Company” refer to Innovative Payment Solutions, Inc., a Delaware corporation and its consolidated subsidiaries unless the context requires otherwise.

 

Overview

 

We are a fintech provider of digital payment solutions presently focused on, through its participation in IPSIPay Express, developing a new account-to-account payment application called Instant Settlement in RealTime as well as traditional credit card processing services. We have in the past (under the name IPSIPay) and may in the future develop and operate “e-wallets” that enable consumers to deposit cash, convert it into a digital form and remit funds quickly and securely.

 

Known Trends, Demands, Commitments, Events or Uncertainties Impacting Our Business

 

Development of IPSIPay Express

 

Our principal business as of the date of this Report consists of our participation in the IPSIPay Express joint venture. Since May 2023, we have been working with our joint venture partners OpenPath and EfinityPay to establish the necessary elements to commercially launch IPEX. This remains our top business priority. As described in Item 1. Business, we have been responsible for certain key aspects of establishing and launching IPEX. We have continued these efforts during 2024. No assurances can be given that we will be able to launch IPEX with our joint venture partners or that IPSIPay Express will generate revenues for us.

 

Potential Business Combination with Business Warrior Corporation

 

On February 13, 2024, we signed an amended and restated non-binding letter of intent relating to a potential business combination with Business Warrior Corporation (“BZWR”), pursuant to which we would acquire BZWR. As of the date of this Report, neither we nor BZWR have any legal obligation of any kind with respect to the proposed transaction. We are presently conducting due diligence on BZWR and working with legal counsel on draft documentation for the transaction.

 

BZWR is a publicly listed, revenue generating fintech company that offers PayPlan, a comprehensive lending software platform that includes marketing services for lenders and businesses. We believe that a potential combination with a fintech company that generates some revenue monthly would complement the development and commercial launch of our IPSIPay Express products and potentially other product offerings. In addition, we and BZWR have certain convertible note investors in common. Therefore, one purpose of the proposed transaction would be to convert the indebtedness of both our company and BZWR held by such note holders into equity securities of our company.

 

No assurances can be given, however, the business combination will ever take place. While this is a transaction we are presently interested in pursuing, we may elect to forego the transaction as we deemed appropriate. Moreover, even if we enter into definitive agreements with respect to the transaction, the transaction will be subject to material conditions to closing which may not be satisfied.

 

Inflation

 

Macro-economic conditions could affect consumer spending adversely and consequently our future operations when we fully launch our e-wallet products commercially. The U.S. has entered a period of significant inflation, and this may impact consumer’s desire to adopt our products and services and may increase our costs overall. However, as of the date of this Report, we do not expect there to be any material impact on our liquidity as forecast in our business plan due to recent inflationary concerns in the U.S.

 

Foreign Exchange Risks

 

We intend to operate in several foreign countries. Changes and fluctuations in the foreign exchange rate between the U.S. Dollar and other foreign currencies may in future have an effect our results of operations.

 

27

 

 

Critical Accounting Estimates

 

Preparation of our consolidated financial statements in accordance with U.S. GAAP requires us to make estimates and assumptions that affect the reported amounts of certain assets, liabilities, revenues and expenses, as well as related disclosure of contingent assets and liabilities. Significant accounting policies are fundamental to understanding our financial condition and results as they require the use of estimates and assumptions which affect the financial statements and accompanying notes. See Note 2 - Summary of Significant Accounting Policies of the Notes to the condensed Consolidated Financial Statements included in Part I, Item I of this Form 10-Q for further information.

  

The critical accounting policies that involved significant estimation included the following:

 

Derivative liabilities

 

We have certain short-term convertible notes and certain warrants which have fundamental transaction clauses which might result in cash settlement. The conversion feature of these convertible notes and warrants are recorded as derivative liabilities which are valued at each reporting date.

 

The derivative liability is valued using the following inputs:

 

  Conversion prices;

 

  Current market prices of our equity

  

  Risk free interest rates;

 

  Expected remaining life of the derivative liability;

 

  Expected volatility of the underlying stock; and expected dividend rates

 

Any change in the above factors such as a change in risk free interest rates, a significant increase or decrease in our current stock prices and a change in the volatility of our Common Stock may result in a significant increase or decrease in the derivative liability.

  

Results of Operations

 

Results of Operations for the Three Months Ended March 31, 2024 and 2023

 

Net revenue

 

We did not have any revenues during the three months ended March 31, 2024 and minimal revenues of $433 for the three months ended March 31, 2023. The revenue in the prior year was generated from the IPSIPay platform which was been novated to a third party in September 2023. We pivoted to focus our attention on the IPSIPay Express joint venture, where we expect to generate initial revenues during the 2024 fiscal year, dependent on product testing, which is currently underway, and market acceptance.

 

Cost of goods sold

 

We did not have any revenues or cost of goods sold for the three months ended March 31, 2024. Cost of goods sold was $2,085 for the three months ended March 31, 2023 and consisted primarily of bank and merchant related fees and chargebacks.

 

28

 

 

General and administrative expenses

 

General and administrative expenses were $626,797 and $949,947 for the three months ended March 31, 2024 and 2023, respectively, a decrease of $323,150 or 34.0%. The decrease primarily due to the following:

 

  (i) Selling and marketing expenses were $75,707 and $169,958 for the three months ended March 31, 2024 and 2023, respectively, a decrease of 94,251 or 55.5%. The decrease is primarily due to the reduction in social media advertising costs which were incurred in the prior year to promote the IPSIPay platform, which was novated to a third party in September 2023.
     
  (ii) Payroll expenses were $269,003 and $279,764 for the three months ended March 31, 2024 and 2023, respectively, a decrease of $10,761 or 3.8%. The decrease is primarily attributable to the reduction in employee taxes which were calculated on the basis of payments made during the current period.
     
  (iii) Consulting fees was $15,000 and $45,000 for the three months ended March 31, 2024 and 2023, respectively, a decrease of $30,000 or 66.7%, The decrease is primarily due to a reduction in technical consulting expenses as we concentrate all our efforts on developing and marketing the IPSIPay Express business model.
     
  (iv) Legal fees were $152,594 and $135,523 for the three months ended March 31, 2024 and 2023, respectively, an increase of $17,071 or 12.6%. The increase in legal fees is primarily due to an increase in corporate related matters, including the Business Warrior potential acquisition, discussed above.
     
  (v) Professional fees were $9,558 and $225,136 for the three months ended March 31, 2024 and 2023, respectively, a decrease of $215,578 or 95.8%. The decrease is primarily due to the cessation of the relationship with Frictionless during May of the prior year and through the prior year disposal of certain assets to Frictionless and the prior year novation of the remaining IPSIPay assets to a third party as we focus all our attention on the IPSIPay Express business opportunity.
     
  (vi) Audit fees was $80,000 and $0 for the three months ended March 31, 2024 and 2023, respectively, an increase of $80,000 or 100.0%. The increase is primarily related to the timing of invoices received from our auditors.
     
  (vii) Other general and administrative expenses were $24,935 and $94,566 for the three months ended March 31, 2024 and 2023, respectively, a decrease of $69,631 or 73.6%. The balance of the general and administrative expenses is made up of several individually insignificant expenses.

 

Depreciation and amortization

 

Depreciation and amortization was $542 and $140,690 for the three months ended March 31, 2024 and 2023, respectively, a decrease of $146,148, primarily due to the prior year amortization of the software platform which was subsequently novated to a third party on September 5, 2023.

 

Deemed interest income

 

Deemed interest income was $3,282 and $0 for the three months ended March 31, 2024 and 2023, respectively, an increase of $3,282 or 100.0%. The deemed interest income arises due to the amortization of debt discount on notes receivable advanced to Business Warrior during the current period.

 

Loss on convertible notes

 

Loss on convertible notes was $66,047 and $0 for the three months ended March 31, 2024 and 2023, respectively an increase of $66,047 or 100.0 The loss on convertible notes related to extension warrants issued to certain noteholders to extend the maturity date of their notes by 6 months, the value of the warrants was determined to be a debt extinguishment and were therefore expensed.

 

Interest expense, net

 

Interest expense was $136,919 and $85,221for the three months ended March 31, 2024 and 2023, respectively, an increase of $51,698 or 60.7%. The increase is related to the increase in the principal amount of convertible debt from $2,718,508 as at March 31, 2023 to $4,487,245 as at March 31, 2024, an increase of $1,768,737 as we raise additional funding for working capital purposes while we develop and market the IPSIPay Express payment processing platform, which we expect to be operational during the current fiscal year.

 

29

 

 

Amortization of debt discount

 

Amortization of debt discount was $319,899 and $22,967 for the three months ended March 31, 2024 and 2023, respectively, an increase of $296,932 or 1,292,90%. The increase is primarily due to the amortization of debt discount related to the valuation of warrants, derivative liabilities and OID’s and fees paid on the increase in convertible debt of $1,768,737 raised since March 31, 2023.

 

Derivative liability movements

 

Derivative liability movements were $815,941 and $940,750 for the three months ended March 31, 2024 and 2023, respectively, a decrease of $124,809 or 13.3%. The derivative liability arose due to the issuance of convertible securities and warrants with a fundamental transaction clause allowing for a cash settlement of the convertible note at the option of the holder. The credit during the current period represents the decrease in the mark-to-market value of the derivative liability due to a decrease in our stock price and the cash settlement of certain convertible notes which had derivative liability features.

 

Net loss from equity method investment

 

Net loss from equity method investment was $484 and $0 for the three months ended March 31, 2024 and 2023 respectively, an increase of $484 or 100.0%. On April 28, 2023, we formed a new Delaware limited liability company called IPSIPay Express LLC as a three-way joint venture with two other entities to develop and market a proprietary consumer to merchant real-time payment platform initially focused on the fast-growing online gaming and entertainment sectors. On June 19, 2023, we entered into the IPEX Operating Agreement with Open Path, Inc. and EfinityPay, LLC to memorialize the terms of our IPSIPay Express joint venture. The loss represents our proportionate share of the operating expenses of the joint venture.

 

Net loss from continuing operations

 

Net loss from continuing operations was $331,465 and $259,727 for the three months ended March 31, 2024 and 2023, respectively, an increase of $71,738 or 27.6%. The increase is primarily due to the decrease in the derivative liability movement, an increase in interest expense, an increase in discount amortization and the loss on convertible notes, offset by the decrease in general and administrative expenses, which are all discussed in detail above.

 

Net loss from discontinued operations

 

Net loss from discontinued operations was $0 and $15,260 for the three months ended March 31, 2024 and 2023, respectively, a decrease of $15,260 or 100.0%. Our Beyond fintech subsidiary was disposed of in the previous year.

 

Net loss

 

Net loss was $331,465 and $274,987 for the three months ended March 31, 2024 and 2023, respectively, an increase of $56,478 or 20.5%. The decrease is primarily attributable to the increase in net loss from continuing operations, as discussed in detail above.

 

Liquidity and Capital Resources

 

To date, our primary sources of cash have been funds raised primarily from the sale of our debt and equity securities.

 

We have an accumulated deficit of approximately $58.6 million through March 31, 2024 and incurred negative cash flow from operations of approximately $0.2 million for the three months ended March 31, 2024. Our primary focus is on IPSIPay Express LLC as a three-way joint venture with two other entities to develop and market a proprietary consumer to merchant real-time payment platform initially focused on the fast-growing online gaming and entertainment sectors. On June 19, 2023, we entered into the IPEX Operating Agreement to memorialize the terms of the joint venture.

 

At March 31, 2024, we had cash of $6,875 and a working capital deficit of $8.4 million including a derivative liability of $0.6 million. After eliminating the derivative liability our working capital deficit is $7.8 million. Subsequent to March 31, 2024, we raised $0.17 million through the issuance of convertible notes to accredited investors.

 

30

 

 

We used cash of $0.2 million and $0.7 million in operations for the three months ended March 31, 2024 and 2023, respectively. Overall cash used in operations decreased by $0.5 million due to cost containment efforts to preserve cash balances.

 

We invested $0.2 million in notes receivable for strategic purposes during the three months ended March 31, 2024. In the prior year we had invested $0.06 million in our payment platforms which we subsequently disposed of or novated to other parties.

 

We generated net cash of $0.3 million during the current period from convertible notes issued to investors to bridge our working capital. In the prior period we generated $0.5 million from convertible notes to fund our operations during the development and launch of the IPSIPay platform.

 

At March 31, 2024, we had outstanding convertible notes, including interest thereon of $4.8 million (before unamortized debt discount of $0.4 million) and outstanding promissory notes, including interest thereon of $1.1 million. The notes contain certain covenants, such as restrictions on: (i) distributions on capital stock, (ii) stock repurchases, and (iii) sales and the transfer of assets. The notes bear interest at rates from 8% to an effective rate of 32% per annum. and are convertible into our Common Stock at conversion prices ranging from fixed conversion prices of $0.345 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events), to variable conversion prices of 60% of lowest trading prices over a 20-trading day period. Should the investors choose not to convert these convertible notes, we may need to repay these notes together with interest thereon which will impact on our liquidity.

 

Pursuant to the IPSIPay Express joint venture agreement, we were required to invest another $0.5 million in IPSIPay Express by November 30, 2023. In late 2023, we agreed with our joint venture partners that such investment was not required. Therefore, our share of the outstanding equity interests of IPSIPay Express remains at 22.22%. There is no penalty for non-payment other than our share of the joint venture remaining at 22.22% and not increasing to 33.33%.

 

Given our losses and negative cash flows, we will be required to raise significant additional funds to progress our business as planned by issuing equity or equity-linked securities. Should this occur, our stockholders would experience dilution, perhaps significantly. Additional debt financing, if available, may involve covenants restricting our operations or our ability to incur additional debt. Any additional debt financing or additional equity that we raise may contain terms that are not favorable to us or our stockholders and require significant debt service payments, which diverts resources from other activities. Moreover, there is a risk that financing may be unavailable to support our operations on favorable terms, or at all.

 

There is also a significant risk that none of our plans to raise financing will be implemented in a manner necessary to sustain us for an extended period of time. If adequate funds are not available to us when needed, we may be required to continue with reduced or discontinued operations or to obtain funds through arrangements that may require us to relinquish rights to technologies or potential markets, any of which could have a material adverse effect on our company. In addition, our inability to secure additional funding when needed could cause our business to fail or become bankrupt or force us to wind down or discontinue operations.

 

We do not have any off-balance sheet financing arrangements as of the date of this Report.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risks

 

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this Item.

 

Item 4. Controls and Procedures

 

(a) Evaluation of Disclosure Controls and Procedures

 

Pursuant to Rule 13a-15(b) under the Exchange Act, our management carried out an evaluation, with the participation of our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), of the effectiveness of our disclosure controls and procedures (as defined under Rule 13a-15(e) under the Exchange Act) as of the end of the period covered by this Report. Based upon that evaluation, our CEO and CFO concluded that our disclosure controls and procedures as of March 31, 2024 are not effective due to a lack of written policies and procedures to address all material transactions and developments impacting our financial statements.

 

31

 

 

Changes in Internal Control over Financial Reporting

 

There has been no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) that occurred during our fiscal quarter ended March 31, 2024.

 

Our management is committed to improving our controls and procedures by, among other matters, continuing to consider and adopt appropriate policies and procedures to address all material transactions and developments impacting our financial statements. However, our management does not expect that our disclosure controls and procedures and our internal control processes, even if improved, will prevent all error and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of error or fraud, if any, within our company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that the breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the control. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and may not be detected. However, these inherent limitations are known features of the financial reporting process. Therefore, it is possible to design into the process safeguards to reduce, though not eliminate, this risk.

 

32

 

 

Part II. Other Information

 

Item 1. Legal Proceedings.

 

From time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. Below is a description of our outstanding pending litigation matters. Litigation is subject to inherent uncertainties and an adverse result in the below described or other matters may arise from time to time that may harm our business. Other than as set forth below, we are not presently a party to any legal proceedings that, if determined adversely to us, would individually or taken together have a material adverse effect on our business, operating results, financial condition or cash flows.

 

Voloshin v. Innovative Payment Solutions, Inc.

 

On October 20, 2021, a complaint was filed against our company and certain of its officers and directors with the Occupational Safety and Health Administration of the United States Department of Labor (“OSHA”), captioned Naum Voloshin, Yulia Rey, Alexander Voloshin, Andrey Novikov, and Frank Perez v. Innovative Payment Solutions, Inc., William Corbett, Richard Rosenblum, Madisson Corbett, Jim Fuller, Cliff Henry and David Rios. The complaint generally alleged that complainants, four former employees of our company and one employee who was on suspension, did not receive compensation to which they claim they were entitled and that they were wrongfully terminated for engaging in protected activities in violation of the Sarbanes-Oxley Act of 2002, 18 U.S.C. § 1514A. The complaint sought reinstatement of complainants’ employment, monetary damages including back pay, raises, bonuses, benefits, overtime, emotional distress and loss of reputation, orders of abatement and injunctive relief, and costs of litigation.

 

In early 2022, OSHA dismissed the claims of Ms. Rey and Mr. Perez, and they appealed that decision. We moved to dismiss the remaining claims and as of this writing OSHA took no action with respect to that motion.

 

On May 25, 2022, the parties held a mediation in an attempt to resolve the matters. The mediation was unsuccessful.

 

On October 26, 2022, OSHA scheduled a hearing on Ms. Rey’s and Mr. Perez’s appeal for April 5, 2023. On November 8, 2022, the claimants’ counsel informed us that all five former employees intended to exercise their right to file a lawsuit in federal court and asked if we would stipulate to dismissal of Rey’s and Perez’s OSHA claims without prejudice. We agreed and a stipulation of dismissal without prejudice was filed on November 10, 2022.

 

On November 7, 2022, the same five employees filed a lawsuit, not in federal court, but in the California Superior Court for the County of Los Angeles, against our company and the same individuals against whom they had asserted their OSHA claim. The complaint asserted claims for, among other things, breach of contract, failure to pay wages and failure to reimburse expenses under the California Labor Code and asserting retaliation claims under the California Labor Code. On December 16, 2022, the same five employees filed an amended complaint dropping all defendants from the case except Mr. Corbett and our company. The amended complaint asserts claims for violations of California Labor Code Section 1102.5; wrongful termination in violation of public policy; breach of contract; breach of covenant of good faith and fair dealing; violation of California Labor Code Section 201; waiting time penalties (Cal. Lab. Code Sections 201 & 203) and violation of California Labor Code Section 2802

 

We and Mr. Corbett, the sole remaining individual defendant, moved to compel arbitration on February 17, 2023. As a result of that motion and a stipulated order entered by the court, all proceedings were stayed.

 

On June 8, 2023, while our motion to compel arbitration was pending in the Superior Court three of the employees (Naum Voloshin, Alexander Voloshin, and Novikov) filed a civil action in the U.S. District Court for the Central District of California. Naum Voloshin, et al., v. Innovative Payment Solutions, Inc., Case No. CV 23-4515-JFW (PVCx), which alleges a single cause of action for retaliation in violation of The Sarbanes-Oxley Act of 2002 (the “Federal Action”). The plaintiffs in the Federal Action made no attempt to serve their complaint or to give notice to any defendant in the Federal Action until August 2023.

 

33

 

 

On August 30, 2023, the Hon. William A. Crowfoot granted our and Mr. Corbett’s motion to compel arbitration, concluding that all of the claims alleged in the former employees’ first amended complaint were subject to arbitration. After the former employees failed to initiate arbitration, Defendants filed a motion to compel the appointment of an arbitrator, which was scheduled for hearing on January 2, 2024. On October 27, 2023, Plaintiffs, Perez, and Rey filed a petition for writ of mandate with the California Court of Appeal, seeking review of Judge Crowfoot’s order granting our motion to compel arbitration. The California Court of Appeal denied the petition for writ of mandate on November 1, 2023. On December 15, 2023, all five former employees filed a demand for arbitration. We withdrew our motion to compel appointment of an arbitration.

 

Upon motion of our company and Mr. Corbett, on January 10, 2024, the U.S. District Court for the Central District of California stayed all proceedings in the Federal Action until the arbitration is completed.

 

Plaintiffs Naum Voloshin, Andrey Novikov, and Alexander Voloshin asserted, in the Federal Action, that they are entitled to damages in the following amounts: Naum Voloshin: $950,000 plus an unstated amount of lost wages and emotional distress damages. The claim is premised upon Mr. Voloshin earning $15,000 per month and a claim that he was entitled to receive 333,334 shares of Common Stock (after giving effect to our August 2023 reverse stock split) on or about June 29, 2021 that he would have sold on July 1, 2021 for $2.85 per share on July 1, 2021 for $950,000. Andrey Novikov: $285,000 plus emotional distress and punitive damages. The claim is premised upon Mr. Novikov earning $15,000 per month and a claim that he was entitled to receive 100,000 shares of Common Stock (after giving effect to our August 2023 reverse stock split) on or about June 29, 2021, that he would have sold at $2.85 per share on July 1, 2021 for $285,000. Alexander Voloshin: $263,000 plus emotional distress and punitive damages. The claim is premised upon an alleged two-year contract signed in May 2021 that paid him $7,000 per month and that promised him 333,334 shares of Common Stock (after giving effect to our August 2023 reverse stock split) on or about June 29, 2021. Mr. Voloshin claims he would have sold those shares on or about July 1, 2021 for $2.85 per share for $950,000.

 

We have not received any information on the amount of the claims of the other two plaintiffs.

 

An arbitrator has been appointed, and the 10-day arbitration has been set for April 7-11 2025 and April 14-18, 2025. Management is vigorously defending the claims and intends to continue to do so.

 

Minkovich v. Corbett, et al.

 

On May 26, 2022, Mr. Jan Minkovich (“Minkovich”) filed a lawsuit in California Superior Court in Los Angeles County (Minkovich v. Corbett, et al., CASE NO. 22CHCV00377) against our company and our Chairman and Chief Executive Officer William Corbett. The complaint asserts six causes of action for: (i) breach of contract; (ii) nonpayment of wages; (iii) waiting time penalties; (iv) failure to indemnify for alleged employee business expenses; (v) violation of Section 17200 of the California Business and Professional Code; and (vi) wrongful termination of employment in violation of public policy. Minkovich seeks $570,000 in damages, penalties, and attorneys’ fees plus shares equal to five percent (5%) ownership of our company.

 

We and Mr. Corbett filed a motion to compel arbitration. The motion was denied on October 4, 2022. We and Mr. Corbett then appealed that decision to the California Court of Appeal. As a result of the appeal, the court case was stayed until the appeal was decided. As a result of the stay, the demurrer (the equivalent of a motion to dismiss) we and Mr. Corbett filed was not decided.

 

On February 27, 2024, the California Court of Appeal, Second District, reversed the Superior Court’s decision denying our motion to compel arbitration. The Court of Appeal remanded the case to the Superior Court with directions to issue a new order compelling to arbitration the parties’ dispute regarding the enforceability of the arbitration clause.

 

We expect that the plaintiff will, most likely, initiate arbitration before the American Arbitration Association (“AAA”) based on this ruling. While, as the court order states, the plaintiff may renew his challenge to the arbitration clause before the arbitrator, we believe such challenges are rare and rarely succeed. Accordingly, we expect that the dispute will be resolved by AAA arbitration. Management is vigorously defending the claims and intends to continue to do so.

 

Item 1A. Risk Factors.

 

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this Item.

 

34

 

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

Unregistered Sales of Equity Securities 

 

Between February 6, 2024 and March 4, 2024, we entered into Securities Purchase Agreements with 5 accredited investors, pursuant to which we received an aggregate of $402,335 in gross proceeds from the Investors through the initial closing of a private placement issuance of:

 

  Convertible Notes Promissory (the “Notes” and each a “Note”); and

 

  five-year warrants (the “Warrants” and each a “Warrant”) to purchase an aggregate 357,764 shares of the Company’s Common Stock at an exercise price of $0.345 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events).

 

The Notes mature between 6 months and 12 months, and bear interest at rates from 8% to 11.12% per annum, and are convertible into shares of Common Stock at a conversion price of $0.345 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events).

 

The Notes may be prepaid at any time without penalty. The Company is under no obligation to register the shares of Common Stock underlying the Notes or the Warrants for public resale, pursuant to Section 4(a)(2) of the Securities Act.

 

On April 1, 2024, the Company closed a transaction with Red Road Holdings Corporation (“RRH”) pursuant to which the Company received net proceeds of $70,000, after an original issue discount and fees of $13,500 in exchange for the issuance of a $85,500 Convertible Note, bearing interest at 13%, which interest is earned on issuance of the note and maturing on December 30, 2024. The RRH Note is convertible into shares of Common Stock at a variable conversion rate of 65% of the lowest trading price ten trading days before conversion.

 

Use of Proceeds from Public Offering of Common Stock

 

Not applicable.

 

Item 3. Defaults upon Senior Securities.

 

None.

 

Item 4. Mine Safety Disclosures.

 

Not applicable.

 

Item 5. Other Information.

 

None

 

35

 

 

Item 6. Exhibits

 

Exhibit No.   Exhibit Description
3.1   Articles of Incorporation of the Company (Incorporated by reference to Exhibit 3.1 to the Registration Statement on Form S-1 (File No. 333-192877) filed with the Securities and Exchange Commission on December 16, 2013)
3.2   Amended and Restated Bylaws of the Company (Incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on May 6, 2021)
3.3   Certificate of Amendment to Articles of Incorporation of the Company (Incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on June 2, 2016)
3.4   Certificate of Amendment to Articles of Incorporation of the Company (Incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on March 6, 2018)
3.5   Certificate of Amendment to the Articles of Incorporation of the Company (Name Change) (Incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 4, 2019)
3.6   Certificate of Correction to the Certificate of Amendment to the Articles of Incorporation of the Company, dated August 24, 2023, to effect a 1-for-30 reverse stock split (Incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on August 30, 2023)
31.1*   Certification of William Corbett, Chief Executive Officer, pursuant to Rule 13a-14(a) or Rule 15d-14(a)
31.2*   Certification of Richard Rosenblum, Chief Financial Officer, pursuant to Rule 13a-14(a) or Rule15d-14(a)
32.1*   Certification of William Corbett, Chief Executive Officer pursuant to Section 1350 of the Sarbanes-Oxley Act of 2002
32.2*   Certification of Richard Rosenblum, Chief Financial Officer pursuant to Section 1350 of the Sarbanes-Oxley Act of 2002
101.INS   Inline XBRL Instance Document.*
101.SCH   Inline XBRL Taxonomy Extension Schema Document.*
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document.*
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document.*
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document.*
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document.*
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).*

 

*Filed herewith

 

36

 

 

SIGNATURES

 

Pursuant to the requirements of the Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  INNOVATIVE PAYMENT SOLUTIONS, INC.
   
Date: May 14, 2024 By: /s/ William D. Corbett
    William D. Corbett
    Chief Executive Officer
    (Principal Executive Officer)

 

Date: May 14, 2024 By: /s/ Richard Rosenblum
    Richard Rosenblum
    President & Chief Financial Officer
    (Principal Financial and Accounting Officer)

 

37

--12-31 0.02 0.02 0.00 0.02 0.02 12563389 13819889 false Q1 0001591913 0001591913 2024-01-01 2024-03-31 0001591913 2024-05-13 0001591913 2024-03-31 0001591913 2023-12-31 0001591913 2023-01-01 2023-03-31 0001591913 us-gaap:PreferredStockMember 2023-12-31 0001591913 us-gaap:CommonStockMember 2023-12-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001591913 us-gaap:RetainedEarningsMember 2023-12-31 0001591913 us-gaap:NoncontrollingInterestMember 2023-12-31 0001591913 us-gaap:PreferredStockMember 2024-01-01 2024-03-31 0001591913 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001591913 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001591913 us-gaap:NoncontrollingInterestMember 2024-01-01 2024-03-31 0001591913 us-gaap:PreferredStockMember 2024-03-31 0001591913 us-gaap:CommonStockMember 2024-03-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001591913 us-gaap:RetainedEarningsMember 2024-03-31 0001591913 us-gaap:NoncontrollingInterestMember 2024-03-31 0001591913 us-gaap:PreferredStockMember 2022-12-31 0001591913 us-gaap:CommonStockMember 2022-12-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001591913 us-gaap:RetainedEarningsMember 2022-12-31 0001591913 us-gaap:NoncontrollingInterestMember 2022-12-31 0001591913 2022-12-31 0001591913 us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001591913 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001591913 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001591913 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-03-31 0001591913 us-gaap:PreferredStockMember 2023-03-31 0001591913 us-gaap:CommonStockMember 2023-03-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001591913 us-gaap:RetainedEarningsMember 2023-03-31 0001591913 us-gaap:NoncontrollingInterestMember 2023-03-31 0001591913 2023-03-31 0001591913 ipsi:InnovativePaymentSolutionsIncMember 2024-01-01 2024-03-31 0001591913 us-gaap:CommonStockMember 2024-03-31 0001591913 ipsi:QpagosCorporationsCapitalStockMember us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001591913 ipsi:QpagosCorporationsCapitalStockMember 2024-01-01 2024-03-31 0001591913 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001591913 srt:MaximumMember 2019-11-01 0001591913 srt:MinimumMember 2019-11-01 0001591913 ipsi:ViviHoldingsIncMember 2019-12-31 2019-12-31 0001591913 ipsi:StockPurchaseAgreementMember 2019-12-31 2019-12-31 0001591913 2019-12-31 0001591913 ipsi:GastonPereiraMember 2019-12-31 0001591913 ipsi:AndreyNovikovMember 2019-12-31 0001591913 ipsi:JosephAbramsMember 2019-12-31 0001591913 ipsi:FrictionlessFinancialTechnologiesIncMember 2021-06-21 2021-06-21 0001591913 ipsi:FrictionlessFinancialTechnologiesIncMember 2021-06-21 0001591913 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2021-06-21 0001591913 ipsi:BeyondFintechIncMember 2021-06-21 0001591913 2021-08-26 2021-08-26 0001591913 2023-05-12 0001591913 2023-05-12 2023-05-12 0001591913 ipsi:ThreeTranchesMember 2024-01-01 2024-03-31 0001591913 ipsi:TrancheMember 2023-06-21 2023-06-21 0001591913 us-gaap:ShareBasedCompensationAwardTrancheOneMember 2023-08-04 2023-08-04 0001591913 us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2023-09-01 2023-09-01 0001591913 us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2023-11-30 2023-11-30 0001591913 ipsi:IPEXWarrantMember 2024-01-01 2024-03-31 0001591913 ipsi:TrancheMember 2024-01-01 2024-03-31 0001591913 ipsi:SecondTrancheMember 2024-01-01 2024-03-31 0001591913 ipsi:ThirdTrancheMember 2024-01-01 2024-03-31 0001591913 ipsi:BeyondFintechIncMember 2024-03-31 0001591913 ipsi:LongTermInvestmentMember 2024-03-31 0001591913 us-gaap:ComputerEquipmentMember 2024-03-31 0001591913 us-gaap:OfficeEquipmentMember 2024-03-31 0001591913 us-gaap:SegmentDiscontinuedOperationsMember 2023-01-01 2023-03-31 0001591913 ipsi:BZWRNoteMember 2024-02-22 0001591913 2024-02-22 0001591913 2024-02-22 2024-02-22 0001591913 ipsi:BZWRNoteMember 2024-02-22 2024-02-22 0001591913 ipsi:BZWRNoteMember us-gaap:CommonStockMember 2024-02-22 0001591913 ipsi:BusinessWarriorCorporationMember 2024-01-01 2024-03-31 0001591913 ipsi:BusinessWarriorCorporationMember 2024-03-31 0001591913 2021-08-01 2021-08-26 0001591913 ipsi:BeyondFintechIncMember 2021-08-26 0001591913 ipsi:FrictionlessFinancialTechnologiesIncMember 2021-08-26 0001591913 2021-01-01 2021-12-31 0001591913 ipsi:IPSIPayExpressMember 2024-01-01 2024-03-31 0001591913 2023-01-01 2023-12-31 0001591913 ipsi:IPSIPayExpressMember 2024-03-31 0001591913 2023-01-01 2023-01-01 0001591913 ipsi:SmallBusinessEconomicInjuryDisasterLoanMember 2020-07-07 0001591913 ipsi:SmallBusinessEconomicInjuryDisasterLoanMember 2020-07-07 2020-07-07 0001591913 ipsi:SmallBusinessEconomicInjuryDisasterLoanMember 2024-01-01 2024-03-31 0001591913 ipsi:SmallBusinessEconomicInjuryDisasterLoanMember 2023-01-01 2023-12-31 0001591913 ipsi:CavalryFundILPMember 2021-02-10 2021-02-16 0001591913 ipsi:MercerStreetGlobalOpportunityFundLLCMember 2021-02-10 2021-02-16 0001591913 ipsi:CavalryAndMercerMember 2021-02-10 2021-02-16 0001591913 ipsi:CavalryAndMercerMember 2021-02-16 0001591913 us-gaap:WarrantMember 2021-02-16 2021-02-16 0001591913 us-gaap:CommonStockMember 2021-02-16 0001591913 ipsi:AmendmentTransactionMember 2022-12-31 0001591913 ipsi:AmendmentTransactionMember 2024-01-01 2024-03-31 0001591913 us-gaap:WarrantMember 2024-01-01 2024-03-31 0001591913 us-gaap:ConvertibleDebtMember 2024-03-31 0001591913 ipsi:AmendmentTransactionMember 2024-01-01 2024-03-31 0001591913 ipsi:NotePayableMember ipsi:CavalryFundILPMember 2024-01-01 2024-03-31 0001591913 ipsi:NotePayableMember ipsi:CavalryFundILPMember 2024-03-31 0001591913 ipsi:NotePayableMember ipsi:CavalryFundILPMember 2023-12-31 0001591913 ipsi:NotePayableMember ipsi:MercerStreetGlobalOpportunityFundLLCMember 2024-01-01 2024-03-31 0001591913 ipsi:NotePayableMember ipsi:MercerStreetGlobalOpportunityFundLLCMember 2024-03-31 0001591913 ipsi:NotePayableMember ipsi:MercerStreetGlobalOpportunityFundLLCMember 2023-12-31 0001591913 ipsi:NotePayableMember 2024-03-31 0001591913 ipsi:NotePayableMember 2024-01-01 2024-03-31 0001591913 ipsi:NotePayableMember 2023-12-31 0001591913 ipsi:CavalryAndMercerMember 2022-02-03 2022-02-03 0001591913 ipsi:CavalryAndMercerMember 2022-02-03 0001591913 us-gaap:WarrantMember 2022-02-03 2022-02-03 0001591913 srt:MaximumMember ipsi:CavalryAndMercerMember 2023-12-31 0001591913 srt:MinimumMember ipsi:CavalryAndMercerMember 2023-12-31 0001591913 ipsi:CavalryAndMercerMember 2023-12-31 0001591913 2021-02-16 0001591913 ipsi:ExchangeNotesMember 2021-02-16 2021-02-16 0001591913 ipsi:ExchangeNotesMember 2021-02-16 0001591913 2022-12-30 2022-12-30 0001591913 2022-12-01 2022-12-28 0001591913 ipsi:CavalryAndMercerMember 2022-12-01 2022-12-28 0001591913 us-gaap:WarrantMember 2022-12-01 2022-12-28 0001591913 srt:MaximumMember ipsi:CavalryAndMercerMember 2024-03-31 0001591913 ipsi:CavalryAndMercerMember 2024-03-31 0001591913 ipsi:CavalryMercerNoteMember 2024-01-01 2024-03-31 0001591913 ipsi:ConvertibleNoteMember 2024-01-01 2024-03-31 0001591913 ipsi:CavalryFundLLPMember 2021-02-16 2021-02-16 0001591913 ipsi:CavalryFundLLPMember 2021-02-16 0001591913 ipsi:CavalryFundLLPMember 2022-11-16 0001591913 ipsi:CavalryFundLLPMember 2022-11-01 2022-11-16 0001591913 srt:MaximumMember ipsi:CavalryFundLLPMember 2022-11-01 2022-11-16 0001591913 srt:MinimumMember ipsi:CavalryFundLLPMember 2022-11-01 2022-11-16 0001591913 ipsi:CavalryFundLLPMember 2023-08-24 2023-08-24 0001591913 ipsi:CavalryFundLLPMember 2023-11-20 2023-11-20 0001591913 2023-08-24 2023-08-24 0001591913 2023-11-20 2023-11-20 0001591913 ipsi:CavalryFundLLPMember 2024-03-31 0001591913 ipsi:MercerStreetGlobalOpportunityFundLLCMember 2021-02-16 2021-02-16 0001591913 ipsi:MercerStreetGlobalOpportunityFundLLCMember 2021-02-16 0001591913 ipsi:MercerStreetGlobalOpportunityFundLLCMember 2022-11-16 0001591913 ipsi:MercerStreetGlobalOpportunityFundLLCMember 2022-11-01 2022-11-16 0001591913 srt:MaximumMember ipsi:MercerStreetGlobalOpportunityFundLLCMember 2022-12-30 0001591913 srt:MinimumMember ipsi:MercerStreetGlobalOpportunityFundLLCMember 2022-12-30 0001591913 ipsi:MercerConvertedMember 2023-05-19 2023-05-19 0001591913 ipsi:MercerConvertedMember 2023-08-30 2023-08-30 0001591913 ipsi:MercerStreetGlobalOpportunityFundLLCMember 2024-03-31 0001591913 ipsi:ConvertibleNoteMember ipsi:DiagonalStreetLendingLLCMember 2023-09-09 0001591913 ipsi:ConvertibleNoteMember ipsi:RedRoadHoldingsCorporationMember 2023-09-09 2023-09-09 0001591913 ipsi:ConvertibleNoteMember ipsi:RedRoadHoldingsCorporationMember 2023-09-09 0001591913 ipsi:RedRoadHoldingsCorporationMember 2023-09-09 2023-09-09 0001591913 ipsi:DiagonalStreetLendingLLCMember 2024-03-31 0001591913 ipsi:AccruedInterestMember ipsi:DiagonalStreetLendingLLCMember 2024-03-31 0001591913 ipsi:ConvertibleNoteMember ipsi:DiagonalStreetLendingLLCMember 2023-10-19 0001591913 ipsi:ConvertibleNoteMember ipsi:RedRoadHoldingsCorporationMember 2023-10-19 2023-10-19 0001591913 ipsi:ConvertibleNoteMember ipsi:RedRoadHoldingsCorporationMember 2023-10-19 0001591913 ipsi:RedRoadHoldingsCorporationMember 2023-10-19 2023-10-19 0001591913 ipsi:RedRoadHoldingsCorporationMember 2023-12-31 0001591913 ipsi:AccruedInterestMember ipsi:RedRoadHoldingsCorporationMember 2023-12-31 0001591913 ipsi:ConvertibleNoteMember 2023-12-20 0001591913 ipsi:ConvertibleNoteMember ipsi:RedRoadHoldingsCorporationMember 2023-12-20 0001591913 ipsi:ConvertibleNoteMember ipsi:RedRoadHoldingsCorporationMember 2023-12-01 2023-12-20 0001591913 ipsi:RedRoadHoldingsCorporationMember 2023-12-01 2023-12-20 0001591913 ipsi:ConvertibleNoteMember ipsi:RedRoadHoldingsCorporationMember 2023-12-31 0001591913 ipsi:QuickCapitalLLCMember 2023-06-01 2023-06-20 0001591913 ipsi:QuickCapitalLLCMember 2023-06-20 0001591913 ipsi:ConvertibleNoteMember ipsi:QuickCapitalLLCMember 2023-06-01 2023-06-20 0001591913 ipsi:ConvertibleNoteMember ipsi:QuickCapitalLLCMember 2023-06-20 0001591913 us-gaap:WarrantMember 2024-03-31 0001591913 ipsi:AccruedInterestMember 2024-03-31 0001591913 ipsi:DiagonalStreetLendingLLCMember 2023-05-10 0001591913 ipsi:DiagonalStreetLendingLLCMember 2023-02-13 0001591913 srt:MinimumMember 2024-03-31 0001591913 srt:MaximumMember 2024-03-31 0001591913 ipsi:ConvertibleNoteMember 2024-03-31 0001591913 ipsi:NoteTwoMember 2023-12-14 0001591913 2023-12-14 0001591913 ipsi:ConvertibleNotesMember 2024-05-04 0001591913 ipsi:NoteTwoMember 2024-05-04 0001591913 2024-05-04 0001591913 2023-03-14 2023-03-14 0001591913 2023-03-14 0001591913 ipsi:CavalryAndMercerMember 2024-01-01 2024-03-31 0001591913 ipsi:CavalryFundILPMember 2024-03-31 0001591913 ipsi:CavalryFundILPMember 2024-01-01 2024-03-31 0001591913 ipsi:CavalryFundILPMember 2023-12-31 0001591913 ipsi:MercerStreetGlobalOpportunityFundLLCMember 2024-03-31 0001591913 ipsi:MercerStreetGlobalOpportunityFundLLCMember 2024-01-01 2024-03-31 0001591913 ipsi:MercerStreetGlobalOpportunityFundLLCMember 2023-12-31 0001591913 srt:MinimumMember ipsi:RedRoadHoldingsCorporationMember 2024-03-31 0001591913 ipsi:RedRoadHoldingsCorporationMember 2024-03-31 0001591913 ipsi:RedRoadHoldingsCorporationMember 2024-01-01 2024-03-31 0001591913 ipsi:RedRoadHoldingsCorporationMember 2023-12-31 0001591913 ipsi:RedRoadHoldingsCorporationOneMember 2024-03-31 0001591913 ipsi:RedRoadHoldingsCorporationOneMember 2024-01-01 2024-03-31 0001591913 ipsi:RedRoadHoldingsCorporationOneMember 2023-12-31 0001591913 ipsi:RedRoadHoldingsCorporationTwoMember 2024-03-31 0001591913 ipsi:RedRoadHoldingsCorporationTwoMember 2024-01-01 2024-03-31 0001591913 ipsi:RedRoadHoldingsCorporationTwoMember 2023-12-31 0001591913 ipsi:QuickCapitalLLCMember 2024-03-31 0001591913 ipsi:QuickCapitalLLCMember 2024-01-01 2024-03-31 0001591913 ipsi:QuickCapitalLLCMember 2023-12-31 0001591913 srt:MinimumMember ipsi:TwoThousandAndTweentyThreeConvertibleNotesMember 2024-03-31 0001591913 srt:MaximumMember ipsi:TwoThousandAndTweentyThreeConvertibleNotesMember 2024-03-31 0001591913 ipsi:TwoThousandAndTweentyThreeConvertibleNotesMember 2024-01-01 2024-03-31 0001591913 ipsi:TwoThousandAndTweentyThreeConvertibleNotesMember 2024-03-31 0001591913 ipsi:TwoThousandAndTweentyThreeConvertibleNotesMember 2023-12-31 0001591913 2023-09-12 0001591913 ipsi:BlackScholesMember 2023-12-20 0001591913 srt:MinimumMember 2024-01-01 2024-03-31 0001591913 srt:MaximumMember 2024-01-01 2024-03-31 0001591913 srt:MinimumMember 2023-01-01 2023-12-31 0001591913 srt:MaximumMember 2023-01-01 2023-12-31 0001591913 us-gaap:CommonStockMember 2023-12-31 0001591913 2023-05-19 2023-05-19 0001591913 2023-08-16 2023-08-16 0001591913 2023-08-30 2023-08-30 0001591913 2023-08-31 2023-08-31 0001591913 2023-11-08 2023-11-08 0001591913 ipsi:DebtConversionNoticesMember 2024-01-01 2024-03-31 0001591913 2023-08-11 0001591913 us-gaap:CommonStockMember 2023-08-11 2023-08-11 0001591913 us-gaap:SubsequentEventMember 2024-05-04 0001591913 2024-03-04 2024-03-04 0001591913 2024-03-04 0001591913 2024-03-14 0001591913 ipsi:TwoThousandEighteenStockIncentivePlanMember 2024-01-01 2024-03-31 0001591913 srt:MaximumMember us-gaap:CommonStockMember 2024-03-31 0001591913 ipsi:TwoThousandTwentyOnePlanMember 2021-10-22 2021-10-22 0001591913 ipsi:TwoThousandTwentyOnePlanMember srt:MaximumMember 2024-03-31 0001591913 ipsi:StockOptionsMember 2024-01-01 2024-03-31 0001591913 ipsi:StockOptionsMember 2023-01-01 2023-03-31 0001591913 ipsi:TotalRestrictedSharesMember 2022-12-31 0001591913 ipsi:WeightedAverageFairMarketValuePerShareMember 2022-12-31 0001591913 ipsi:TotalUnvestedRestrictedSharesMember 2022-12-31 0001591913 ipsi:UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember 2022-12-31 0001591913 ipsi:TotalVestedRestrictedSharesMember 2022-12-31 0001591913 ipsi:VestedRestrictedWeightedAverageFairMarketValuePerShareMember 2022-12-31 0001591913 ipsi:TotalRestrictedSharesMember 2023-01-01 2023-12-31 0001591913 ipsi:WeightedAverageFairMarketValuePerShareMember 2023-01-01 2023-12-31 0001591913 ipsi:TotalUnvestedRestrictedSharesMember 2023-01-01 2023-12-31 0001591913 ipsi:UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember 2023-01-01 2023-12-31 0001591913 ipsi:TotalVestedRestrictedSharesMember 2023-01-01 2023-12-31 0001591913 ipsi:VestedRestrictedWeightedAverageFairMarketValuePerShareMember 2023-01-01 2023-12-31 0001591913 ipsi:TotalRestrictedSharesMember 2023-12-31 0001591913 ipsi:WeightedAverageFairMarketValuePerShareMember 2023-12-31 0001591913 ipsi:TotalUnvestedRestrictedSharesMember 2023-12-31 0001591913 ipsi:UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember 2023-12-31 0001591913 ipsi:TotalVestedRestrictedSharesMember 2023-12-31 0001591913 ipsi:VestedRestrictedWeightedAverageFairMarketValuePerShareMember 2023-12-31 0001591913 ipsi:TotalRestrictedSharesMember 2024-01-01 2024-03-31 0001591913 ipsi:WeightedAverageFairMarketValuePerShareMember 2024-01-01 2024-03-31 0001591913 ipsi:TotalUnvestedRestrictedSharesMember 2024-01-01 2024-03-31 0001591913 ipsi:UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember 2024-01-01 2024-03-31 0001591913 ipsi:TotalVestedRestrictedSharesMember 2024-01-01 2024-03-31 0001591913 ipsi:VestedRestrictedWeightedAverageFairMarketValuePerShareMember 2024-01-01 2024-03-31 0001591913 ipsi:TotalRestrictedSharesMember 2024-03-31 0001591913 ipsi:WeightedAverageFairMarketValuePerShareMember 2024-03-31 0001591913 ipsi:TotalUnvestedRestrictedSharesMember 2024-03-31 0001591913 ipsi:UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember 2024-03-31 0001591913 ipsi:TotalVestedRestrictedSharesMember 2024-03-31 0001591913 ipsi:VestedRestrictedWeightedAverageFairMarketValuePerShareMember 2024-03-31 0001591913 ipsi:GrantDatePriceOnePointFourSevanMember 2024-01-01 2024-03-31 0001591913 ipsi:GrantDatePriceOnePointFourSevanMember 2024-03-31 0001591913 ipsi:GrantDatePriceOnePointFiveZeroMember 2024-01-01 2024-03-31 0001591913 ipsi:GrantDatePriceOnePointFiveZeroMember 2024-03-31 0001591913 ipsi:GrantDatePriceOnePointSixFiveMember 2024-01-01 2024-03-31 0001591913 ipsi:GrantDatePriceOnePointSixFiveMember 2024-03-31 0001591913 srt:MinimumMember us-gaap:WarrantMember 2024-01-01 2024-03-31 0001591913 srt:MaximumMember us-gaap:WarrantMember 2024-01-01 2024-03-31 0001591913 us-gaap:WarrantMember 2022-12-31 0001591913 srt:MinimumMember us-gaap:WarrantMember 2022-12-31 0001591913 srt:MaximumMember us-gaap:WarrantMember 2022-12-31 0001591913 us-gaap:WarrantMember 2023-01-01 2023-12-31 0001591913 srt:MinimumMember us-gaap:WarrantMember 2023-01-01 2023-12-31 0001591913 srt:MaximumMember us-gaap:WarrantMember 2023-01-01 2023-12-31 0001591913 us-gaap:WarrantMember 2023-12-31 0001591913 srt:MinimumMember us-gaap:WarrantMember 2023-12-31 0001591913 srt:MaximumMember us-gaap:WarrantMember 2023-12-31 0001591913 srt:MinimumMember us-gaap:WarrantMember 2024-03-31 0001591913 srt:MaximumMember us-gaap:WarrantMember 2024-03-31 0001591913 us-gaap:WarrantMember ipsi:ExercisePriceZeroPointThreeFourFiveMember 2024-03-31 0001591913 us-gaap:WarrantMember ipsi:ExercisePriceZeroPointThreeFourFiveMember 2024-01-01 2024-03-31 0001591913 us-gaap:WarrantMember ipsi:ExercisePriceZeroPointFourFiveZeroMember 2024-03-31 0001591913 us-gaap:WarrantMember ipsi:ExercisePriceZeroPointFourFiveZeroMember 2024-01-01 2024-03-31 0001591913 us-gaap:WarrantMember ipsi:ExercisePriceOnePointZeroThreeFiveMember 2024-03-31 0001591913 us-gaap:WarrantMember ipsi:ExercisePriceOnePointZeroThreeFiveMember 2024-01-01 2024-03-31 0001591913 us-gaap:WarrantMember ipsi:ExercisePriceOnePointFiveZeroZeroMember 2024-03-31 0001591913 us-gaap:WarrantMember ipsi:ExercisePriceOnePointFiveZeroZeroMember 2024-01-01 2024-03-31 0001591913 us-gaap:WarrantMember ipsi:ExercisePriceFourPointFiveZeroMember 2024-03-31 0001591913 us-gaap:WarrantMember ipsi:ExercisePriceFourPointFiveZeroMember 2024-01-01 2024-03-31 0001591913 us-gaap:WarrantMember ipsi:ExercisePriceFivePointSixTwoFiveMember 2024-03-31 0001591913 us-gaap:WarrantMember ipsi:ExercisePriceFivePointSixTwoFiveMember 2024-01-01 2024-03-31 0001591913 us-gaap:StockOptionMember 2024-01-01 2024-03-31 0001591913 us-gaap:StockOptionMember 2022-12-31 0001591913 srt:MinimumMember us-gaap:StockOptionMember 2022-12-31 0001591913 srt:MaximumMember us-gaap:StockOptionMember 2022-12-31 0001591913 us-gaap:StockOptionMember 2023-01-01 2023-12-31 0001591913 srt:MinimumMember us-gaap:StockOptionMember 2023-01-01 2023-12-31 0001591913 srt:MaximumMember us-gaap:StockOptionMember 2023-01-01 2023-12-31 0001591913 us-gaap:StockOptionMember 2023-12-31 0001591913 srt:MinimumMember us-gaap:StockOptionMember 2023-12-31 0001591913 srt:MaximumMember us-gaap:StockOptionMember 2023-12-31 0001591913 us-gaap:StockOptionMember 2024-03-31 0001591913 srt:MinimumMember us-gaap:StockOptionMember 2024-03-31 0001591913 srt:MaximumMember us-gaap:StockOptionMember 2024-03-31 0001591913 us-gaap:StockOptionMember ipsi:ExercisePriceOnePointTwoZeroMember 2024-03-31 0001591913 us-gaap:StockOptionMember ipsi:ExercisePriceOnePointTwoZeroMember 2024-01-01 2024-03-31 0001591913 us-gaap:StockOptionMember ipsi:ExercisePriceFourPointFiveZeroMember 2024-03-31 0001591913 us-gaap:StockOptionMember ipsi:ExercisePriceFourPointFiveZeroMember 2024-01-01 2024-03-31 0001591913 2024-03-14 2024-03-14 0001591913 us-gaap:ConvertibleDebtSecuritiesMember 2024-01-01 2024-03-31 0001591913 us-gaap:ConvertibleDebtSecuritiesMember 2023-01-01 2023-03-31 0001591913 ipsi:StockOptionsMember 2024-01-01 2024-03-31 0001591913 ipsi:StockOptionsMember 2023-01-01 2023-03-31 0001591913 us-gaap:WarrantMember 2024-01-01 2024-03-31 0001591913 us-gaap:WarrantMember 2023-01-01 2023-03-31 0001591913 ipsi:WilliamCorbettMember 2024-01-01 2024-03-31 0001591913 ipsi:WilliamCorbettMember 2023-01-01 2023-03-31 0001591913 ipsi:RichardRosenblumMember 2024-01-01 2024-03-31 0001591913 ipsi:RichardRosenblumMember 2023-01-01 2023-03-31 0001591913 ipsi:NotePayableMember us-gaap:ConvertibleNotesPayableMember 2024-01-01 2024-03-31 0001591913 us-gaap:SubsequentEventMember 2024-04-01 2024-04-01 0001591913 us-gaap:SubsequentEventMember 2024-04-01 0001591913 ipsi:SecuritiesPurchaseAgreementsMember us-gaap:SubsequentEventMember 2024-04-01 2024-04-01 0001591913 ipsi:BZWRMember us-gaap:SubsequentEventMember 2024-04-01 0001591913 ipsi:SecuritiesPurchaseAgreementsMember us-gaap:CommonStockMember 2024-03-31 0001591913 ipsi:SecuritiesPurchaseAgreementsMember 2024-01-01 2024-03-31 0001591913 ipsi:SecuritiesPurchaseAgreementsMember us-gaap:SubsequentEventMember 2024-05-04 0001591913 srt:ScenarioForecastMember 2024-06-30 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure

Exhibit 31.1

 

CERTIFICATION PURSUANT TO RULE 13a-14 OR RULE

15d-14 OF THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, William Corbett, certify that:

 

1.I have reviewed this Quarterly Report on Form 10-Q of Innovative Payment Solutions, Inc.:

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and.

 

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: May 14, 2024 /s/ William Corbett
  William Corbett
  Chief Executive Officer
  (Principal Executive Officer)

 

Exhibit 31.2

 

CERTIFICATION PURSUANT TO RULE 13a-14 OR RULE

15d-14 OF THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Richard Rosenblum, certify that:

 

1.I have reviewed this Quarterly Report on Form 10-Q of Innovative Payment Solutions, Inc.:

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and.

 

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: May 14, 2024 /s/ Richard Rosenblum
  Richard Rosenblum
  President and Chief Financial Officer
  (Principal Financial and Accounting Officer)

 

Exhibit 32.1

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Innovative Payment Solutions, Inc. (the “Registrant”) on Form 10-Q for the three months ended March 31, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, William Corbett, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section. 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

 

(1)The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)To my knowledge, the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

 

Date: May 14, 2024 By: /s/ William Corbett
    William Corbett
    Chief Executive Officer
    (Principal Executive Officer)

 

Exhibit 32.2

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Innovative Payment Solutions, Inc. (the “Registrant”) on Form 10-Q for the three months ended March 31, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Richard Rosenblum, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section. 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

 

(1)The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)To my knowledge, the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

 

Date: May 14, 2024 By: /s/ Richard Rosenblum
    Richard Rosenblum
    President and Chief Financial Officer
    (Principal Financial and Accounting Officer)

 

v3.24.1.1.u2
Cover - shares
3 Months Ended
Mar. 31, 2024
May 13, 2024
Document Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Transition Report false  
Entity Interactive Data Current Yes  
Amendment Flag false  
Document Period End Date Mar. 31, 2024  
Document Fiscal Year Focus 2024  
Document Fiscal Period Focus Q1  
Entity Information [Line Items]    
Entity Registrant Name INNOVATIVE PAYMENT SOLUTIONS, INC.  
Entity Central Index Key 0001591913  
Entity File Number 000-55648  
Entity Tax Identification Number 33-1230229  
Entity Incorporation, State or Country Code NV  
Current Fiscal Year End Date --12-31  
Entity Current Reporting Status Yes  
Entity Shell Company false  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Contact Personnel [Line Items]    
Entity Address, Address Line One 56B 5th Avenue  
Entity Address, Address Line Two Lot 1 #AT  
Entity Address, City or Town Carmel By The Sea  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 93921  
Entity Phone Fax Numbers [Line Items]    
City Area Code (866)  
Local Phone Number 477-4729  
Entity Listings [Line Items]    
Entity Common Stock, Shares Outstanding   13,819,889
v3.24.1.1.u2
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Current Assets    
Cash $ 6,875 $ 50,433
Other current assets 12,597 38,818
Total Current Assets 19,472 89,251
Non-current assets    
Plant and equipment 6,484 7,027
Notes receivable 161,615  
Security deposit 5,000 5,000
Equity method investment 703,954 703,938
Total Non-Current Assets 877,053 715,965
Total Assets 896,525 805,216
Current Liabilities    
Accounts payable 2,307,053 2,023,375
Federal relief loans – current portion 9,309 9,369
Notes payable 1,086,374 1,062,007
Convertible debt, net of unamortized discount of $432,702 and $687,503, respectively 4,393,479 3,704,280
Derivative liability 618,255 1,434,196
Total Current Liabilities 8,414,470 8,233,227
Non-Current Liabilities    
Federal relief loans 150,000 150,000
Total Non-Current Liabilities 150,000 150,000
Total Liabilities 8,564,470 8,383,227
Equity (Deficit)    
Preferred stock, $0.0001 par value, 25,000,000 shares authorized, and 0 shares issued and outstanding as of March 31, 2024 and December 31, 2023.
Common stock, $0.0001 par value; 750,000,000 shares authorized, 13,819,889 issued and outstanding as of March 31, 2024 and December 31, 2023. 1,382 1,382
Additional paid-in-capital 50,897,756 50,656,225
Accumulated deficit (58,567,083) (58,235,618)
Total Equity (Deficit) (7,667,945) (7,578,011)
Total Liabilities and Equity (Deficit) $ 896,525 $ 805,216
v3.24.1.1.u2
Condensed Consolidated Balance Sheets (Parentheticals) - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Statement of Financial Position [Abstract]    
Convertible debt, net of unamortized discount (in Dollars) $ 432,702 $ 687,503
Preferred stock, par value (in Dollars per share) $ 0.0001 $ 0.0001
Preferred stock, shares authorized 25,000,000 25,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, par value (in Dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized 750,000,000 750,000,000
Common stock, shares issued 13,819,889 13,819,889
Common stock, shares outstanding 13,819,889 13,819,889
v3.24.1.1.u2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]    
Net Revenue $ 433
Cost of Goods Sold 2,085
Gross loss (1,652)
General and administrative 626,797 949,947
Depreciation and amortization 542 140,690
Total Expense 627,339 1,090,637
Loss from Operations (627,339) (1,092,289)
Deemed Interest income 3,282
Loss on convertible notes (66,047)
Interest expense (136,919) (85,221)
Amortization of debt discount (319,899) (22,967)
Derivative liability movements 815,941 940,750
Loss before Income Taxes (330,981) (259,727)
Income Taxes
Net Loss after income taxes (330,981) (259,727)
Net loss from equity method investments (484)  
Net loss from continuing operations (331,465) (259,727)
Discontinued operations    
Net loss from discontinued operations (15,260)
Net loss from discontinued operations, total (15,260)
Net loss (331,465) (274,987)
Net loss attributable to non-controlling interest 1,597
Net loss attributable to Innovative Payment Solutions, Inc. stockholders $ (331,465) $ (273,390)
Basic and diluted loss per share*    
Continuing operations (in Dollars per share) [1] $ (0.02) $ (0.02)
Discontinued operations (in Dollars per share) [1] 0
Basic loss per share total (in Dollars per share) $ (0.02) $ (0.02)
Weighted Average Number of Shares Outstanding – Basic (in Shares) 13,819,889 12,563,389
[1] After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
v3.24.1.1.u2
Condensed Consolidated Statements of Operations (Unaudited) (Parentheticals) - $ / shares
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]    
Continuing operations diluted [1] $ (0.02) $ (0.02)
Discontinued operations diluted [1] 0.00
Diluted loss per share $ (0.02) $ (0.02)
Weighted Average Number of Shares Outstanding – Diluted (in Shares) 13,819,889 12,563,389
[1] After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
v3.24.1.1.u2
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Deficit) (Unaudited) - USD ($)
Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Non-controlling shareholders interest
Total
Balance at Dec. 31, 2022 $ 1,256 [1] $ 48,442,355 [1] $ (52,399,858) $ 1,597 $ (3,954,650)
Balance (in Shares) at Dec. 31, 2022 12,563,426 [1]        
Fair value of warrants issued to convertible debt holders [1] 251,856 [1] 251,856
Fair value of warrants issued for services     36,207     36,207
Stock based compensation [1] 94,464 [1] 94,464
Net loss [1] [1] (273,390) (1,597) (274,987)
Balance at Mar. 31, 2023 $ 1,256 [1] 48,824,882 [1] (52,673,248) (3,847,110)
Balance (in Shares) at Mar. 31, 2023 12,563,426 [1]        
Balance at Dec. 31, 2023 $ 1,382 [1] 50,656,225 [1] (58,235,618) (7,578,011)
Balance (in Shares) at Dec. 31, 2023 13,819,889 [1]        
Fair value of warrants issued to convertible debt holders [1] 44,813 [1] 44,813
Fair value of warrants issued on debt extinguishment 66,047 66,047
Fair value of warrants issued for services [1] 36,207 [1] 36,207
Stock based compensation [1] 94,464 [1] 94,464
Net loss [1] [1] (331,465) (331,465)
Balance at Mar. 31, 2024 $ 1,382 [1] $ 50,897,756 [1] $ (58,567,083) $ (7,667,945)
Balance (in Shares) at Mar. 31, 2024 13,819,889 [1]        
[1] After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
v3.24.1.1.u2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (331,465) $ (274,987)
Net loss from discontinued operations 15,260
Net loss from continuing operations (331,465) (259,727)
Adjustments to reconcile net loss to net cash used in operating activities:    
Derivative liability movements (815,941) (940,750)
Depreciation 542 140,690
Amortization of debt discount 319,899 22,967
Loss on convertible notes 66,047
Deemed interest income (3,282)
Unrealized loss on equity method investments 484
Warrants issued for services 36,207 36,207
Stock based compensation 94,464 94,464
Changes in Assets and Liabilities    
Other current assets 26,221 21,957
Accounts payable and accrued expenses 283,679 76,420
Interest accruals 120,396 83,837
Cash used in operating activities – continuing operations (202,749) (723,935)
Cash provided by operating activities – discontinued operations 35,631
CASH USED IN OPERATING ACTIVITIES (202,749) (688,304)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Investment in intangibles (28,893)
Investment in notes receivable (158,333)
Investment in equity method investment (500)  
Net cash used in investing activities – continuing operations (158,833) (28,893)
Net cash used in investing activities – discontinued operations (35,890)
CASH USED IN INVESTING ACTIVITIES (158,833) (64,783)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from convertible notes 402,335 535,000
Repayment of convertible notes (84,311)
Repayment of federal relief loans (809)
NET CASH PROVIDED BY FINANCING ACTIVITIES 318,024 534,191
NET DECREASE IN CASH (43,558) (218,896)
Cash and cash included in assets held for sale at the beginning of the period 50,433 374,765
CASH AT END OF PERIOD 6,875 155,869
RECONCILIATION OF OPENING CASH WITHIN THE BALANCE SHEET TO THE STATEMENT OF CASH FLOWS    
Cash 50,433 373,822
Cash included in assets held for sale 943
CASH AT BEGINNING OF THE YEAR 50,433 374,765
RECONCILIATION OF CLOSING CASH WITHIN THE BALANCE SHEET TO THE STATEMENT OF CASH FLOWS    
Cash 6,875 155,185
Cash included in assets held for sale 684
CASH AT THE END OF THE PERIOD 6,875 155,869
CASH PAID FOR INTEREST AND TAXES:    
Cash paid for income taxes
Cash paid for interest 16,522 1,384
NON CASH INVESTING AND FINANCING ACTIVITIES    
Fair value of warrants issued with convertible notes $ 44,813 $ 251,856
v3.24.1.1.u2
Organization and Description of Business
3 Months Ended
Mar. 31, 2024
Organization and Description of Business [Abstract]  
ORGANIZATION AND DESCRIPTION OF BUSINESS
1 ORGANIZATION AND DESCRIPTION OF BUSINESS

 

a)Organizational History

 

On May 12, 2016, Innovative Payment Solutions, Inc., a Nevada corporation (“IPSI” or the “Company”) (originally formed on September 23, 2013 under the name “Asiya Pearls, Inc.”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Qpagos Corporation, a Delaware corporation (“Qpagos Corporation”), and Qpagos Merge, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“Merger Sub”). Pursuant to the Merger Agreement, on May 12, 2016, the merger was consummated, and Qpagos Corporation and Merger Sub merged (the “Merger”), with Qpagos Corporation continuing as the surviving corporation of the Merger. On May 27, 2016, the Company’s name was changed from “Asiya Pearls, Inc.” to “QPAGOS”.

 

Pursuant to the Merger Agreement, upon consummation of the Merger, each share of Qpagos Corporation’s capital stock issued and outstanding immediately prior to the Merger was converted into the right to receive two shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”). Additionally, pursuant to the Merger Agreement, upon consummation of the Merger, the Company assumed all of Qpagos Corporation’s warrants issued and outstanding immediately prior to the Merger, which were exercisable for an aggregate of approximately 621,920 shares of Common Stock as of the date of the Merger. Prior to and as a condition to the closing of the Merger, a then-current holder of 500,000 shares of Common Stock agreed to return 497,500 shares of Common Stock held by such holder to the Company and such holder retained an aggregate of 2,500 shares of Common Stock. The other then stockholders of the Company retained 500,000 shares of Common Stock. Therefore, immediately following the Merger, Qpagos Corporation’s former stockholders held 4,992,900 shares of Common Stock which represented approximately 91% of the outstanding Common Stock.

 

The Merger was treated as a reverse acquisition of the Company, then a public shell company, for financial accounting and reporting purposes. As such, Qpagos Corporation was treated as the acquirer for accounting and financial reporting purposes while the Company was treated as the acquired entity for accounting and financial reporting purposes.

 

Qpagos Corporation was incorporated on May 1, 2015 under the laws of the state of Delaware to effectuate a reverse merger transaction with Qpagos, S.A.P.I. de C.V. (“Qpagos Mexico”) and Redpag Electrónicos S.A.P.I. de C.V. (“Redpag”). Each of the entities were incorporated in November 2013 in Mexico. Qpagos Mexico was formed to process payment transactions for service providers it contracts with, and Redpag was formed to deploy and operate kiosks as a distributor. 

 

On June 1, 2016, the board of directors of the Company (the “Board”) changed the Company’s fiscal year end from October 31 to December 31.

 

On November 1, 2019, the Company changed its corporate name from “QPAGOS” to “Innovative Payment Solutions, Inc.” Additionally, and immediately following the name change, the Company filed a Certificate of Change with the Secretary of State of the State of Nevada to effect a reverse split of the then outstanding Common Stock at a ratio of 1-for-10, effective on November 1, 2019 (the “Reverse Stock Split”). As a result of the Reverse Stock Split, each ten pre-split shares of Common Stock outstanding automatically combined into one new share of Common Stock without any further action on the part of the holders, and the number of outstanding shares of Common Stock was reduced from 320,477,867 shares to 32,047,817 after rounding for fractional shares.

 

On December 31, 2019, the Company consummated the disposal of Qpagos Corporation, Qpagos Mexico and Redpag in exchange for 2,250,000 shares (the “Vivi Shares”) of common stock of Vivi Holdings, Inc. (“Vivi. or “Vivi Holdings”) pursuant to a Stock Purchase Agreement dated August 5, 2019 (the “SPA”). Of the 2,250,000 shares of Vivi, nine percent (9%) was allocated as follows: Gaston Pereira (5%), Andrey Novikov (2.5%), and Joseph Abrams (1.5%). The transactions contemplated by the SPA closed on December 31, 2019 after the satisfaction of customary conditions, the receipt of a final fairness opinion and the approval of the Company’s shareholders. As a result, the Company no longer has any business operations in Mexico and has retained its U.S. operations, currently based in Carmel By The Sea, California.

  

On June 21, 2021. the Company acquired a 10% strategic interest in Frictionless Financial Technologies, Inc. (“Frictionless”). Frictionless agreed to deliver to the Company, a live fully compliant financial payment Software as a Service solution for use by the Company as a digital payment platform (which was subsequently branded as IPSIPay) that enables payments within the United States and abroad, including Mexico, together with a service agreement providing a full suite of product services to facilitate the Company’s anticipated product offerings. The Company had an irrevocable right to acquire up to an additional 41% of the outstanding common stock of Frictionless at a purchase price of $300,000 for each 1% acquired.

 

On August 26, 2021, the Company formed a new subsidiary, Beyond Fintech, Inc. (“Beyond Fintech”), in which it owns a 51% stake, with Frictionless owning the remaining 49%. Beyond Fintech acquired an exclusive license to a product known as Beyond Wallet, to further its objective of providing virtual payment services allowing U.S. persons to transfer funds to Mexico and other countries.

 

On May 12, 2023, the Company entered into an Agreement with Frictionless (the “May 2023 Frictionless Agreement”) to unwind the equity ownership stakes that the Company and Frictionless have in each other and in Beyond Fintech. Pursuant to the May 2023 Frictionless Agreement: (i) the Company assigned to Frictionless all common stock of Frictionless owned by the Company; (ii) the warrant to purchase 1,000,000 shares of Common Stock previously issued by the Company to Frictionless as of December 30, 2022 was cancelled; (iii) the Company assigned to Frictionless all shares of common stock of Beyond Fintech owned by the Company (the “Beyond Fintech Shares”); and (iv) the rights previously granted to the Company to (a) acquire additional equity interests in Frictionless, (b) participate in future financings of Frictionless and (c) appoint a board member of Frictionless, were terminated. The consideration to the Company for the assignment of the Beyond Fintech Shares to Frictionless was a credit against potential future services to be provided by Frictionless to the Company in an amount up to $250,000. As a result of the novation agreement with Frictionless discussed below, the Company no longer utilizes, and does not expect to utilize, the services of Frictionless for the foreseeable future. The collectability of the remaining credit receivable of $231,431 has been impaired.

 

On August 30, 2023, the Company implemented a 1 for 30 reverse stock split of its Common Stock. Unless the context expressly requires otherwise, as used in this Report, all share and per share numbers reflect such reverse stock split.

 

On September 5, 2023, the Company’s entered into a novation agreement whereby it assigned all its rights and interest in its e-wallet product, IPSIPay, and its receivables and payables due from and to Frictionless, related to IPSIPay, to a third party in order to concentrate all of its efforts on the IPSIPay Express LLC (“IPSIPay Express”) joint venture. See note 1(b) for further information.

 

b)Description of current business

 

The Company is currently a fintech provider of digital payment solutions presently focused on, through its participation in IPSIPay Express, developing a new account-to-account payment application called Instant Settlement in RealTime as well as traditional credit card processing services. The Company has in the past (under the name IPSIPay) and may in the future develop and operate “e-wallets” that enable consumers to deposit cash, convert it into a digital form and remit funds quickly and securely.

 

IPSIPay Express

 

On April 28, 2023, the Company formed a new company called IPSIPay Express. This entity was formed as a Delaware limited liability company joint venture with OpenPath, Inc. (“OpenPath”) and EfinityPay, LLC (“EfinityPay”, and the Company, collectively with OpenPath and EfinityPay, the “Members”) to develop and market a proprietary consumer to merchant real-time payment platform initially focused on the fast-growing online gaming and entertainment sectors.

 

On June 19, 2023, the Company entered into a Limited Liability Company Operating Agreement (the “Operating Agreement”) with OpenPath and EfinityPay to jointly provide for the governance of and rights of the Members with respect to IPSIPay Express. The effective date of the Operating Agreement is April 28, 2023.

 

IPSIPay Express was formed by the Members with the initial business purposes of providing credit card processing solutions and also a proprietary solution for real time bank-to-bank payment transactions in a manner that provides seamless and frictionless consumer and merchant experiences, with an initial focus on merchants operating in gaming and entertainment sectors. Such solutions are collectively referred to herein as “IPEX.”

 

Pursuant to the Operating Agreement, the Company agreed to contribute cash to or on behalf IPSIPay Express to be used for the IPEX business in the aggregate amount of up to $1,500,000 (the “IPSI Capital Contribution”). The Company is required to make the IPSIPay Capital Contribution in three tranches of $500,000 (each, a “Tranche”), or such lesser amounts as may be unanimously approved by the Board of Managers of IPSIPay Express. With the full funding of each Tranche, the Company will automatically receive an 11.11% membership interest in IPSIPay Express (or a pro rata portion thereof if less than a full Tranche is funded), and OpenPath and EfinityPay’s percentage interest in IPSIPay Express will be reduced pro rata accordingly. Should the Company contribute the full IPSI Capital Contribution, the Members will each own one-third (1/3) of the membership interests in IPSIPay Express. The IPSI Capital Contribution has been or will be made by the following dates and in the following amounts: (i) $200,000 of the initial Tranche was paid by the Company on June 21, 2023; (ii) the $300,000 balance of the initial Tranche was paid on August 4, 2023; (iii) the second $500,000 Tranche was paid in September 2023 and (iv) the third $500,000 Tranche was expected to be paid on or before November 30, 2023. In late 2023, the Company agreed with its joint venture partners that such investment was not required as the joint venture is not operational as yet. The need for any additional advances will be addressed with the joint venture partners once IPEX becomes operational and begins generating revenue, our current shareholding in the joint venture remains at 22%.

 

Simultaneously with the funding of the initial Tranche, the Company issued to each of OpenPath and EfinityPay a five-year Common Stock purchase warrant (the “IPEX Warrant”) to purchase 133,334 shares of Common Stock with an exercise price of $0.45 per share. We are still obligated to issue to each of OpenPath and EfinityPay an additional IPEX Warrant to purchase 199,999 shares of Common Stock with an exercise price equal to the average public closing price of the Common Stock for the three trading days immediately prior to the funding of the initial Tranche. Simultaneously with the funding of the second Tranche, we are obligated to issue to each of OpenPath and EfinityPay an additional IPEX Warrant to purchase 166,667 shares of Common Stock with an exercise price equal to the average public closing price of the Common Stock for the three trading days immediately prior to the funding of the second Tranche. Should we decide to fund a third Tranche, we will be obligated to issue to each of OpenPath and EfinityPay an additional IPEX Warrant to purchase 166,667 shares of Common Stock with an exercise price equal to the average public closing price of the Common Stock for the three trading days immediately prior to the funding of the third Tranche. If the full IPSI Capital Contribution is funded, OpenPath and EfinityPay will receive IPEX Warrants to purchase an aggregate of 1,333,334 shares of Common Stock.

v3.24.1.1.u2
Accounting Policies and Estimates
3 Months Ended
Mar. 31, 2024
Accounting Policies and Estimates [Abstract]  
ACCOUNTING POLICIES AND ESTIMATES
2 ACCOUNTING POLICIES AND ESTIMATES

 

a)Basis of Presentation

 

The accompanying unaudited condensed financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X. Accordingly, these unaudited condensed financial statements do not include all of the information and disclosures required by U.S. GAAP for complete financial statements. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments (consisting only of normal recurring adjustments), which the Company considers necessary, for a fair presentation of those financial statements. The results of operations and cash flows for the three months ended March 31, 2024 may not necessarily be indicative of results that may be expected for any succeeding quarter or for the entire fiscal year. The information contained in this Report should be read in conjunction with the audited financial statements of IPSI for the year ended December 31, 2023, included in the Company’s Annual Report on Form 10-K as filed with the Securities and Exchange Commission (the “SEC”) on March 29, 2024 and amended on April 17, 2024.

 

All amounts referred to in the notes to the unaudited condensed consolidated financial statements are in United States Dollars ($) unless stated otherwise.

  

b)Principles of Consolidation

 

The unaudited condensed consolidated financial statements as of March 31, 2024, include the financial statements of the Company. The unaudited condensed consolidated financial statements as of March 31, 2023, include the financial statements of the Company and its subsidiary in which it has a majority voting interest, until May 12, 2023, the date of disposal of its Beyond Fintech subsidiary. Pursuant to the May 2023 Frictionless Agreement, the Company disposed of its 51% interest in Beyond Fintech. Therefore the Company currently has no subsidiaries.

 

All significant inter-company accounts and transactions have been eliminated in the unaudited condensed consolidated financial statements.

 

The accompanying consolidated financial statements have been prepared in accordance with U.S. GAAP.

 

All amounts referred to in the notes to the consolidated financial statements are in United States Dollars ($) unless stated otherwise.

 

c)Use of Estimates

 

The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions, which are evaluated on an ongoing basis, that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the amounts of revenues and expenses that are not readily apparent from other sources. Actual results could differ from those estimates and judgments. In particular, significant estimates and judgments include those related to, the estimated useful lives for plant and equipment, the fair value of long-lived investments, the fair value of warrants and stock options granted for services or compensation, convertible notes and amendments thereto, derivative liabilities, the valuation allowance for deferred tax assets due to continuing operating losses and the allowance for doubtful accounts.

 

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from our estimates.

 

d)Contingencies

 

Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company, but which will only be resolved when one or more future events occur or fail to occur.

 

The Company’s management assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment.

 

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s unaudited condensed consolidated financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material would be disclosed. Loss contingencies considered to be remote by management are generally not disclosed unless they involve guarantees, in which case the guarantee would be disclosed.

 

e)Fair Value of Financial Instruments

 

The Company adopted the guidance of Accounting Standards Codification (“ASC”) 820 for fair value measurements which clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:

 

Level 1 - Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date.

 

Level 2 - Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated by observable market data.

 

Level 3 - Inputs are unobservable inputs which reflect the reporting entity’s own assumptions on what assumptions the market participants would use in pricing the asset or liability based on the best available information.

 

The carrying amounts reported in the balance sheets for cash, accounts receivable, other current assets, other assets, accounts payable, accrued liabilities, and notes payable, approximate fair value due to the relatively short period to maturity for these instruments. The Company has identified the short-term convertible notes and certain warrants attached to certain of the notes that are required to be presented on the balance sheets at fair value in accordance with the accounting guidance.

 

ASC 825-10 “Financial Instruments” allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (fair value option). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable unless a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent reporting date. We evaluate the fair value of variably priced derivative liabilities on a quarterly basis and report any movements thereon in earnings.

 

f)Risks and Uncertainties

 

The Company’s operations and prospects are and will be subject to significant risks and uncertainties including financial, operational, regulatory, and other risks, including the potential risk of business failure. The recent wars in Ukraine and Israel and the global inflationary environment which has resulted in significant interest rate increases in the U.S and abroad has resulted in a general tightening in the credit markets, lower levels of liquidity, increases in the rates of default and bankruptcy, and extreme volatility in credit, equity and fixed income markets. These conditions may not only limit the Company’s access to capital, but also make it difficult for its customers, vendors and the Company to accurately forecast and plan future business activities, which may have an adverse impact on its business and financial condition and may hamper the Company’s ability to generate revenue and access usual sources of liquidity on reasonable terms.

 

The Company’s results may be adversely affected by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, and rates and methods of taxation, among other things.

 

g)Recent accounting pronouncements

 

The Financial Accounting Standards Board (“FASB”) issued additional updates during the quarter ended March 31, 2024. None of these standards are either applicable to the Company or require adoption at a future date and none are expected to have a material impact on the Company’s unaudited condensed consolidated financial statements upon adoption.

 

h)Reporting by Segment

 

No segmental information is required as the Company has only one operating segment.

 

i)Cash and Cash Equivalents

 

The Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents. At March 31, 2024 and December 31, 2023, respectively, the Company had no cash equivalents.

 

The Company minimizes credit risk associated with cash by periodically evaluating the credit quality of its primary financial institution in the United States. The balance at times may exceed federally insured limits. At March 31, 2024 and December 31, 2023, the balance did not exceed federally insured limits.

 

j)Accounts Receivable and Allowance for Doubtful Accounts

 

Accounts receivable are reported at realizable value, net of allowances for doubtful accounts, which is estimated and recorded in the period the related revenue is recorded. The Company has a standardized approach to estimate and review the collectability of its receivables based on a number of factors, including the period they have been outstanding. Historical collection and payer reimbursement experience is an integral part of the estimation process related to allowances for doubtful accounts. In addition, the Company regularly assesses the state of its billing operations in order to identify issues, which may impact the collectability of these receivables or reserve estimates. Revisions to the allowance for doubtful accounts estimates are recorded as an adjustment to bad debt expense. Receivables deemed uncollectible are charged against the allowance for doubtful accounts at the time such receivables are written-off. Recoveries of receivables previously written-off are recorded as credits to the allowance for doubtful accounts. There were no recoveries during the period ended March 31, 2024 and 2023.

 

k)Investments

 

The Company’s non-marketable equity securities are investments in privately held companies without readily determinable market values. The carrying value of our non-marketable equity securities is adjusted to fair value for observable transactions for identical or similar investments of the same issuer or impairment (referred to as the measurement alternative). All gains and losses on non-marketable equity securities, realized and unrealized, are recognized in other income (expense), net. Non-marketable equity securities that have been remeasured during the period are classified within Level 3 in the fair value hierarchy because the Company estimates the value based on valuation methods using the observable transaction price at the transaction date and other unobservable inputs including volatility, rights, and obligations of the securities the Company holds. The cost method is used when the Company has a passive, long-term investment that doesn’t result in influence over the Company. The cost method is used when the investment results in an ownership stake of less than 20%, and there is no substantial influence. Under the cost method, the stock purchased is recorded on a balance sheet as a non-current asset at the historical acquisition/purchase price, and is not modified unless shares are sold, additional shares are purchased or there is evidence of the fair market value of the investment declining below carrying value. Any dividends received are recorded as income.

 

l)Plant and Equipment

 

Plant and equipment is stated at cost, less accumulated depreciation. Plant and equipment with costs greater than $1,000 are capitalized and depreciated. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The estimated useful lives of the assets are as follows:

 

Description  Estimated Useful Life
    
Computer equipment  3 years
    
Office equipment  10 years

 

The cost of repairs and maintenance is expensed as incurred. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gains or losses are included in income in the year of disposition.

 

m)Long-Term Assets

 

Assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets.

 

n)Revenue Recognition

 

The Company’s revenue recognition policy is consistent with the requirements of FASB ASC 606, Revenue.

 

The Company’s revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those services. The Company derives its revenues from the sale of its services, as defined below. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its revenue transactions:

 

i.identify the contract with a customer;

 

ii.identify the performance obligations in the contract;

 

iii.determine the transaction price;

 

iv.allocate the transaction price to performance obligations in the contract; and

 

v.recognize revenue as the performance obligation is satisfied.

 

The Company had minimal revenues of $0 and $433 for the three months ended March 31, 2024 and 2023, respectively. 

 

o)Share-Based Payment Arrangements

 

Generally, all forms of share-based payments, including stock option grants, restricted stock grants and stock appreciation rights are measured at their fair value on the awards’ grant date, based on the estimated number of awards that are ultimately expected to vest. Share-based compensation awards issued to non-employees for services rendered are recorded at either the fair value of the services rendered or the fair value of the share-based payment, whichever is more readily determinable. The expense resulting from share-based payments is recorded in operating expenses in the consolidated statement of operations.

 

Prior to the Company’s reverse merger which took place on May 12, 2016, all share-based payments were based on management’s estimate of market value of the Company’s equity. The factors considered in determining managements estimate of market value includes, assumptions of future revenues, expected cash flows, market acceptability of our technology and the current market conditions. These assumptions are complex and highly subjective, compounded by the business being in its early stage of development in a new market with limited data available.

 

Where equity transactions with arms-length third parties, who had applied their own assumptions and estimates in determining the market value of our equity, had taken place prior to and within a reasonable time frame of any share-based payments, the value of those share transactions have been used as the fair value for any share-based equity payments.

 

Where equity transactions with arms-length third parties, included both shares and warrants, the value of the warrants have been eliminated from the unit price of the securities using a Black-Scholes valuation model to determine the value of the warrants. The assumptions used in the Black Scholes valuation model includes market related interest rates for risk-free government issued treasury securities with similar maturities; the expected volatility of the Common Stock based on companies operating in similar industries and markets; the estimated stock price of the Company; the expected dividend yield of the Company and; the expected life of the warrants being valued.

 

Subsequent to the Company’s reverse merger which took place on May 12, 2016, the Company has utilized the market value of its Common Stock as quoted on the OTCQB, as an indicator of the fair value of its Common Stock in determining share- based payment arrangements.

 

p)Derivative Liabilities

 

ASC 815 generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re- measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional, as described.

 

q)Income Taxes

 

The Company is based in the U.S. and currently enacted U.S. tax laws are used in the calculation of income taxes.

 

Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A full valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized. It is the Company’s policy to classify interest and penalties on income taxes as interest expense or penalties expense. As of March 31, 2024 and December 31, 2023, there have been no interest or penalties incurred on income taxes.

 

r)Comprehensive income

 

Comprehensive income is defined as the change in equity of a company during a period from transactions and other events and circumstances excluding transactions resulting from investments from owners and distributions to owners. The Company does not have any comprehensive income (loss) for the periods presented.

 

s)Reclassification of prior year presentation

 

Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations.

v3.24.1.1.u2
Liquidity Matters and Going Concern
3 Months Ended
Mar. 31, 2024
Liquidity Matters and Going Concern [Abstract]  
LIQUIDITY MATTERS AND GOING CONCERN
3 LIQUIDITY MATTERS AND GOING CONCERN

 

The Company’s financial statements are prepared using U.S. GAAP applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has incurred net losses since its inception and anticipates net losses and negative operating cash flows for the near future. For and as of the three months ended March 31, 2024, the Company had a net loss of $331,465 In connection with preparing the unaudited condensed consolidated financial statements for the three months ended March 31, 2024, management evaluated the risks described in Note 2(f) above on the Company’s business and its future liquidity for the next twelve months from the date of issuance of these financial statements.

 

The accompanying financial statements for the period ended March 31, 2024 have been prepared assuming the Company will continue as a going concern, but the ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it establishes a revenue stream and becomes profitable. Management’s plans to continue as a going concern include raising additional capital through sales of equity securities and borrowing. However, management cannot provide any assurances that the Company will be successful in accomplishing any of its plans. If the Company is not able to obtain the necessary additional financing on a timely basis, the Company will be required to delay, and reduce the scope of the Company’s development and operations. Continuing as a going concern is dependent upon its ability to successfully secure other sources of financing and attain profitable operations. The accompanying unaudited condensed consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

 

The Company has determined that there is substantial doubt about their ability to continue as a going concern.

v3.24.1.1.u2
Discontinued Operations
3 Months Ended
Mar. 31, 2024
Discontinued Operations [Abstract]  
DISCONTINUED OPERATIONS
4 DISCONTINUED OPERATIONS

 

In the prior year, effective May 12, 2023, the Company disposed of its investment in Beyond Fintech.

 

The statement of operations from discontinued operations is as follows:

 

   Three months ended 
   March 31 
   2023 
     
Net Revenue  $
-
 
Cost of Goods Sold   
-
 
Gross loss   
-
 
      
General and administrative   15,260 
Depreciation and amortization   
-
 
Total Expense   15,260 
      
Loss from operations before income taxes   (15,260)
Income Taxes   
-
 
Loss from discontinued operations, net of taxation  $(15,260)
v3.24.1.1.u2
Loans Receivable
3 Months Ended
Mar. 31, 2024
Loans Receivable [Abstract]  
LOANS RECEIVABLE
5 LOANS RECEIVABLE

 

On February 22, 2024, the Company (utilizing a portion of the proceeds from the issuance of convertible notes) loaned funds to Business Warrior Corporation (“BZWR”) in the principal amount of $226,190, which includes an original issue discount equal to $67,857, for net proceeds of $158,333. The loan is memorialized by a secured promissory note (the “BZWR Note”). The BZWR Note does not accrued interest, except in the case of an event of default, which case interest accrues at 15% per annum. The BZWR Note matures on the earlier to occur of December 31, 2025 and the date that BZWR’s securities are listed on a national securities exchange. The BZWR Note may be prepaid at any time for an amount equal to 110% of the then principal and accrued interest. IPSI shall have the right to exchange the BZWR Note for securities issued by BZWR in any subsequent private placement by BZWR. The principal and accrued interest under BZWR Note is convertible into common stock of BZWR at a price equal to $0.0036 per share, subject to certain adjustments and potential resets. BZWR’s obligations under the BZWR Note are guaranteed by BZWR’s subsidiaries and secured by a lien on BZWR’s accounts receivable.

 

The debt discount on the BZWR note is amortized as income utilizing the effective interest rate method.

 

Loans receivable consists of the following:

 

Description  Interest
Rate
   Maturity
date
  Principal   Unamortized discount  

March 31,

2024 Amount, net

 
Business Warrior Corporation   0%  December 31, 2025   226,190    (64,575)   161,615 

 

Discount amortized to income as deemed interest during the three months ended March 31, 2024 was $3,282.

v3.24.1.1.u2
Intangibles
3 Months Ended
Mar. 31, 2024
Intangibles [Abstract]  
INTANGIBLES
6 INTANGIBLES

 

On August 26, 2021, the Company formed Beyond Fintech to acquire a product known as Beyond Wallet from a third party for gross proceeds of $250,000, together with the logo, use of name and implementation of the product into the Company’s technology. The Company owned 51% of Beyond Fintech with the other 49% owned by Frictionless. Prior to the disposal of Beyond Fintech to Frictionless the Company spent an additional 77,211 on the software to further enhance the Beyond Wallet product offering.  On May 12, 2023, Beyond Fintech was sold to Frictionless.

 

During the year ended December 31, 2021, the Company paid gross proceeds of $375,000 to Frictionless for the development of the IPSIPay wallet, prior to the novation of the rights and obligation to a third party, the company spent an additional $1,171,805 to facilitate the functioning of the IPSIPay software in the cloud environment. On September 5, 2023, the Company novated all its rights and obligations to its IPSIPay wallet to a third party.

 

Amortization expense was $0 and $125,856 for the three months ended March 31, 2024 and 2023, respectively.

v3.24.1.1.u2
Equity Method Investment
3 Months Ended
Mar. 31, 2024
Equity Method Investment [Abstract]  
EQUITY METHOD INVESTMENT
7 EQUITY METHOD INVESTMENT

 

On April 28, 2023, the Company formed IPSIPay Express with OpenPath and EFinityPay. As described in note 1(b), the Company has agreed to make the IPSI Capital Contributions to IPSIPay Express. As of March 31, 2024, the initial Tranche of $500,000 and the second Tranche of $500,000 of capital contributions was paid by the Company to or on behalf of IPSIPay Express.

 

The Company accounts for its investment in IPSIPay Express in accordance with ASC 323, Investments – Equity Method and Joint Ventures, the movement in equity method investments related to IPSIPay Express for the period ended March 31, 2024 and December 31, 2023 is as follows:

 

  

March 31,
2024

   December 31,
2023
 
Cash contribution to IPSIPay Express  $999,500   $999,000 
Fair value of warrants issued to third party joint venture partners   108,220    108,220 
    1,107,720    1,107,220 
Prior period equity loss from joint venture   (403,282)   (403,282)
Current period equity income (loss) from joint venture   (484)   
-
 
   $703,954   $703,938 
v3.24.1.1.u2
Leases
3 Months Ended
Mar. 31, 2024
Leases [Abstract]  
LEASES
8 LEASES

 

On March 22, 2021, the Company entered into a real property lease for an office located at 56B 5th Street, Lot 1, #AT, Carmel By The Sea, California. The lease commenced on April 1, 2021 and is for a twelve month period, terminating on April 1, 2022. Following the expiry of the lease term, the landlord has agreed to continue the lease on a month-to-month basis at $4,800 per month. On January 1, 2023, the Company entered into a new month-to-month lease, with a 90 day termination clause, for a monthly rental of $5,088. The lease was terminated effective August 31, 2023.

 

The Company applied the practical expedient whereby operating leases with a duration of twelve months or less are expensed as incurred.

 

Total Lease Cost

 

Individual components of the total lease cost incurred by the Company is as follows:

 

   Three
months
ended
March 31,
2024
   Three
months
ended
March 31,
2023
 
Operating lease expense  $          -   $15,264 

 

Other lease information:

 

   Three
months
ended
March 31,
2024
   Three
months
ended
March 31,
2023
 
Cash paid for amounts included in the measurement of lease liabilities        
Operating cash flows from operating leases  $
     -
   $(15,264)
           
Remaining lease term – operating lease   -    Monthly 
v3.24.1.1.u2
Federal Relief Loans
3 Months Ended
Mar. 31, 2024
Federal Relief Loans [Abstract]  
FEDERAL RELIEF LOANS
9 FEDERAL RELIEF LOANS

 

Small Business Administration Disaster Relief loan

 

On July 7, 2020, the Company received a Small Business Economic Injury Disaster loan amounting to $150,000, bearing interest at 3.75% per annum and repayable in monthly installments of $731 commencing twelve months after inception with the balance of interest and principal repayable on July 7, 2050. The loan is secured by all tangible and intangible assets of the Company. The proceeds are to be used for working capital purposes to alleviate economic injury caused by the COVID-19 pandemic.

 

The company has accrued interest of $9,309 and $9,369 on this loan as of March 31, 2024 and December 31, 2023, respectively.

v3.24.1.1.u2
Notes Payable
3 Months Ended
Mar. 31, 2024
Notes Payable [Abstract]  
NOTES PAYABLE
10 NOTES PAYABLE

 

On February 16, 2021, the Company entered into separate Securities Purchase Agreements (the “SPAs”), with each of Cavalry Fund I LP (“Cavalry”) and Mercer Street Global Opportunity Fund, LLC (“Mercer”), pursuant to which the Company received $500,500 and $500,500 from Cavalry and Mercer, respectively, in exchange for the issuance of: (i) Original Issue Discount 12.5% Convertible Notes (the “Notes” and each a “Note”) in the principal amount of $572,000 to each of Cavalry and Mercer; and (ii) five-year warrants (the “Original Warrants”) issued to each of Cavalry and Mercer to purchase 2,486,957 shares of Common Stock at an exercise price of $0.24 per share.

 

In terms of the December 30, 2022 Note Amendment Transaction, described in more detail in Note 9 below, the Original Warrants issued on February 16, 2021 were irrevocably exchanged for 12-month non-convertible promissory notes in the amount of $482,000 (the “Exchange Notes”) to each of Cavalry and Mercer. This exchange caused the cancellation of the Original Warrants for all purposes. The Company accounted for the aggregate value of the notes issued of $964,000, less the fair value of the warrants exchanged for these notes of $43,608, totaling $920,392 as a component of the loss on convertible debt.

 

The Exchange Notes have a maturity date of December 30, 2023 and carry an interest rate of ten percent (10%). The Company shall have the right, but not the obligation, in lieu of a cash payment upon maturity of the Exchange Notes, to issue 51,901,711 shares of Common Stock, as adjusted for any stock splits, dividends or other similar corporate events, in full satisfaction of its obligations under each of the Exchange Notes (or any pro rata portion of such number of shares in partial satisfaction of such obligations). The Company is under no legal obligation to reserve such number of shares for future issuance.

 

On February 27, 2024, the maturity date of the notes was extended to April 30, 2024 with an automatic one month extension each month until such time as the note is declared to be in default, all other terms remain the same as the previous notes. The Company performed an analysis in terms of ASC 470 and it was determined that the extension was a debt modification, in addition, no additional consideration was paid for the maturity date extension.

 

Notes payable consists of the following: 

 

Description  Interest
Rate
   Maturity
date
  Principal   Accrued
Interest
   March 31, 2024 Amount, net  

December 31,
2023
Amount, net

 
Cavalry Fund I LP   10%  April 30, 2024   482,000    61,187    543,187    531,004 
Mercer Street Global Opportunity Fund, LLC   10%  April 30, 2024   482,000    61,187    543,187    531,003 
Total convertible notes payable          $964,000   $122,374   $1,086,374   $1,062,007 

    

Interest expense totaled $24,368 and $24,100 for the three months ended March 31, 2024 and 2023, respectively.

v3.24.1.1.u2
Convertible Notes Payable
3 Months Ended
Mar. 31, 2024
Convertible Notes Payable [Abstract]  
CONVERTIBLE NOTES PAYABLE
11 CONVERTIBLE NOTES PAYABLE

 

December 2022 Note Amendment Transaction

 

The Company twice extended its indebtedness to each Cavalry and Mercer. On February 3, 2022, the Company agreed to extend the maturity date of the Cavalry/Mercer Notes to August 16, 2022. Additionally, on August 30, 2022, the Company entered agreements for an additional maturity date extension to November 16, 2022. In consideration for the second extension, the Company agreed to (i) increase the principal amount outstanding and due to Cavalry and Mercer under the Cavalry/Mercer Notes by twenty percent (20%) and (ii) issue to each of Cavalry and Mercer a new five-year warrant (each, an “Extension Warrant”) to purchase an additional 100,000 shares of Common Stock at an exercise price of $4.50 per share. The Extension Warrant contains the same terms and provisions in all material respects as the Original Warrants, except for difference in exercise price.

 

On December 30, 2022, the Company again extended the maturity dates of each of the Cavalry/Mercer Notes to December 30, 2023. Each of Cavalry and Mercer entered into Note Amendment Letter Agreement with the Company (the “Note Amendment”) pursuant to which the parties agreed to the following:

 

(1)The conversion price of the Cavalry/Mercer Notes was reduced from $4.50 to $0.345 per share (such reduced conversion price being the current conversion price of the Notes give the passage of the November 16, 2022 maturity date of the Cavalry/Mercer Notes). As a result of this change in conversion price, under the existing terms of the Cavalry/Mercer Notes, the 100,000 shares of Common Stock underlying the Extension Warrants was increased to 1,304,348 shares;

 

(2)The Original Warrants issued on February 16, 2021 were irrevocably exchanged for 12-month non-convertible promissory notes in the amount of $482,000 (the “Exchange Notes”). This exchange caused the cancellation of the Original Warrants for all purposes. The Exchange Notes have a maturity date of December 30, 2023 and carry an interest rate of ten percent (10%). The Company shall have the right, but not the obligation, in lieu of a cash payment upon maturity of the Exchange Notes, to issue 1,730,057 shares of Common Stock, as adjusted for any stock splits, dividends or other similar corporate events, in full satisfaction of its obligations under each of the Exchange Notes (or any pro rata portion of such number of shares in partial satisfaction of such obligations). The Company is under no legal obligation to reserve such number of shares for future issuance;

 

(3)Each of Cavalry and Mercer agreed (i) not to convert all or any portion of the Cavalry/Mercer Notes until after March 30, 2023 and (ii) waive any events of default under the Cavalry/Mercer Notes and the Cavalry/Mercer SPAs;

 

(4)Certain other warrants held by Cavalry and Mercer which contain a mandatory exercise provision allowing us to force exercise of such warrants if the price of the Common Stock is $1.80 per share or above were amended effective December 30, 2022 to reduce such forced exercise price to $1.20 per share; and

 

(5)The Company was obligated to register the shares of Common Stock underlying the Cavalry/Mercer Notes and the shares underlying all warrants held by Cavalry and Mercer for resale with the Securities and Exchange Commission and the Company filed the registration statement to satisfy such registration obligation.

 

The parties also acknowledged that the principal and accrued interest under the Cavalry/Mercer Notes as of December 28, 2022 is equal to an aggregate of $2,264,784, or $1,132,392 for each of Cavalry and Mercer. In addition, as a result of the reduction in the conversion price of the Cavalry/Mercer Notes, certain other warrants held by third parties have their exercise price of such warrants reduced to $0.345 per share. All of the shares of our Common Stock underlying the Cavalry/Mercer Notes as amended and all warrants held by Cavalry and Mercer as adjusted were registered for resale pursuant to a registration statement that was declared effective on February 6, 2023.

 

The amendments to the Cavalry/Mercer Notes were evaluated in terms of ASC 470, Debt, to determine if the amendments to the Cavalry/Mercer Notes were considered a modification of the debt or an extinguishment of the debt. Based on the penalty interest incurred on the convertible notes of $836,414, the reduction in the conversion price of the Cavalry/Mercer Notes from $4.50 to $0.345 per share, which was valued at $1,499,577 using a Black-Scholes valuation model, the issuance of additional warrants to the Cavalry and Mercer valued at $238,182 using a Black-Scholes valuation model and the conversion of certain warrants held by Cavalry and Mercer to notes payable, resulting in an additional charge of $920,392, consisting of a mark-to-market warrant cost of $43,608 and the value of the notes of $964,000 (see note 11 above) and the value of full rachet provisions of certain of the warrants issued to the Cavalry and Mercer amounting to $841,003 (see note 14 below), the amendment of the Cavalry/Mercer Notes was determined to be a debt extinguishment.

 

Effective December 30, 2023, on February 27, 2024, the Company again extended the maturity dates of each of the Cavalry/Mercer Notes to April 30, 2024, with an automatic one month extension each month until such time as the note is declared to be in default, other than the maturity date all other terms remained the same. The Company performed an analysis in terms of ASC 470 and it was determined that the extension was a debt modification, in addition, no additional consideration was paid for the maturity date extension.

 

Convertible notes payable consists of the following:

 

Description  Interest
Rate
   Maturity
date
  Principal   Accrued
Interest
   Unamortized
debt discount
   March 31,
2024
Amount, net
   December 31,
2023
Amount, net
 
Cavalry Fund I LP   10.00 %  April 30, 2024  $898,980   $32,963   $
-
   $931,943   $909,218 
Mercer Street Global  Opportunity Fund, LLC   10.00 %  April 30, 2024   991,754    173,079    
-
    1,164,833    1,139,764 
Red Road Holdings Corporation*   
29.32
%  June 15, 2024   52,691    722    (14,457)   38,956    41,771 
    27.77 %  July 30, 2024   43,385    880    (18,419)   25,846    18,683 
    32.04 %  September 30, 2024   51,148    1,209    (32,843)   19,514    3,109 
Quick Capital, LLC*   11.12 %  September 30, 2024   114,286    2,348    (52,602)   64,032    
-
 
2023 and 2024 convertible notes    8.00 to 12.00 %  May 22, 2024 to February 21, 2025   2,335,001    127,735    (314,381)   2,148,355    1,591,735 
Total convertible notes payable           $4,487,245   $338,936   $(432,702)  $4,393,479   $3,704,280 

  

*The Red Road Holdings Corporation and Quick Capital LLC, interest rates are an effective interest rate as these convertible notes have a fixed interest charge which is earned on the issuance date, regardless of when payments are made.

 

Interest expense totaled $110,769 and $59,737 for the three months ended March 31, 2024 and 2023, respectively.

 

Amortization of debt discount totaled $319,899 and $22,967 for the three months ended March 31, 2024 and 2023, respectively.

 

The Cavalry, Mercer and Red Road Holdings convertible notes have variable conversion prices based on a discount to market price of trading activity over a specified period of time. The variable conversion features were valued using a Black Scholes valuation model. The difference between the fair market value of the Common Stock and the calculated conversion price on the issuance date was recorded as a debt discount with a corresponding credit to derivative financial liability.

 

Cavalry Fund LP

 

On February 16, 2021, the Company closed a transaction with Cavalry pursuant to which the Company received net proceeds of $500,500, after an original issue discount of $71,500 in exchange for the issuance of a $572,000 Senior Secured Convertible Note, bearing interest at 10% per annum and maturing on February 16, 2022. The Note was convertible into shares of Common Stock at an initial conversion price of $0.23 per share, in addition, the Company issued a warrant exercisable for 82,899 shares of Common Stock at an initial exercise price of $7.20 per share.

 

As described more fully above, the maturity date of the note was extended to August 16, 2022, additionally to November 16, 2022 and again to December 30, 2023. In consideration for the November 16, 2022 extension, the Company agreed to (i) increase the principal amount outstanding and due to Cavalry by twenty percent (20%) and (ii) issue a new five-year warrant to purchase an additional 100,000 shares of Common Stock at an exercise price of $4.50 per share. In consideration of the December 30, 2022 extension, the Company agreed to the following terms; (i) the conversion price of the Note was reduced from $4.50 to $0.345 per share; (ii) Cavalry agreed (a) not to convert all or any portion of the Notes until after March 30, 2023 and (b) waive any events of default under the Note and the SPA; (iii) the Company agreed to and registered the shares of Common Stock underlying the Note and the shares underlying all warrants held by Cavalry for resale with the Securities and Exchange Commission and filed the registration statement to satisfy the Company’s registration obligation.  

 

Between August 24, 2023 and November 20, 2023, Cavalry converted $139,726 of interest and $192,774 of interest into 963,769 shares of Common Stock at a conversion price of $0.345 per share realizing a loss on conversion of $42,210.

 

On February 27, 2024, the maturity date of the notes was extended to April 30, 2024, , with an automatic one month extension each month until such time as the note is declared to be in default, all other terms remain the same as the previous notes. Based on an analysis performed in terms of ASC470, the amendment to the agreement was determined to be a debt modification, there were no expenses incurred on the amendment and interest will be accrued at the effective interest rate.

 

The balance of the Cavalry Note plus accrued interest at March 31, 2024 was $931,943.

 

Mercer Street Global Opportunity Fund, LLC

 

On February 16, 2021, the Company closed a transaction with Mercer, pursuant to which the Company received net proceeds of $500,500, after an original issue discount of $71,500 in exchange for the issuance of a $572,000 Senior Secured Convertible Note, bearing interest at 10% per annum and maturing on February 16, 2022. The Note is convertible into shares of Common Stock at an initial conversion price of $6.90 per share, in addition, the Company issued a warrant exercisable for 82,899 shares of Common Stock at an initial exercise price of $7.20 per share.

 

As described more fully above, the maturity date of the note was extended to August 16, 2022, additionally to November 16, 2022 and again to December 30, 2023. In consideration for the November 16, 2022 extension, the Company agreed to (i) increase the principal amount outstanding and due to Mercer by twenty percent (20%) and (ii) issue a new five-year warrant to purchase an additional 100,000 shares of Common Stock at an exercise price of $4.50 per share. In consideration of the December 30, 2022 extension, the Company agreed to the following terms; (i) the conversion price of the Note was reduced from $4.50 to $0.345 per share; (ii) Mercer agreed (a) not to convert all or any portion of the Notes until after March 30, 2023 and (b) waive any events of default under the Note and the SPA; (iii) the Company agreed to and registered the shares of Common Stock underlying the Note and the shares underlying all warrants held by Mercer for resale with the Securities and Exchange Commission and filed the registration statement to satisfy the Company’s registration obligation.

 

Between May 19, 2023 and August 30, 2023, Mercer converted an aggregate of $100,000 into 289,856 shares of Common Stock at a conversion price of $0.345 per share, realizing a loss on conversion of $48,551.

 

On February 27, 2024, Cavalry entered into a note amendment with the company extending the maturity date of the convertible note to April 30, 2024. with an automatic one month extension each month until such time as the note is declared to be in default, all other terms remain the same as the previous notes. Based on an analysis performed in terms of ASC 470, the amendment to the agreement was determined to be a debt modification, there were no expenses incurred on the amendment and interest will be accrued at the effective interest rate.

 

The balance of the Mercer Note plus accrued interest at March 31, 2024 was $1,164,833.

 

Red Road Holdings Corporation

 

 

On September 9, 2023, the Company closed a transaction with Red Road Holdings Corporation (“RRH”) pursuant to which the Company received net proceeds of $125,000, after an original issue discount and fees of $21,900 in exchange for the issuance of a $146,900 Convertible Note (“RRH Note 1”), bearing interest at 13%, which interest is earned on issuance of the note, an effective interest rate of 29.3%, and maturing on June 15, 2024. The RRH Note 1 has mandatory monthly repayments of $18,444 which commenced on October 14, 2023. The RRH Note 1 is convertible into shares of Common Stock at a variable conversion rate of 60% of the lowest trading price twenty trading days before conversion.

 

The balance of the RRH Note 1 plus accrued interest at March 31, 2024 was $38,956, net of unamortized debt discount of $14,457.

     
 

On October 19, 2023, the Company closed a transaction with RRH pursuant to which the Company received net proceeds of $60,000, after an original issue discount and fees of $13,450 in exchange for the issuance of a $73,450 Convertible Note (“RRH Note 2”), bearing interest at 13%, which interest is earned on issuance of the note, an effective interest rate of 27.8%, and maturing on July 30, 2024. The RRH Note 2 has mandatory monthly repayments of $9,222 which commenced on November 30, 2023. The RRH Note 2 is convertible into shares of Common Stock at a variable conversion rate of 60% of the lowest trading price twenty trading days before conversion.

 

The balance of the RRH Note 2 plus accrued interest at March 31, 2024 was $25,846, net of unamortized debt discount of $18,419.

     
 

On December 20, 2023, the Company closed a transaction with RRH pursuant to which the Company received net proceeds of $50,000, after an original issue discount and fees of $13,250 in exchange for the issuance of a $63,250 Convertible Note (“RRH Note 3”), bearing interest at 15%, which interest is earned on issuance of the note, an effective interest rate of 32.0%, and maturing on September 30, 2024. The RRH Note 3 has mandatory monthly repayments of $8,082. The RRH Note 3 is convertible into shares of Common Stock at a variable conversion rate of 60% of the lowest trading price twenty trading days before conversion.

 

The balance of the RRH Note 3 plus accrued interest at March 31, 2024 was $19,514, net of unamortized debt discount of $32,842.

 

Quick Capital, LLC

 

On March 4, 2024, the Company closed a transaction with Quick Capital, LLC pursuant to which the Company received net proceeds of $94,000, after an original issue discount and fees of $20,286 in exchange for the issuance of a $114,286 Convertible Note, bearing interest at an effective interest rate of 11.12% per annum, which interest is earned on issuance of the note, and maturing on September 4, 2024. The Note is convertible into shares of Common Stock at an initial conversion price of $0.345 per share, in addition, the Company issued a warrant exercisable for 357,764 shares of Common Stock at an initial exercise price of $0.345 per share.

 

The balance of the Quick Capital note plus accrued interest at March 31, 2024 was $64,032, net of unamortized debt discount of $52,602.

 

2023 and 2024 Convertible Notes

 

Between February 13, 2023 and November 27, 2023, the Company entered into Securities Purchase Agreements with 30 accredited investors (the “2023 Notes”), and between February 6, 2024 and February 21, 2024 (the “2024 Notes”), the Company entered into Securities Purchase Agreements with 4 accredited investors, pursuant to which the Company received an aggregate of $2,026,666 from the 2023 Notes and $308,335 from the 2024 Notes,  in gross proceeds in private placements through the issuance of:

 

  Convertible Promissory Notes (the “2023 Notes and 2024 Notes”); and

 

  five-year warrants to purchase an aggregate 5,696,586 shares of Common Stock (the “2023 Warrants”), at an exercise price of $0.345 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events).

 

The 2023 Notes and the 2024 Notes mature between 3.5 months and 12 months, bear interest at rates between 8% and 12% per annum, and are convertible into shares of Common Stock at a conversion price of $0.345 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events). The 2023 Notes and 2024 Notes may be prepaid at any time without penalty. The Company is under no obligation to register the shares of Common Stock underlying the 2023 Notes and the 2024 Notes or the 2023 Warrants for public resale.

 

The 2023 Notes, the 2024 Notes and the 2023 Warrants contain conversion limitations providing that a holder thereof may not convert the 2023 Notes or exercise the 2023 Warrants to the extent that, if after giving effect to such conversion, the holder or any of its affiliates would beneficially own in excess of 4.99% (the “Maximum Percentage”) of the outstanding shares of the Common Stock immediately after giving effect to such conversion or exercise. A holder may increase or decrease its beneficial ownership limitation upon notice to the Company provided that in no event such limitation exceeds 9.99%, and that any increase shall not be effective until the 61st day after such notice.

 

On December 14, 2023, two notes totaling $225,000 which matured on December 31, 2023 were rolled over for an additional 3 months to March 30, 2024. In exchange for the roll-over, the Company issued the note holders warrants exercisable for 292,463 shares of Common Stock at an exercise price of $0.345 per share. On May 4, 2024, the maturity date of the $200,000 note was further extended to June 14, 2024, and the maturity date of the $25,000 note was further extended to June 30, 2024. In exchange for the maturity date extension, the Company issued to note holders warrants exercisable for 292,463 shares of Common Stock at an exercise price of $0.345 per share.

 

On March 14, 2024, the Company extended the maturity date of 11 convertible notes maturing between February 13, 2024 and February 23, 2024 by an additional six months and as compensation for the extension, the note holders were issued warrants exercisable for 387,673 shares of Common Stock at an exercise price of $0.345 per share. The modification was assessed in terms of ASC 470 and determined to be a debt extinguishment, resulting in the warrant value of $66,047 being expensed as a loss on convertible notes.

 

The balance of the 2023 Notes and the 2024 Notes plus accrued interest at March 31, 2024 was $2,148,355, net of unamortized debt discount of $314,381.

v3.24.1.1.u2
Derivative Liability
3 Months Ended
Mar. 31, 2024
Derivative Liability [Abstract]  
DERIVATIVE LIABILITY
12 DERIVATIVE LIABILITY

 

The convertible notes and warrants issued by the Company to Cavalry, Mercer and RRH as described herein have variable priced conversion rights with no fixed floor price and will re-price dependent on the share price performance over varying periods of time and certain notes and warrants have fundamental transaction clauses which might result in cash settlement, due to these factors, all convertible notes and any warrants attached thereto are valued and give rise to a derivative financial liability, which was initially valued at inception of the convertible notes using a Black-Scholes valuation model.

 

Between September 12, 2023 and December 20, 2023, the Company entered into a convertible note agreement with RRH which have variable priced conversion rights with no fixed floor price and will re-price dependent on the share price performance over varying periods of time, which gave rise to a derivative financial liability, which was initially valued at inception of the convertible notes at $416,317 but limited to the cash value of the convertible notes of $235,000, using a Black-Scholes valuation model.

 

The net movement on the derivative liability for the three months ended March 31, 2024 was a net mark-to-market credit of $815,941 determined by using a Black-Scholes valuation model.

 

The following assumptions were used in the Black-Scholes valuation model:

 

   Three months
ended
March 31,
2024
   Year ended
December 31,
2023
 
Conversion price   $ 0.0684 to $0.345     $ 0.104 to $0.345  
Risk free interest rate   4.40 to 5.49 %    3.60 to 5.55 %
Expected life of derivative liability   1 to 41 months      3.5 to 47 months  
Expected volatility of underlying stock   157.83 to 201.11 %     158.72 to 217.01 %
Expected dividend rate   0%   0%

 

The movement in derivative liability is as follows:

 

   March 31,
2024
   December 31,
2023
 
Opening balance  $1,434,196   $2,550,642 
Derivative financial liability arising from convertible note and warrants   
-
    385,000 
Fair value adjustment to derivative liability   (815,941)   (1,501,446)
   $618,255   $1,434,196 
v3.24.1.1.u2
Stockholders’ Equity
3 Months Ended
Mar. 31, 2024
Stockholders’ Equity [Abstract]  
STOCKHOLDERS’ EQUITY
13 STOCKHOLDERS’ EQUITY

 

  a. Common Stock

 

The Company has total authorized Common Stock of 750,000,000 shares with a par value of $0.0001 each. The Company had 13,819,889 shares of Common Stock issued and outstanding as of March 31, 2024 and December 31, 2023.

 

On May 19, 2023, in terms of a conversion notice received from a convertible note holder, the Company issued 72,464 shares of Common Stock for the conversion of $25,000 of convertible debt, refer Note 11 above.

 

On August 16, 2023, in terms of a conversion notice received from a convertible note holder, the Company issued 72,464 shares of Common Stock for the conversion of $25,000 of convertible debt, refer Note 11 above.

 

On August 24, 2023, in terms of a conversion notice received from a convertible note holder, the Company issued 173,914 shares of Common Stock for the conversion of $60,000 of interest on convertible debt, refer Note 11 above.

 

On August 30, 2023, the Company effectuated a 1 for 30 reverse stock split, resulting in the issuance of an additional 2,838 shares to existing stockholders due to rounding of existing shareholdings. All share amounts disclosed in the unaudited condensed consolidated financial statements have been adjusted to reflect the Company’s 1 for 30 reverse stock split effectuated on August 30, 2023.

 

On August 31, 2023, in terms of a conversion notice received from a convertible note holder, the Company issued 144,928 shares of Common Stock for the conversion of $50,000 of convertible debt, refer note 11 above.

 

On November 8, 2023, in terms of a conversion notice received from a convertible note holder, the Company issued 289,855 shares of Common Stock for the conversion of $100,000 of convertible debt, refer note 11 above.

 

On November 20, 2023, in terms of a conversion notice received from a convertible note holder, the Company issued 500,000 shares of Common Stock for the conversion of $172,500 of convertible debt, refer note 11 above.

 

  b. Restricted stock awards

 

A summary of restricted stock activity during the period January 1, 2023 to March 31, 2024 is as follows:

 

   Total
restricted
shares*
   Weighted
average
fair market
value per
share*
   Total
unvested
restricted
shares*
   Weighted
average
fair market
value per
share*
   Total vested
restricted
shares*
   Weighted
average
fair market
value per share*
 
Outstanding January 1, 2023   783,167   $1.50    170,792   $1.47    612,375   $1.50 
Granted and issued   
-
    
-
    
-
    
-
    
-
    
-
 
Forfeited/Cancelled   
-
    
-
    
-
    
-
    
-
    
-
 
Vested   
-
    
-
    (170,792)   (1.47)   170,792    1.47 
Outstanding December 31, 2023   783,167   $1.50    
-
   $
-
    783,167   $1.50 
Granted and issued   
-
    
-
    
-
    
-
    
-
    
-
 
Forfeited/Cancelled   
-
    
-
    
-
    
-
    
-
    
-
 
Vested   
-
    
-
    
-
    
-
    
-
    
-
 
Outstanding March 31, 2024   783,167   $1.50    
-
   $
-
    783,167   $1.50 

 

*After giving effect to a 1 for 30 reverse stock split on August 30, 2023.

 

The restricted stock granted, issued and exercisable at March 31, 2024 is as follows:

 

    Restricted Stock
Granted and
Vested
 
Grant date Price   Number Granted*   Weighted Average Fair Value per Share* 
$1.47    683,167   $1.47 
$1.50    33,333    1.50 
$1.65    66,667    1.65 
      783,167   $1.50 

 

*After giving effect to a 1 for 30 reverse stock split on August 30, 2023.

 

The Company has recorded an expense of $0  for the three months ended March 31, 2024 and 2023. 

 

c.Preferred Stock

 

The Company has authorized 25,000,000 shares of preferred stock with a par value of $0.0001 authorized. No preferred stock was issued and outstanding as of March 31, 2024 and December 31, 2023.

 

  d. Warrants

 

Between February 13, 2023 and November 27, 2023, the Company entered into Securities Purchase Agreements with 30 accredited investors, as disclosed in note 11 above. In terms of these Securities Purchase Agreements, the Company issued five-year warrants to purchase an aggregate 5,696,586 shares of the Common Stock at an exercise price of $0.345 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events). The Company is under no obligation to register the shares of Common Stock underlying the 2023 Notes or the 2023 Warrants for public resale.

 

On August 11, 2023, the company issued an investor a five-year replacement warrant for a warrant that had expired on February 13, 2023 exercisable for 33,334 shares of Common Stock at an exercise price of $1.50 per share.

 

In connection with the formation of IPSIPay Express, the Company issued to each of the other venture partners, OpenPath and EfinityPay, IPEX Warrants to purchase an aggregate of 133,334 shares of Common Stock with an exercise of $0.45 per share. The Company is obligated to issue each of OpenPath and EfinityPay additional IPEX Warrants to purchase 199,999 shares of Common Stock at a price equal to the average public closing price of the Common Stock for the three trading days immediately prior to the funding of the remaining initial Tranche. Simultaneously with the funding of the second Tranche in September 2023, the Company became obligated to issue to each of OpenPath and EfinityPay an additional IPEX Warrant to purchase 166,667 shares of Common Stock with an exercise price equal to the average public closing price of the Common Stock for the three trading days immediately prior to the funding of the second Tranche. Simultaneously with the funding of the third Tranche, the Company will issue to each of OpenPath and EfinityPay an additional IPEX warrant to purchase 166,667 shares of Common Stock with an exercise price equal to the average public closing price of the Common Stock for the three trading days immediately prior to the funding of the third Tranche. If the full IPSI Capital Contribution is funded, OpenPath and EfinityPay will receive IPEX Warrants to purchase an aggregate of 1,333,334 shares of Common Stock. See note 1(b) above.

 

On December 14, 2023, the maturity date of two notes totaling $225,000 which matured on December 31, 2023 were extended for an additional 3 months to March 30, 2024. In exchange for the maturity date extension, the Company issued the note holders five-year warrants exercisable for 292,463 shares of Common Stock at an exercise price of $0.345 per share. On May 4, 2024, the maturity date of the $200,000 note was further extended to June 14, 2024, and the maturity date of the $25,000 note was further extended to June 30, 2024. In exchange for the maturity date extension, the Company issued to note holders warrants exercisable for 292,463 shares of Common Stock at an exercise price of $0.345 per share.

  

During 2023, warrants exercisable for 33,334 shares expired as unexercised and an additional warrant exercisable for 1,000,000 shares of Common Stock was forfeited on the disposal of Frictionless and Beyond Fintech.

 

On March 4, 2024, the Company entered into a Securities Purchase Agreement with an accredited investor, as disclosed in note 11 above. In terms of the Securities Purchase Agreement, the Company issued a five-year warrant to purchase an aggregate of 357,764 shares of the Common Stock at an exercise price of $0.345 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events). The Company is under no obligation to register the shares of Common Stock underlying the Note or the Warrant, for public resale.

 

On March 14, 2024, the Company extended the maturity date of 11 convertible notes maturing between February 13, 2024 and February 23, 2024 by an additional six months and as compensation for the extension, the note holders were issued warrants exercisable for 387,673 shares of Common Stock at an exercise price of $0.345 per share.

 

The 2023 and 2024 Warrants contain conversion limitations providing that a holder thereof may not exercise the Warrants to the extent that, if after giving effect to such exercise, the holder or any of its affiliates would beneficially own in excess of 4.99% (the “Maximum Percentage”) of the outstanding shares of the Common Stock immediately after giving effect to such exercise. A holder may increase or decrease its beneficial ownership limitation upon notice to the Company provided that in no event such limitation exceeds 9.99%, and that any increase shall not be effective until the 61st day after such notice.

  

The fair value of the warrants granted and issued, as described above, were determined by using a Black Scholes valuation model using the following assumptions:

 

   Three months ended
March 31,
2024
 
Exercise price  $0.345 
Risk free interest rate   4.15 to 4.21%
Expected life    5 years 
Expected volatility of underlying stock    190.72 to 191.17%
Expected dividend rate   0%

 

A summary of warrant activity during the period January 1, 2023 to March 31, 2024 is as follows:

 

   Shares
Underlying
Warrants*
   Exercise
price per
share*
   Weighted
average
exercise
price*
 
Outstanding January 1, 2023   5,186,376   $0.345 – 5.625   $0.9000 
Granted   6,289,051     0.345 – 1.50    0.3556 
Forfeited   (33,334)   1.50    1.5000 
Cancelled on disposal of investment in Frictionless and Beyond Fintech   (1,000,000)   0.345    0.3450 
Exercised   
-
    
-
    
-
 
Outstanding December 31, 2023   10,442,093   $0.345 – 5.625   $0.6265 
Granted   745,437    0.345    0.345 
Forfeited   
-
    
-
    
-
 
Cancelled on disposal of investment in Frictionless and Beyond Fintech   
-
    
-
    
-
 
Exercised   -    
-
    
-
 
Outstanding March 31, 2024   11,187,530   $0.345 – 5.625   $0.6077 

 

*After giving effect to a 1 for 30 reverse stock split on August 30, 2023.

 

The warrants outstanding and exercisable at March 31, 2024 are as follows:

 

    Warrants Outstanding*   Warrants Exercisable* 
Exercise Price*   Number
Outstanding*
   Weighted
Average
Remaining
Contractual
life in years
   Weighted
Average
Exercise
Price*
   Number
Exercisable*
   Weighted
Average
Exercise
Price*
   Weighted
Average
Remaining
Contractual
life in years
 
$0.345    9,801,079    3.99         9,801,079         3.99 
$0.450    266,668    4.23         266,668         4.23 
$1.035    500,000    1.27         468,750         1.27 
$1.500    33,334    4.37         33,334         4.37 
$4.50    505,560    1.96         505,560         1.96 
$5.625    80,889    1.96         80,889         1.96 
      11,187,530    3.77   $0.6077    11,156,280   $0.6065    3.78 

 

*After giving effect to a 1 for 30 reverse stock split on August 30, 2023.

 

The warrants outstanding have an intrinsic value of $0 as of March 31, 2024 and 2023.

 

e.Stock options

 

On June 18, 2018, the Company established its 2018 Stock Incentive Plan (the “Plan”). The purpose of the Plan is to promote the interests of the Company and the stockholders of the Company by providing directors, officers, employees and consultants of the Company with appropriate incentives and rewards to encourage them to enter into and continue in the employ or service of the Company, to acquire a proprietary interest in the long-term success of the Company and to reward the performance of individuals in fulfilling long-term corporate objectives. The Plan terminates after a period of ten years in June 2028.

 

The Plan is administered by the Board or a committee appointed by the Board, who have the authority to administer the Plan and to exercise all the powers and authorities specifically granted to it under the Plan.

 

The maximum number of securities available under the Plan is 26,667 shares of Common Stock. The maximum number of shares of Common Stock awarded to any individual during any fiscal year may not exceed 100,000 shares of Common Stock.

 

On October 22, 2021, the Company established its 2021 Stock Incentive Plan (“2021 Plan”). The purpose of the Plan is to promote the interests of the Company and the stockholders of the Company by providing directors, officers, employees and consultants, advisors and service providers of the Company with appropriate incentives and rewards to encourage them to enter into and continue in the employ or service of the Company, to acquire a proprietary interest in the long-term success of the Company and to reward the performance of individuals in fulfilling long-term corporate objectives. The Plan terminates after a period of ten years in August 2031.

 

The 2021 Plan is administered by the Board or a Compensation Committee appointed by the Board, who have the authority to administer the Plan and to exercise all the powers and authorities specifically granted to it under the Plan.

 

The maximum number of securities available under the 2021 Plan is 1,766,667 shares of Common Stock.

 

Under the 2021 Plan the Company may award the following: (i) non-qualified stock options; (ii)) incentive stock options; (iii) stock appreciation rights; (iv) restricted stock; (v) restricted stock unit; and (vi) other stock-based awards.

  

During 2023, the Company cancelled options exercisable for 23,891 shares of Common Stock due to the previous resignation or termination of employees and officers whose stock options were not exercised in accordance with the terms allowed under the plan and were therefore canceled.

 

A summary of option activity during the period January 1, 2023 to March 31, 2024 is as follows:

 

    Shares
Underlying
options*
    Exercise
price per
share*
    Weighted
average
exercise
price*
 
Outstanding January 1, 2023     1,543,891     $ 1.20 to 12.00     $ 4.47  
Granted    
-
     
-
     
-
 
Forfeited/Cancelled     (23,889 )   $
1.20 to 12.00
      5.41  
Exercised    
-
     
-
     
-
 
Outstanding December 31, 2023     1,520,002     $ 1.20 to 12.00     $ 4.46  
Granted    
-
     
-
     
-
 
Forfeited/Cancelled    
-
     
-
     
-
 
Exercised    
-
     
-
     
-
 
Outstanding March 31, 2024     1,520,002     $ 1.20 to 12.00     $ 4.46  

 

*After giving effect to a 1 for 30 reverse stock split on August 30, 2023.

 

The options outstanding and exercisable at March 31, 2024 are as follows:

 

    Options Outstanding*   Options Exercisable* 
Exercise Price*   Number
Outstanding*
   Weighted
Average
Remaining
Contractual
life in years
   Weighted
Average
Exercise
Price*
   Number
Exercisable*
   Weighted
Average
Exercise
Price*
   Weighted
Average
Remaining
Contractual
life in years
 
$1.20    20,001    5.61         20,001         5.61 
$4.50    1,500,001    7.69                      1,430,557                           7.71 
      1,520,002    7.66   $4.46    1,450,558   $4.45    7.68 

 

The options outstanding have an intrinsic value of $0 as of March 31, 2024 and 2023.

 

The option expense was $94,464 and $94,464 for the three months ended March 31, 2024 and 2023, respectively.

v3.24.1.1.u2
Loss on Convertible Notes
3 Months Ended
Mar. 31, 2024
Loss on Convertible Notes [Abstract]  
LOSS ON CONVERTIBLE NOTES
14LOSS ON CONVERTIBLE NOTES

 

The loss on convertible notes consists of the following:

 

  

Three months ended

March 31,
2024

  

Three months ended

March 31,
2023

 
Expense on extension of maturity date of convertible notes   66,047    
-
 

 

On March 14, 2024, the Company extended the maturity date of 11 convertible notes which matured between February 13, 2024 and February 23, 2024 by six months and issued the note holders additional warrants exercisable for 387,673 shares of Common Stock, the modification of the terms and the issue of the new warrants was assessed as a debt extinguishment, resulting in a charge of $66,047 for the three months ended March 31, 2024.

v3.24.1.1.u2
Net Loss Per Share
3 Months Ended
Mar. 31, 2024
Net Loss Per Share [Abstract]  
NET LOSS PER SHARE
15NET LOSS PER SHARE

 

Basic loss per share is based on the weighted-average number of Common Stock outstanding during each period. Diluted loss per share is based on basic shares as determined above plus Common Stock equivalents. The computation of diluted net loss per share does not assume the issuance of Common Stock that have an anti-dilutive effect on net loss per share. For the three months ended March 31, 2024 and 2023 all warrants options and convertible debt securities were excluded from the computation of diluted net loss per share.

 

Dilutive shares which could exist pursuant to the exercise of outstanding stock instruments and which were not included in the calculation because their affect would have been anti-dilutive for the three months ended March 31, 2024 and 2023 are as follows:

 

  

Three months ended
March 31,
2024

(Shares)

   Three months ended
March 31, 
2023
(Shares)
 
Convertible debt   15,232,285    8,293,738 
Stock options   1,520,002    1,543,891 
Warrants to purchase shares of Common Stock   11,187,530    6,703,760 
    27,939,817    16,541,389 
v3.24.1.1.u2
Related Party Transactions
3 Months Ended
Mar. 31, 2024
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS
16RELATED PARTY TRANSACTIONS

 

The following transactions were entered into with related parties during the quarter ended March 31, 2024:

 

William Corbett

 

An option expense for options still vesting for Mr. Corbett was $66,587 for each of the three months ended March 31, 2024 and 2023.

 

Richard Rosenblum

 

An option expense for options still vesting for Mr. Rosenblum was $27,877 for each of the three months ended March 31, 2024 and 2023.

v3.24.1.1.u2
Commitments and Contingencies
3 Months Ended
Mar. 31, 2024
Commitments and Contingencies [Abstract]  
COMMITMENTS AND CONTINGENCIES
17COMMITMENTS AND CONTINGENCIES

 

The Company has notes payable and convertible notes payable, disclosed under notes 10 and 11 above, which have maturity dates between March 30, 2024 and February 21,2025. The Company may settle the notes payable, at its option by the issue of common shares and should the convertible notes not be converted to Common Stock prior to their maturity dates, the Company may need to repay the principal and interest outstanding on these notes.

v3.24.1.1.u2
Subsequent Events
3 Months Ended
Mar. 31, 2024
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS
18SUBSEQUENT EVENTS

 

Convertible note funding

  

On April 1, 2024, the Company received gross proceeds of $70,000 for a Securities Purchase Agreement entered into on March 26, 2024, pursuant to which the Company issued convertible promissory notes to one accredited investment entity for a principal amount outstanding of $88,500. The Note is unsecured, matures on December 30,2024 and has a one-time interest charge of 15% totaling $13,275. The note is convertible into Common Stock upon an event of default at a variable conversion price of 65% of the lowest trading price for the 10 days immediately prior to conversion. The note may be prepaid at a discount to the full amount outstanding, including once-off interest of 96%.

  

On April 12, 2024 and May 3, 2024, the Company entered into Securities Purchase Agreements with 3 accredited investors pursuant to which the Company received an aggregate of $100,000 in gross proceeds in private placements through the issuance of convertible promissory notes and five-year warrants to purchase an aggregate 289,856 shares of Common Stock at an exercise price of $0.345 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events). The notes are unsecured, may be converted into Common Stock at a conversion price of $0.345 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events), mature 12 months from the date of issuance and bear interest at 8% per annum, based on a 360-day year, and may be prepaid at any time without penalty.

 

On May 4, 2024, the maturity date of two notes totaling $225,000 which originally matured on December 31, 2023 and which maturity dates were extended to March 30, 2024, on May 4, 2024, the maturity date of the $200,000 note was further extended to June 14, 2024, and the maturity date of the $25,000 note was further extended to June 30, 2024. In exchange for the maturity date extension, the Company issued to note holders warrants exercisable for 292,463 shares of Common Stock at an exercise price of $0.345 per share.

 

Other than the above, the Company has evaluated subsequent events through the date the financial statements were issued and did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.

v3.24.1.1.u2
Pay vs Performance Disclosure - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Pay vs Performance Disclosure    
Net Income (Loss) $ (331,465) $ (273,390)
v3.24.1.1.u2
Insider Trading Arrangements
3 Months Ended
Mar. 31, 2024
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.24.1.1.u2
Accounting Policies, by Policy (Policies)
3 Months Ended
Mar. 31, 2024
Accounting Policies and Estimates [Abstract]  
Basis of Presentation
a)Basis of Presentation

The accompanying unaudited condensed financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X. Accordingly, these unaudited condensed financial statements do not include all of the information and disclosures required by U.S. GAAP for complete financial statements. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments (consisting only of normal recurring adjustments), which the Company considers necessary, for a fair presentation of those financial statements. The results of operations and cash flows for the three months ended March 31, 2024 may not necessarily be indicative of results that may be expected for any succeeding quarter or for the entire fiscal year. The information contained in this Report should be read in conjunction with the audited financial statements of IPSI for the year ended December 31, 2023, included in the Company’s Annual Report on Form 10-K as filed with the Securities and Exchange Commission (the “SEC”) on March 29, 2024 and amended on April 17, 2024.

All amounts referred to in the notes to the unaudited condensed consolidated financial statements are in United States Dollars ($) unless stated otherwise.

Principles of Consolidation
b)Principles of Consolidation

The unaudited condensed consolidated financial statements as of March 31, 2024, include the financial statements of the Company. The unaudited condensed consolidated financial statements as of March 31, 2023, include the financial statements of the Company and its subsidiary in which it has a majority voting interest, until May 12, 2023, the date of disposal of its Beyond Fintech subsidiary. Pursuant to the May 2023 Frictionless Agreement, the Company disposed of its 51% interest in Beyond Fintech. Therefore the Company currently has no subsidiaries.

All significant inter-company accounts and transactions have been eliminated in the unaudited condensed consolidated financial statements.

The accompanying consolidated financial statements have been prepared in accordance with U.S. GAAP.

All amounts referred to in the notes to the consolidated financial statements are in United States Dollars ($) unless stated otherwise.

Use of Estimates
c)Use of Estimates

The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions, which are evaluated on an ongoing basis, that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the amounts of revenues and expenses that are not readily apparent from other sources. Actual results could differ from those estimates and judgments. In particular, significant estimates and judgments include those related to, the estimated useful lives for plant and equipment, the fair value of long-lived investments, the fair value of warrants and stock options granted for services or compensation, convertible notes and amendments thereto, derivative liabilities, the valuation allowance for deferred tax assets due to continuing operating losses and the allowance for doubtful accounts.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from our estimates.

 

Contingencies
d)Contingencies

Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company, but which will only be resolved when one or more future events occur or fail to occur.

The Company’s management assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment.

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s unaudited condensed consolidated financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material would be disclosed. Loss contingencies considered to be remote by management are generally not disclosed unless they involve guarantees, in which case the guarantee would be disclosed.

Fair Value of Financial Instruments
e)Fair Value of Financial Instruments

The Company adopted the guidance of Accounting Standards Codification (“ASC”) 820 for fair value measurements which clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:

Level 1 - Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date.

Level 2 - Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated by observable market data.

Level 3 - Inputs are unobservable inputs which reflect the reporting entity’s own assumptions on what assumptions the market participants would use in pricing the asset or liability based on the best available information.

The carrying amounts reported in the balance sheets for cash, accounts receivable, other current assets, other assets, accounts payable, accrued liabilities, and notes payable, approximate fair value due to the relatively short period to maturity for these instruments. The Company has identified the short-term convertible notes and certain warrants attached to certain of the notes that are required to be presented on the balance sheets at fair value in accordance with the accounting guidance.

ASC 825-10 “Financial Instruments” allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (fair value option). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable unless a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent reporting date. We evaluate the fair value of variably priced derivative liabilities on a quarterly basis and report any movements thereon in earnings.

Risks and Uncertainties
f)Risks and Uncertainties

The Company’s operations and prospects are and will be subject to significant risks and uncertainties including financial, operational, regulatory, and other risks, including the potential risk of business failure. The recent wars in Ukraine and Israel and the global inflationary environment which has resulted in significant interest rate increases in the U.S and abroad has resulted in a general tightening in the credit markets, lower levels of liquidity, increases in the rates of default and bankruptcy, and extreme volatility in credit, equity and fixed income markets. These conditions may not only limit the Company’s access to capital, but also make it difficult for its customers, vendors and the Company to accurately forecast and plan future business activities, which may have an adverse impact on its business and financial condition and may hamper the Company’s ability to generate revenue and access usual sources of liquidity on reasonable terms.

The Company’s results may be adversely affected by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, and rates and methods of taxation, among other things.

 

Recent accounting pronouncements
g)Recent accounting pronouncements

The Financial Accounting Standards Board (“FASB”) issued additional updates during the quarter ended March 31, 2024. None of these standards are either applicable to the Company or require adoption at a future date and none are expected to have a material impact on the Company’s unaudited condensed consolidated financial statements upon adoption.

Reporting by Segment
h)Reporting by Segment

No segmental information is required as the Company has only one operating segment.

Cash and Cash Equivalents
i)Cash and Cash Equivalents

The Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents. At March 31, 2024 and December 31, 2023, respectively, the Company had no cash equivalents.

The Company minimizes credit risk associated with cash by periodically evaluating the credit quality of its primary financial institution in the United States. The balance at times may exceed federally insured limits. At March 31, 2024 and December 31, 2023, the balance did not exceed federally insured limits.

Accounts Receivable and Allowance for Doubtful Accounts
j)Accounts Receivable and Allowance for Doubtful Accounts

Accounts receivable are reported at realizable value, net of allowances for doubtful accounts, which is estimated and recorded in the period the related revenue is recorded. The Company has a standardized approach to estimate and review the collectability of its receivables based on a number of factors, including the period they have been outstanding. Historical collection and payer reimbursement experience is an integral part of the estimation process related to allowances for doubtful accounts. In addition, the Company regularly assesses the state of its billing operations in order to identify issues, which may impact the collectability of these receivables or reserve estimates. Revisions to the allowance for doubtful accounts estimates are recorded as an adjustment to bad debt expense. Receivables deemed uncollectible are charged against the allowance for doubtful accounts at the time such receivables are written-off. Recoveries of receivables previously written-off are recorded as credits to the allowance for doubtful accounts. There were no recoveries during the period ended March 31, 2024 and 2023.

Investments
k)Investments

The Company’s non-marketable equity securities are investments in privately held companies without readily determinable market values. The carrying value of our non-marketable equity securities is adjusted to fair value for observable transactions for identical or similar investments of the same issuer or impairment (referred to as the measurement alternative). All gains and losses on non-marketable equity securities, realized and unrealized, are recognized in other income (expense), net. Non-marketable equity securities that have been remeasured during the period are classified within Level 3 in the fair value hierarchy because the Company estimates the value based on valuation methods using the observable transaction price at the transaction date and other unobservable inputs including volatility, rights, and obligations of the securities the Company holds. The cost method is used when the Company has a passive, long-term investment that doesn’t result in influence over the Company. The cost method is used when the investment results in an ownership stake of less than 20%, and there is no substantial influence. Under the cost method, the stock purchased is recorded on a balance sheet as a non-current asset at the historical acquisition/purchase price, and is not modified unless shares are sold, additional shares are purchased or there is evidence of the fair market value of the investment declining below carrying value. Any dividends received are recorded as income.

 

Plant and Equipment
l)Plant and Equipment

Plant and equipment is stated at cost, less accumulated depreciation. Plant and equipment with costs greater than $1,000 are capitalized and depreciated. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The estimated useful lives of the assets are as follows:

Description  Estimated Useful Life
    
Computer equipment  3 years
    
Office equipment  10 years

The cost of repairs and maintenance is expensed as incurred. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gains or losses are included in income in the year of disposition.

Long-Term Assets
m)Long-Term Assets

Assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets.

Revenue Recognition
n)Revenue Recognition

The Company’s revenue recognition policy is consistent with the requirements of FASB ASC 606, Revenue.

The Company’s revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those services. The Company derives its revenues from the sale of its services, as defined below. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its revenue transactions:

i.identify the contract with a customer;
ii.identify the performance obligations in the contract;
iii.determine the transaction price;
iv.allocate the transaction price to performance obligations in the contract; and
v.recognize revenue as the performance obligation is satisfied.

The Company had minimal revenues of $0 and $433 for the three months ended March 31, 2024 and 2023, respectively. 

 

Share-Based Payment Arrangements
o)Share-Based Payment Arrangements

Generally, all forms of share-based payments, including stock option grants, restricted stock grants and stock appreciation rights are measured at their fair value on the awards’ grant date, based on the estimated number of awards that are ultimately expected to vest. Share-based compensation awards issued to non-employees for services rendered are recorded at either the fair value of the services rendered or the fair value of the share-based payment, whichever is more readily determinable. The expense resulting from share-based payments is recorded in operating expenses in the consolidated statement of operations.

Prior to the Company’s reverse merger which took place on May 12, 2016, all share-based payments were based on management’s estimate of market value of the Company’s equity. The factors considered in determining managements estimate of market value includes, assumptions of future revenues, expected cash flows, market acceptability of our technology and the current market conditions. These assumptions are complex and highly subjective, compounded by the business being in its early stage of development in a new market with limited data available.

Where equity transactions with arms-length third parties, who had applied their own assumptions and estimates in determining the market value of our equity, had taken place prior to and within a reasonable time frame of any share-based payments, the value of those share transactions have been used as the fair value for any share-based equity payments.

Where equity transactions with arms-length third parties, included both shares and warrants, the value of the warrants have been eliminated from the unit price of the securities using a Black-Scholes valuation model to determine the value of the warrants. The assumptions used in the Black Scholes valuation model includes market related interest rates for risk-free government issued treasury securities with similar maturities; the expected volatility of the Common Stock based on companies operating in similar industries and markets; the estimated stock price of the Company; the expected dividend yield of the Company and; the expected life of the warrants being valued.

Subsequent to the Company’s reverse merger which took place on May 12, 2016, the Company has utilized the market value of its Common Stock as quoted on the OTCQB, as an indicator of the fair value of its Common Stock in determining share- based payment arrangements.

Derivative Liabilities
p)Derivative Liabilities

ASC 815 generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re- measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional, as described.

Income Taxes
q)Income Taxes

The Company is based in the U.S. and currently enacted U.S. tax laws are used in the calculation of income taxes.

Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A full valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized. It is the Company’s policy to classify interest and penalties on income taxes as interest expense or penalties expense. As of March 31, 2024 and December 31, 2023, there have been no interest or penalties incurred on income taxes.

 

Comprehensive income
r)Comprehensive income

Comprehensive income is defined as the change in equity of a company during a period from transactions and other events and circumstances excluding transactions resulting from investments from owners and distributions to owners. The Company does not have any comprehensive income (loss) for the periods presented.

Reclassification of prior year presentation
s)Reclassification of prior year presentation

Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations.

v3.24.1.1.u2
Accounting Policies and Estimates (Tables)
3 Months Ended
Mar. 31, 2024
Accounting Policies and Estimates [Abstract]  
Schedule of Estimated Useful Lives of the Assets Plant and equipment is stated at cost, less accumulated depreciation. Plant and equipment with costs greater than $1,000 are capitalized and depreciated. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The estimated useful lives of the assets are as follows:
Description  Estimated Useful Life
    
Computer equipment  3 years
    
Office equipment  10 years
v3.24.1.1.u2
Discontinued Operations (Tables)
3 Months Ended
Mar. 31, 2024
Discontinued Operations [Abstract]  
Schedule of Statement of Operations from Discontinued Operations The statement of operations from discontinued operations is as follows:
   Three months ended 
   March 31 
   2023 
     
Net Revenue  $
-
 
Cost of Goods Sold   
-
 
Gross loss   
-
 
      
General and administrative   15,260 
Depreciation and amortization   
-
 
Total Expense   15,260 
      
Loss from operations before income taxes   (15,260)
Income Taxes   
-
 
Loss from discontinued operations, net of taxation  $(15,260)
v3.24.1.1.u2
Loans Receivable (Tables)
3 Months Ended
Mar. 31, 2024
Loans Receivable [Abstract]  
Schedule of Loans Receivable Loans receivable consists of the following:
Description  Interest
Rate
   Maturity
date
  Principal   Unamortized discount  

March 31,

2024 Amount, net

 
Business Warrior Corporation   0%  December 31, 2025   226,190    (64,575)   161,615 
v3.24.1.1.u2
Equity Method Investment (Tables)
3 Months Ended
Mar. 31, 2024
Equity Method Investment [Abstract]  
Schedule of Equity Method Investments The Company accounts for its investment in IPSIPay Express in accordance with ASC 323, Investments – Equity Method and Joint Ventures, the movement in equity method investments related to IPSIPay Express for the period ended March 31, 2024 and December 31, 2023 is as follows:
  

March 31,
2024

   December 31,
2023
 
Cash contribution to IPSIPay Express  $999,500   $999,000 
Fair value of warrants issued to third party joint venture partners   108,220    108,220 
    1,107,720    1,107,220 
Prior period equity loss from joint venture   (403,282)   (403,282)
Current period equity income (loss) from joint venture   (484)   
-
 
   $703,954   $703,938 
v3.24.1.1.u2
Leases (Tables)
3 Months Ended
Mar. 31, 2024
Leases [Abstract]  
Schedule of Total Lease Cost Incurred Individual components of the total lease cost incurred by the Company is as follows:
   Three
months
ended
March 31,
2024
   Three
months
ended
March 31,
2023
 
Operating lease expense  $          -   $15,264 
Schedule of Other Lease Information Other lease information:
   Three
months
ended
March 31,
2024
   Three
months
ended
March 31,
2023
 
Cash paid for amounts included in the measurement of lease liabilities        
Operating cash flows from operating leases  $
     -
   $(15,264)
           
Remaining lease term – operating lease   -    Monthly 
v3.24.1.1.u2
Notes Payable (Tables)
3 Months Ended
Mar. 31, 2024
Notes Payable [Abstract]  
Schedule of Notes Payable Notes payable consists of the following:
Description  Interest
Rate
   Maturity
date
  Principal   Accrued
Interest
   March 31, 2024 Amount, net  

December 31,
2023
Amount, net

 
Cavalry Fund I LP   10%  April 30, 2024   482,000    61,187    543,187    531,004 
Mercer Street Global Opportunity Fund, LLC   10%  April 30, 2024   482,000    61,187    543,187    531,003 
Total convertible notes payable          $964,000   $122,374   $1,086,374   $1,062,007 
v3.24.1.1.u2
Convertible Notes Payable (Tables)
3 Months Ended
Mar. 31, 2024
Convertible Notes Payable [Abstract]  
Schedule of Convertible Notes Payable Convertible notes payable consists of the following:
Description  Interest
Rate
   Maturity
date
  Principal   Accrued
Interest
   Unamortized
debt discount
   March 31,
2024
Amount, net
   December 31,
2023
Amount, net
 
Cavalry Fund I LP   10.00 %  April 30, 2024  $898,980   $32,963   $
-
   $931,943   $909,218 
Mercer Street Global  Opportunity Fund, LLC   10.00 %  April 30, 2024   991,754    173,079    
-
    1,164,833    1,139,764 
Red Road Holdings Corporation*   
29.32
%  June 15, 2024   52,691    722    (14,457)   38,956    41,771 
    27.77 %  July 30, 2024   43,385    880    (18,419)   25,846    18,683 
    32.04 %  September 30, 2024   51,148    1,209    (32,843)   19,514    3,109 
Quick Capital, LLC*   11.12 %  September 30, 2024   114,286    2,348    (52,602)   64,032    
-
 
2023 and 2024 convertible notes    8.00 to 12.00 %  May 22, 2024 to February 21, 2025   2,335,001    127,735    (314,381)   2,148,355    1,591,735 
Total convertible notes payable           $4,487,245   $338,936   $(432,702)  $4,393,479   $3,704,280 
*The Red Road Holdings Corporation and Quick Capital LLC, interest rates are an effective interest rate as these convertible notes have a fixed interest charge which is earned on the issuance date, regardless of when payments are made.
v3.24.1.1.u2
Derivative Liability (Tables)
3 Months Ended
Mar. 31, 2024
Derivative Liability [Abstract]  
Schedule of Assumptions were used in the Black-Scholes Valuation Model The following assumptions were used in the Black-Scholes valuation model:
   Three months
ended
March 31,
2024
   Year ended
December 31,
2023
 
Conversion price   $ 0.0684 to $0.345     $ 0.104 to $0.345  
Risk free interest rate   4.40 to 5.49 %    3.60 to 5.55 %
Expected life of derivative liability   1 to 41 months      3.5 to 47 months  
Expected volatility of underlying stock   157.83 to 201.11 %     158.72 to 217.01 %
Expected dividend rate   0%   0%

 

Schedule of Movement in Derivative Liability The movement in derivative liability is as follows:
   March 31,
2024
   December 31,
2023
 
Opening balance  $1,434,196   $2,550,642 
Derivative financial liability arising from convertible note and warrants   
-
    385,000 
Fair value adjustment to derivative liability   (815,941)   (1,501,446)
   $618,255   $1,434,196 
v3.24.1.1.u2
Stockholders’ Equity (Tables)
3 Months Ended
Mar. 31, 2024
Stockholders’ Equity [Line Items]  
Schedule of Restricted Stock Activity A summary of restricted stock activity during the period January 1, 2023 to March 31, 2024 is as follows:
   Total
restricted
shares*
   Weighted
average
fair market
value per
share*
   Total
unvested
restricted
shares*
   Weighted
average
fair market
value per
share*
   Total vested
restricted
shares*
   Weighted
average
fair market
value per share*
 
Outstanding January 1, 2023   783,167   $1.50    170,792   $1.47    612,375   $1.50 
Granted and issued   
-
    
-
    
-
    
-
    
-
    
-
 
Forfeited/Cancelled   
-
    
-
    
-
    
-
    
-
    
-
 
Vested   
-
    
-
    (170,792)   (1.47)   170,792    1.47 
Outstanding December 31, 2023   783,167   $1.50    
-
   $
-
    783,167   $1.50 
Granted and issued   
-
    
-
    
-
    
-
    
-
    
-
 
Forfeited/Cancelled   
-
    
-
    
-
    
-
    
-
    
-
 
Vested   
-
    
-
    
-
    
-
    
-
    
-
 
Outstanding March 31, 2024   783,167   $1.50    
-
   $
-
    783,167   $1.50 
*After giving effect to a 1 for 30 reverse stock split on August 30, 2023.

 

Schedule of Restricted Stock Granted Issued and Exercisable The restricted stock granted, issued and exercisable at March 31, 2024 is as follows:
    Restricted Stock
Granted and
Vested
 
Grant date Price   Number Granted*   Weighted Average Fair Value per Share* 
$1.47    683,167   $1.47 
$1.50    33,333    1.50 
$1.65    66,667    1.65 
      783,167   $1.50 
*After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
Schedule of Fair Value of the Warrants Granted and Issued The fair value of the warrants granted and issued, as described above, were determined by using a Black Scholes valuation model using the following assumptions:
   Three months ended
March 31,
2024
 
Exercise price  $0.345 
Risk free interest rate   4.15 to 4.21%
Expected life    5 years 
Expected volatility of underlying stock    190.72 to 191.17%
Expected dividend rate   0%
Warrant [Member]  
Stockholders’ Equity [Line Items]  
Schedule of Warrant Activity A summary of warrant activity during the period January 1, 2023 to March 31, 2024 is as follows:
   Shares
Underlying
Warrants*
   Exercise
price per
share*
   Weighted
average
exercise
price*
 
Outstanding January 1, 2023   5,186,376   $0.345 – 5.625   $0.9000 
Granted   6,289,051     0.345 – 1.50    0.3556 
Forfeited   (33,334)   1.50    1.5000 
Cancelled on disposal of investment in Frictionless and Beyond Fintech   (1,000,000)   0.345    0.3450 
Exercised   
-
    
-
    
-
 
Outstanding December 31, 2023   10,442,093   $0.345 – 5.625   $0.6265 
Granted   745,437    0.345    0.345 
Forfeited   
-
    
-
    
-
 
Cancelled on disposal of investment in Frictionless and Beyond Fintech   
-
    
-
    
-
 
Exercised   -    
-
    
-
 
Outstanding March 31, 2024   11,187,530   $0.345 – 5.625   $0.6077 
*After giving effect to a 1 for 30 reverse stock split on August 30, 2023.

 

Schedule of Warrants Outstanding and Exercisable The warrants outstanding and exercisable at March 31, 2024 are as follows:
    Warrants Outstanding*   Warrants Exercisable* 
Exercise Price*   Number
Outstanding*
   Weighted
Average
Remaining
Contractual
life in years
   Weighted
Average
Exercise
Price*
   Number
Exercisable*
   Weighted
Average
Exercise
Price*
   Weighted
Average
Remaining
Contractual
life in years
 
$0.345    9,801,079    3.99         9,801,079         3.99 
$0.450    266,668    4.23         266,668         4.23 
$1.035    500,000    1.27         468,750         1.27 
$1.500    33,334    4.37         33,334         4.37 
$4.50    505,560    1.96         505,560         1.96 
$5.625    80,889    1.96         80,889         1.96 
      11,187,530    3.77   $0.6077    11,156,280   $0.6065    3.78 
*After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
Options [Member]  
Stockholders’ Equity [Line Items]  
Schedule of Warrant Activity A summary of option activity during the period January 1, 2023 to March 31, 2024 is as follows:
    Shares
Underlying
options*
    Exercise
price per
share*
    Weighted
average
exercise
price*
 
Outstanding January 1, 2023     1,543,891     $ 1.20 to 12.00     $ 4.47  
Granted    
-
     
-
     
-
 
Forfeited/Cancelled     (23,889 )   $
1.20 to 12.00
      5.41  
Exercised    
-
     
-
     
-
 
Outstanding December 31, 2023     1,520,002     $ 1.20 to 12.00     $ 4.46  
Granted    
-
     
-
     
-
 
Forfeited/Cancelled    
-
     
-
     
-
 
Exercised    
-
     
-
     
-
 
Outstanding March 31, 2024     1,520,002     $ 1.20 to 12.00     $ 4.46  
*After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
Schedule of Warrants Outstanding and Exercisable The options outstanding and exercisable at March 31, 2024 are as follows:
    Options Outstanding*   Options Exercisable* 
Exercise Price*   Number
Outstanding*
   Weighted
Average
Remaining
Contractual
life in years
   Weighted
Average
Exercise
Price*
   Number
Exercisable*
   Weighted
Average
Exercise
Price*
   Weighted
Average
Remaining
Contractual
life in years
 
$1.20    20,001    5.61         20,001         5.61 
$4.50    1,500,001    7.69                      1,430,557                           7.71 
      1,520,002    7.66   $4.46    1,450,558   $4.45    7.68 
v3.24.1.1.u2
Loss on Convertible Notes (Tables)
3 Months Ended
Mar. 31, 2024
Loss on Convertible Notes [Abstract]  
Schedule of the Loss on Convertible Notes The loss on convertible notes consists of the following:
  

Three months ended

March 31,
2024

  

Three months ended

March 31,
2023

 
Expense on extension of maturity date of convertible notes   66,047    
-
 
v3.24.1.1.u2
Net Loss Per Share (Tables)
3 Months Ended
Mar. 31, 2024
Net Loss Per Share [Abstract]  
Schedule of Anti-dilutive Shares Dilutive shares which could exist pursuant to the exercise of outstanding stock instruments and which were not included in the calculation because their affect would have been anti-dilutive for the three months ended March 31, 2024 and 2023 are as follows:
  

Three months ended
March 31,
2024

(Shares)

   Three months ended
March 31, 
2023
(Shares)
 
Convertible debt   15,232,285    8,293,738 
Stock options   1,520,002    1,543,891 
Warrants to purchase shares of Common Stock   11,187,530    6,703,760 
    27,939,817    16,541,389 
v3.24.1.1.u2
Organization and Description of Business (Details) - USD ($)
3 Months Ended
Nov. 30, 2023
Sep. 01, 2023
Aug. 11, 2023
Aug. 04, 2023
Jun. 21, 2023
May 12, 2023
Dec. 30, 2022
Aug. 26, 2021
Jun. 21, 2021
Dec. 31, 2019
Mar. 31, 2024
Dec. 31, 2023
Nov. 01, 2019
Organization and Description of Business [Line Items]                          
Common stock, par value (in Dollars per share)                     $ 0.0001 $ 0.0001  
Aggregate shares of common stock                     621,920    
Aggregate of shares                     2,500    
Retained shares of common stock                     500,000    
Shares percentage                   9.00%      
Percentage of remaining shares owned               49.00%          
Number of warrant purchase           1,000,000              
Credit consideration amount (in Dollars)           $ 250,000              
Credit receivables (in Dollars)           $ 231,431              
Capital contribution (in Dollars)                     $ 1,500,000    
Percentage of membership interest                     11.11%    
Joint venture percentage                     22.00%    
Shares of common stock                     1,333,334    
Exercise price per share (in Dollars per share)             $ 1.2       $ 0.345    
IPEX Warrant [Member]                          
Organization and Description of Business [Line Items]                          
Shares of common stock                     133,334    
Exercise price per share (in Dollars per share)                     $ 0.45    
Beyond Fintech Inc [Member]                          
Organization and Description of Business [Line Items]                          
Ownership percentage                 51.00%   51.00%    
Share-Based Payment Arrangement, Tranche One [Member]                          
Organization and Description of Business [Line Items]                          
Payments (in Dollars)       $ 300,000                  
Share-Based Payment Arrangement, Tranche Two [Member]                          
Organization and Description of Business [Line Items]                          
Payments (in Dollars)   $ 500,000                      
Share-Based Payment Arrangement, Tranche Three [Member]                          
Organization and Description of Business [Line Items]                          
Payments (in Dollars) $ 500,000                        
Maximum [Member]                          
Organization and Description of Business [Line Items]                          
Aggregate of shares                         320,477,867
Minimum [Member]                          
Organization and Description of Business [Line Items]                          
Aggregate of shares                         32,047,817
Stock Purchase Agreement [Member]                          
Organization and Description of Business [Line Items]                          
Stock purchase agreement                   2,250,000      
Series of Individually Immaterial Business Acquisitions [Member]                          
Organization and Description of Business [Line Items]                          
Acquired interest                 1.00%        
Qpagos Corporation’s Capital Stock [Member]                          
Organization and Description of Business [Line Items]                          
Aggregate shares of common stock                     4,992,900    
Vivi Holdings, Inc [Member]                          
Organization and Description of Business [Line Items]                          
Exchange shares                   2,250,000      
Gaston Pereira [Member]                          
Organization and Description of Business [Line Items]                          
Shares percentage                   5.00%      
Andrey Novikov [Member]                          
Organization and Description of Business [Line Items]                          
Shares percentage                   2.50%      
Joseph Abrams [Member]                          
Organization and Description of Business [Line Items]                          
Shares percentage                   1.50%      
Frictionless Financial Technologies, Inc.[Member]                          
Organization and Description of Business [Line Items]                          
Variable interest entity ownership percentage                 10.00%        
Common stock outstanding percentage                 41.00%        
Purchase price (in Dollars)                 $ 300,000        
Three Tranches [Member]                          
Organization and Description of Business [Line Items]                          
Capital contribution (in Dollars)                     $ 500,000    
Tranche [Member]                          
Organization and Description of Business [Line Items]                          
Payments (in Dollars)         $ 200,000                
Shares of common stock                     199,999    
Second Tranche [Member]                          
Organization and Description of Business [Line Items]                          
Shares of common stock                     166,667    
Third Tranche [Member]                          
Organization and Description of Business [Line Items]                          
Shares of common stock                     166,667    
Innovative Payment Solutions, Inc [Member]                          
Organization and Description of Business [Line Items]                          
Date of incorporation                     May 12, 2016    
Common Stock [Member]                          
Organization and Description of Business [Line Items]                          
Common stock, par value (in Dollars per share)                     $ 0.0001    
Common stock shares holder current                     500,000    
Common stock outstanding, percentage                     91.00%    
Number of warrant purchase                     289,856    
Exercise price per share (in Dollars per share)     $ 1.5                    
Common Stock [Member] | Qpagos Corporation’s Capital Stock [Member]                          
Organization and Description of Business [Line Items]                          
Aggregate shares of common stock                     497,500    
v3.24.1.1.u2
Accounting Policies and Estimates (Details)
3 Months Ended
Mar. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Mar. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Jun. 21, 2021
Accounting Policies and Estimates [Abstract]          
Operating segment 1        
Cash equivalents $ 50,433 $ 374,765  
Plant and equipment costs 1,000        
Revenues $ 0   $ 433    
Beyond Fintech Inc. [Member]          
Accounting Policies and Estimates [Abstract]          
Ownership percentage 51.00%       51.00%
Long Term Investment [Member]          
Accounting Policies and Estimates [Abstract]          
Ownership percentage 20.00%        
v3.24.1.1.u2
Accounting Policies and Estimates (Details) - Schedule of Estimated Useful Lives of the Assets
Mar. 31, 2024
Computer Equipment [Member]  
Accounting Policies and Estimates (Details) - Schedule of Estimated Useful Lives of the Assets [Line Items]  
Estimated Useful Life 3 years
Office Equipment [Member]  
Accounting Policies and Estimates (Details) - Schedule of Estimated Useful Lives of the Assets [Line Items]  
Estimated Useful Life 10 years
v3.24.1.1.u2
Liquidity Matters and Going Concern (Details) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Liquidity Matters and Going Concern [Abstract]    
Net loss $ (331,465) $ (274,987)
v3.24.1.1.u2
Discontinued Operations (Details) - Schedule of Statement of Operations from Discontinued Operations - Discontinued Operations [Member]
3 Months Ended
Mar. 31, 2023
USD ($)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]  
Net Revenue
Cost of Goods Sold
Gross loss
General and administrative 15,260
Depreciation and amortization
Total Expense 15,260
Loss from operations before income taxes (15,260)
Income Taxes
Loss from discontinued operations, net of taxation $ (15,260)
v3.24.1.1.u2
Loans Receivable (Details) - USD ($)
3 Months Ended
Feb. 22, 2024
Mar. 31, 2024
Loans Receivable (Details) [Line Items]    
Original issue discount equal $ 67,857  
Net proceeds from issuance of convertible notes $ 158,333  
Percentage of amount equals prepayment of note 110.00%  
Discount amortized to income as deemed interest   $ 3,282
BZWR Note [Member]    
Loans Receivable (Details) [Line Items]    
Principal amount $ 226,190  
Interest accrues percentage 15.00%  
Common Stock [Member] | BZWR Note [Member]    
Loans Receivable (Details) [Line Items]    
Conversion price per share (in Dollars per share) $ 0.0036  
v3.24.1.1.u2
Loans Receivable (Details) - Schedule of Loans Receivable - Business Warrior Corporation [Member]
3 Months Ended
Mar. 31, 2024
USD ($)
Accounts, Notes, Loans and Financing Receivable [Line Items]  
Interest Rate 0.00%
Maturity date Dec. 31, 2025
Principal $ 226,190
Unamortized discount (64,575)
Amount, net $ 161,615
v3.24.1.1.u2
Intangibles (Details) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Aug. 26, 2021
Aug. 26, 2021
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2021
Intangibles [Line Items]          
Gross proceeds   $ 250,000     $ 375,000
Additional amount for aquisition $ 77,211   $ 1,171,805    
Amortization expense     $ 0 $ 125,856  
Beyond Fintech [Member]          
Intangibles [Line Items]          
Ownership percentage 51.00% 51.00%      
Frictionless [Member]          
Intangibles [Line Items]          
Ownership percentage 49.00% 49.00%      
v3.24.1.1.u2
Equity Method Investment (Details)
Mar. 31, 2024
USD ($)
Equity Method Investment [Abstract]  
Capital contribution initial tranche amount $ 500,000
Capital contribution second tranche amount $ 500,000
v3.24.1.1.u2
Equity Method Investment (Details) - Schedule of Equity Method Investments - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Schedule of Equity Method Investments [Line Items]    
Cash contribution to IPSIPay Express   $ 999,000
Fair value of warrants issued to third party joint venture partners   108,220
Equity total $ (484) 1,107,220
Prior period equity loss from joint venture   (403,282)
Current period equity income (loss) from joint venture  
Joint venture total 703,954 $ 703,938
IPSIPay Express [Member]    
Schedule of Equity Method Investments [Line Items]    
Cash contribution to IPSIPay Express 999,500  
Fair value of warrants issued to third party joint venture partners 108,220  
Equity total 1,107,720  
Prior period equity loss from joint venture (403,282)  
Current period equity income (loss) from joint venture (484)  
Joint venture total $ 703,954  
v3.24.1.1.u2
Leases (Details) - USD ($)
3 Months Ended
Jan. 01, 2023
Mar. 31, 2024
Leases [Abstract]    
Lease, description   The lease commenced on April 1, 2021 and is for a twelve month period, terminating on April 1, 2022.
Operating lease payment   $ 4,800
Rent payments $ 5,088  
v3.24.1.1.u2
Leases (Details) - Schedule of Total Lease Cost Incurred - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Schedule of Total Lease Cost Incurred [Abstract]    
Operating lease expense $ 15,264
v3.24.1.1.u2
Leases (Details) - Schedule of Other Lease Information - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash paid for amounts included in the measurement of lease liabilities    
Operating cash flows from operating leases $ (15,264)
Remaining lease term – operating lease Monthly
v3.24.1.1.u2
Federal Relief Loans (Details) - Small Business Economic Injury Disaster Loan [Member] - USD ($)
3 Months Ended 12 Months Ended
Jul. 07, 2020
Mar. 31, 2024
Dec. 31, 2023
Federal Relief Loans [Line Items]      
Loan amount $ 150,000    
Interest rate 3.75%    
Loan monthly payment $ 731    
Aggregate principal amount interest   $ 9,309 $ 9,369
v3.24.1.1.u2
Notes Payable (Details) - USD ($)
3 Months Ended
Feb. 16, 2021
Feb. 16, 2021
Mar. 31, 2024
Mar. 31, 2023
Dec. 14, 2023
Dec. 31, 2022
Debt Instrument [Line Items]            
Exercise price (in Dollars per share)     $ 0.45   $ 0.345  
Non-convertible promissory notes $ 482,000 $ 482,000        
Interest expense     $ 24,368 $ 24,100    
Warrant [Member]            
Debt Instrument [Line Items]            
Class of warrant or right number of securities called by warrants 2,486,957          
Warrants     $ 43,608      
Cavalry and Mercer [Member]            
Debt Instrument [Line Items]            
Interest rate   12.50%        
Debt principal amount $ 572,000 $ 572,000        
Amendment Transaction [Member]            
Debt Instrument [Line Items]            
Interest rate     10.00%      
Maturity date     Dec. 30, 2023      
Conversion shares issued (in Shares)     51,901,711      
Amendment Transaction [Member]            
Debt Instrument [Line Items]            
Non-convertible promissory notes           $ 482,000
Notes issued     $ 964,000      
Cavalry Fund I LP [Member]            
Debt Instrument [Line Items]            
Company received   500,500        
Mercer Street Global Opportunity Fund, LLC [Member]            
Debt Instrument [Line Items]            
Company received   $ 500,500        
Convertible Debt [Member]            
Debt Instrument [Line Items]            
Convertible debt     $ 920,392      
Common Stock [Member]            
Debt Instrument [Line Items]            
Exercise price (in Dollars per share) $ 0.24 $ 0.24 $ 0.345      
v3.24.1.1.u2
Notes Payable (Details) - Schedule of Notes Payable - Note Payable [Member] - USD ($)
3 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Debt Instrument [Line Items]    
Principal $ 964,000  
Accrued Interest 122,374  
Amount, net $ 1,086,374 $ 1,062,007
Cavalry Fund I LP [Member]    
Debt Instrument [Line Items]    
Interest Rate 10.00%  
Maturity date Apr. 30, 2024  
Principal $ 482,000  
Accrued Interest 61,187  
Amount, net $ 543,187 531,004
Mercer Street Global Opportunity Fund, LLC [Member]    
Debt Instrument [Line Items]    
Interest Rate 10.00%  
Maturity date Apr. 30, 2024  
Principal $ 482,000  
Accrued Interest 61,187  
Amount, net $ 543,187 $ 531,003
v3.24.1.1.u2
Convertible Notes Payable (Details) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Nov. 20, 2023
Oct. 19, 2023
Sep. 09, 2023
Aug. 30, 2023
Aug. 24, 2023
May 19, 2023
Mar. 14, 2023
Dec. 30, 2022
Feb. 03, 2022
Feb. 16, 2021
Dec. 20, 2023
Jun. 20, 2023
Dec. 28, 2022
Nov. 16, 2022
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
May 04, 2024
Dec. 14, 2023
May 10, 2023
Feb. 13, 2023
Convertible Notes Payable [Line Items]                                          
Exercise price per share (in Dollars per share)               $ 1.2             $ 0.345            
Warrant exercisable (in Shares)                                 1,304,348        
Non-convertible promissory notes                   $ 482,000                      
Common stock price per share (in Dollars per share)               1.8                          
Aggregate amount                         $ 2,264,784                
Convertible notes                             $ 836,414            
Black-scholes valuation model                             1,499,577            
Convertible note holders                             $ 238,182            
Warrant share (in Shares)                             43,608            
Value of notes                             $ 964,000            
Holders amount                             841,003            
Interest expense                             110,769 $ 59,737          
Amortization of debt discount total                               $ 22,967          
Common stock conversion price (in Shares) 963,769       963,769                                
Loss on conversion         $ 42,210                                
Unamortized debt discount                             432,702   $ 687,503        
Aggregate of gross proceeds received                             $ 308,335            
Purchase of aggregate shares (in Shares)                             5,696,586            
Beneficially own of percentage                             4.99%            
Limitation exceeds of percentage                             9.99%            
Principal amount                                     $ 225,000    
Exercise price per share (in Dollars per share)                                   $ 0.345 $ 0.345    
Warrant Exercise Price (in Shares)             387,673                            
Common s tock e xercise price (in Dollars per share)             $ 0.345                            
Warrant value             $ 66,047                            
Issuance of convertible note                             $ 314,381            
Warrant [Member]                                          
Convertible Notes Payable [Line Items]                                          
Additional shares of common stock (in Shares)                 100,000                        
Exercise price per share (in Dollars per share)                 $ 4.5       $ 0.345   [1]   [1]        
Purchase an additional shares (in Shares)                   1,730,057                      
Accrued interest                             $ 64,032            
Cavalry and Mercer [Member]                                          
Convertible Notes Payable [Line Items]                                          
Maturity date                 Aug. 16, 2022                        
Interest rate percentage                 20.00%                        
Conversion price, per share (in Dollars per share)                             $ 0.345            
Shares of common stock (in Shares)                                 100,000        
Aggregate amount                         $ 1,132,392                
Original issue discount                             $ 2,148,355            
Exchange Notes [Member]                                          
Convertible Notes Payable [Line Items]                                          
Maturity date                   Dec. 30, 2023                      
Interest rate percentage                   10.00%                      
Cavalry/Mercer Note [Member]                                          
Convertible Notes Payable [Line Items]                                          
Additional Charge                             $ 920,392            
Convertible Note [Member]                                          
Convertible Notes Payable [Line Items]                                          
Conversion price, per share (in Dollars per share)                             $ 0.345            
Amortization of debt discount total                             $ 319,899            
Accrued interest                     $ 50,000                    
Accrued Interest [Member]                                          
Convertible Notes Payable [Line Items]                                          
Unamortized debt discount                             52,602            
Note Two [Member]                                          
Convertible Notes Payable [Line Items]                                          
Warrant exercisable (in Shares)                                   292,463 292,463    
Principal amount                                   $ 25,000 $ 225,000    
Convertible Note [Member]                                          
Convertible Notes Payable [Line Items]                                          
Principal amount                                   $ 200,000      
Cavalry Fund I LP [Member]                                          
Convertible Notes Payable [Line Items]                                          
Interest rate percentage                   10.00%       20.00%              
Exercise price per share (in Dollars per share)                   $ 7.2       $ 4.5              
Warrant exercisable (in Shares)                   82,899                      
Purchase an additional shares (in Shares)                           100,000              
Net proceeds                   $ 500,500                      
Original issue discount                   71,500                      
Senior secured convertible note                   $ 572,000                      
Initial conversion price per share (in Dollars per share)                   $ 0.23                      
Converted interest         $ 139,726                                
Common stock conversion price (in Shares) 192,774                                        
Conversion price per share (in Dollars per share) $ 0.345       $ 0.345                                
Accrued interest                             931,943            
Mercer Street Global Opportunity Fund, LLC [Member]                                          
Convertible Notes Payable [Line Items]                                          
Interest rate percentage                           20.00%              
Exercise price per share (in Dollars per share)                   $ 7.2       $ 4.5              
Warrant exercisable (in Shares)                   82,899                      
Purchase an additional shares (in Shares)                           100,000              
Net proceeds                   $ 500,500                      
Original issue discount                   572,000                      
Senior secured convertible note                   $ 71,500                      
Accrued interest                             1,164,833            
Original issue discount rate                   10.00%                      
Conversion price (in Dollars per share)                   $ 6.9                      
Mercer Converted [Member]                                          
Convertible Notes Payable [Line Items]                                          
Converted interest       $ 100,000   $ 100,000                              
Common stock conversion price (in Shares)       289,856   289,856                              
Conversion price per share (in Dollars per share)       $ 0.345   $ 0.345                              
Loss on conversion           $ 48,551                              
Diagonal Street Lending LLC [Member]                                          
Convertible Notes Payable [Line Items]                                          
Senior secured convertible note                                       $ 4  
Accrued interest                             38,956            
Aggregate of gross proceeds received                                         $ 2,026,666
Diagonal Street Lending LLC [Member] | Convertible Note [Member]                                          
Convertible Notes Payable [Line Items]                                          
Accrued interest   $ 60,000 $ 125,000                                    
Net of unamortized debt discount   13,450 21,900                                    
Diagonal Street Lending LLC [Member] | Accrued Interest [Member]                                          
Convertible Notes Payable [Line Items]                                          
Net of unamortized debt discount                             $ 14,457            
Red Road Holdings Corporation [Member]                                          
Convertible Notes Payable [Line Items]                                          
Accrued interest                                 $ 25,846        
Repayment debt   $ 9,222 $ 18,444               $ 8,082                    
Red Road Holdings Corporation [Member] | Convertible Note [Member]                                          
Convertible Notes Payable [Line Items]                                          
Interest rate percentage   13.00% 13.00%               15.00%                    
Original issue discount   $ 73,450 $ 146,900               $ 63,250                    
Accrued interest                                 19,514        
Net of unamortized debt discount                     $ 13,250           32,842        
Effective interest rate   27.80% 29.30%               32.00%                    
Variable conversion rate percentage   60.00% 60.00%               60.00%                    
Red Road Holdings Corporation [Member] | Accrued Interest [Member]                                          
Convertible Notes Payable [Line Items]                                          
Net of unamortized debt discount                                 $ 18,419        
Quick Capital, LLC [Member]                                          
Convertible Notes Payable [Line Items]                                          
Exercise price per share (in Dollars per share)                       $ 0.345                  
Warrant exercisable (in Shares)                       357,764                  
Net proceeds                       $ 94,000                  
Senior secured convertible note                       $ 20,286                  
Original issue discount rate                       11.12%                  
Quick Capital, LLC [Member] | Convertible Note [Member]                                          
Convertible Notes Payable [Line Items]                                          
Original issue discount                       $ 114,286                  
Conversion price (in Dollars per share)                       $ 0.345                  
Maximum [Member]                                          
Convertible Notes Payable [Line Items]                                          
Interest rate percentage                             12.00%            
Maximum [Member] | Cavalry and Mercer [Member]                                          
Convertible Notes Payable [Line Items]                                          
Conversion price, per share (in Dollars per share)                             $ 4.5   $ 4.5        
Maximum [Member] | Cavalry Fund I LP [Member]                                          
Convertible Notes Payable [Line Items]                                          
Conversion price per share (in Dollars per share)                           $ 4.5              
Maximum [Member] | Mercer Street Global Opportunity Fund, LLC [Member]                                          
Convertible Notes Payable [Line Items]                                          
Conversion price, per share (in Dollars per share)               4.5                          
Minimum [Member]                                          
Convertible Notes Payable [Line Items]                                          
Interest rate percentage                             8.00%            
Minimum [Member] | Cavalry and Mercer [Member]                                          
Convertible Notes Payable [Line Items]                                          
Conversion price, per share (in Dollars per share)                                 $ 0.345        
Minimum [Member] | Cavalry Fund I LP [Member]                                          
Convertible Notes Payable [Line Items]                                          
Conversion price per share (in Dollars per share)                           $ 0.345              
Minimum [Member] | Mercer Street Global Opportunity Fund, LLC [Member]                                          
Convertible Notes Payable [Line Items]                                          
Conversion price, per share (in Dollars per share)               $ 0.345                          
[1] After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
v3.24.1.1.u2
Convertible Notes Payable (Details) - Schedule of Convertible Notes Payable - USD ($)
3 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Schedule of Convertible Notes Payable [Line Items]    
Principal $ 4,487,245  
Accrued Interest 338,936  
Unamortized debt discount (432,702) $ (687,503)
Amount, net $ 4,393,479 3,704,280
Cavalry Fund I LP [Member]    
Schedule of Convertible Notes Payable [Line Items]    
Interest Rate 10.00%  
Maturity date April 30, 2024  
Principal $ 898,980  
Accrued Interest 32,963  
Unamortized debt discount  
Amount, net $ 931,943 909,218
Mercer Street Global Opportunity Fund, LLC [Member]    
Schedule of Convertible Notes Payable [Line Items]    
Interest Rate 10.00%  
Maturity date April 30, 2024  
Principal $ 991,754  
Accrued Interest 173,079  
Unamortized debt discount  
Amount, net $ 1,164,833 1,139,764
Red Road Holdings Corporation [Member]    
Schedule of Convertible Notes Payable [Line Items]    
Interest Rate [1] 29.32%  
Maturity date June 15, 2024  
Principal $ 52,691  
Accrued Interest 722  
Unamortized debt discount (14,457)  
Amount, net $ 38,956 41,771
Red Road Holdings Corporation One [Member]    
Schedule of Convertible Notes Payable [Line Items]    
Interest Rate [1] 27.77%  
Maturity date July 30, 2024  
Principal $ 43,385  
Accrued Interest 880  
Unamortized debt discount (18,419)  
Amount, net $ 25,846 18,683
Red Road Holdings Corporation Two [Member]    
Schedule of Convertible Notes Payable [Line Items]    
Interest Rate [1] 32.04%  
Maturity date September 30, 2024  
Principal $ 51,148  
Accrued Interest 1,209  
Unamortized debt discount (32,843)  
Amount, net $ 19,514 3,109
Quick Capital, LLC [Member]    
Schedule of Convertible Notes Payable [Line Items]    
Interest Rate [1] 11.12%  
Maturity date September 30, 2024  
Principal $ 114,286  
Accrued Interest 2,348  
Unamortized debt discount (52,602)  
Amount, net $ 64,032
2023 convertible notes [Member]    
Schedule of Convertible Notes Payable [Line Items]    
Maturity date May 22, 2024 to February 21, 2025  
Principal $ 2,335,001  
Accrued Interest 127,735  
Unamortized debt discount (314,381)  
Amount, net $ 2,148,355 $ 1,591,735
Minimum [Member] | Red Road Holdings Corporation [Member]    
Schedule of Convertible Notes Payable [Line Items]    
Interest Rate [1]  
Minimum [Member] | 2023 convertible notes [Member]    
Schedule of Convertible Notes Payable [Line Items]    
Interest Rate 8.00%  
Maximum [Member] | 2023 convertible notes [Member]    
Schedule of Convertible Notes Payable [Line Items]    
Interest Rate 12.00%  
[1] The Red Road Holdings Corporation and Quick Capital LLC, interest rates are an effective interest rate as these convertible notes have a fixed interest charge which is earned on the issuance date, regardless of when payments are made.
v3.24.1.1.u2
Derivative Liability (Details) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 20, 2023
Sep. 12, 2023
Derivative Liability [Abstract]        
Convertible notes       $ 416,317
Derivative liability movements $ 815,941 $ 940,750    
Black-Scholes [Member]        
Derivative Liability [Abstract]        
Convertible notes     $ 235,000  
v3.24.1.1.u2
Derivative Liability (Details) - Schedule of Assumptions were used in the Black-Scholes Valuation Model - $ / shares
3 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Expected dividend rate 0.00% 0.00%
Minimum [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Conversion price (in Dollars per share) $ 0.0684 $ 0.104
Risk free interest rate 4.40% 3.60%
Expected life of derivative liability 1 month 3 months 15 days
Expected volatility of underlying stock 157.83% 158.72%
Maximum [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Conversion price (in Dollars per share) $ 0.345 $ 0.345
Risk free interest rate 5.49% 5.55%
Expected life of derivative liability 41 months 47 months
Expected volatility of underlying stock 201.11% 217.01%
v3.24.1.1.u2
Derivative Liability (Details) - Schedule of Movement in Derivative Liability - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Schedule of Movement in Derivative Liability [Abstract]    
Opening balance $ 1,434,196 $ 2,550,642
Derivative financial liability arising from convertible note and warrants 385,000
Fair value adjustment to derivative liability (815,941) (1,501,446)
Total $ 618,255 $ 1,434,196
v3.24.1.1.u2
Stockholders’ Equity (Details) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Mar. 04, 2024
Nov. 20, 2023
Nov. 08, 2023
Aug. 31, 2023
Aug. 30, 2023
Aug. 24, 2023
Aug. 16, 2023
Aug. 11, 2023
May 19, 2023
Dec. 30, 2022
Feb. 03, 2022
Oct. 22, 2021
Dec. 28, 2022
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
May 04, 2024
Mar. 14, 2024
Dec. 14, 2023
Feb. 16, 2021
Stockholders’ Equity [Line Items]                                        
Common stock authorized                           750,000,000   750,000,000        
Common stock par value (in Dollars per share)                           $ 0.0001   $ 0.0001        
Common stock issued                           13,819,889   13,819,889        
Common stock outstanding                           13,819,889   13,819,889        
Common stock conversion shares   500,000 289,855 144,928 2,838 173,914 72,464   72,464                      
Convertible debt (in Dollars)   $ 172,500 $ 100,000 $ 50,000   $ 60,000 $ 25,000   $ 25,000                      
Expense (in Dollars)                           $ 0 $ 0          
Preferred stock, authorized                           25,000,000   25,000,000        
Preferred stock, par value (in Dollars per share)                           $ 0.0001   $ 0.0001        
Preferred stock, issued                           0   0        
Preferred stock, outstanding                           0   0        
Exercisable shares               33,334           33,334       387,673    
Exercise price per share (in Dollars per share)                   $ 1.2       $ 0.345            
Purchase an aggregate shares                           133,334            
Exercise price (in Dollars per share)                           $ 0.45         $ 0.345  
Purchase shares of common stock                           166,667            
Additional purchase shares of common stock                           166,667            
Aggregate purchase of common stock                           1,333,334            
Principal amount (in Dollars)                                     $ 225,000  
Class of Warrant or Right and Exercisable of warrant                                     292,463  
Exercisabls shares                           1,000,000            
Agreement fee (in Dollars) $ 357,764                                      
Exercise price per share (in Dollars per share) $ 0.345                                 $ 0.345    
Limitation exceeds percentage                           9.99%            
Intrinsic value outstanding options (in Dollars)                           $ 0   $ 0        
Warrant [Member]                                        
Stockholders’ Equity [Line Items]                                        
Exercise price per share (in Dollars per share)                     $ 4.5   $ 0.345 [1]   [1]        
Purchase an aggregate shares                           199,999            
Exercise price per share (in Dollars per share)                           $ 0.345            
Maximum [Member]                                        
Stockholders’ Equity [Line Items]                                        
Warrants beneficially percentage                           4.99%            
Shares of common stock                           26,667            
Preferred Stock [Member]                                        
Stockholders’ Equity [Line Items]                                        
Preferred stock, authorized                           25,000,000            
Preferred stock, par value (in Dollars per share)                           $ 0.0001            
Preferred stock, issued                           0            
Preferred stock, outstanding                               0        
2021 Stock Incentive Plan [Member] | Maximum [Member]                                        
Stockholders’ Equity [Line Items]                                        
Shares of common stock                           1,766,667            
2018 Stock Incentive Plan [Member]                                        
Stockholders’ Equity [Line Items]                                        
Terminates period                           10 years            
2021 Stock Incentive Plan [Member]                                        
Stockholders’ Equity [Line Items]                                        
Terminates period                       10 years                
Debt Conversion Notices [Member]                                        
Stockholders’ Equity [Line Items]                                        
Aggregate shares of common stock                           5,696,586            
Convertible debt amount (in Dollars)                           $ 0.345            
Subsequent Event [Member]                                        
Stockholders’ Equity [Line Items]                                        
Exercise price (in Dollars per share)                                 $ 0.345      
Principal amount (in Dollars)                                 $ 25,000      
Class of Warrant or Right and Exercisable of warrant                                 292,463      
Extension of maturity date                                 Jun. 30, 2024      
Common Stock [Member]                                        
Stockholders’ Equity [Line Items]                                        
Common stock authorized                           750,000,000            
Common stock par value (in Dollars per share)                           $ 0.0001            
Common stock issued                           13,819,889            
Common stock outstanding                               13,819,889        
Exercise price per share (in Dollars per share)               $ 1.5                        
Exercise price (in Dollars per share)                           $ 0.345           $ 0.24
Options exercisable shares                           23,891            
Common Stock [Member] | Maximum [Member]                                        
Stockholders’ Equity [Line Items]                                        
Shares of common stock                           100,000            
Stock Options [Member]                                        
Stockholders’ Equity [Line Items]                                        
Option expense (in Dollars)                           $ 94,464 $ 94,464          
[1] After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
v3.24.1.1.u2
Stockholders’ Equity (Details) - Schedule of Restricted Stock Activity - $ / shares
3 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Total restricted shares [Member]    
Schedule of Restricted Stock Activity [Line Items]    
Total restricted shares, Outstanding at beginning [1] 783,167 783,167
Total restricted shares, Granted and issued [1]
Total restricted shares, Forfeited/Cancelled [1]
Total restricted shares, Vested [1]
Total restricted shares, Outstanding at ending [1] 783,167 783,167
Weighted average fair market value per share [Member]    
Schedule of Restricted Stock Activity [Line Items]    
Weighted average fair market value per share, Outstanding at beginning [1] $ 1.5 $ 1.5
Weighted average fair market value per share, Granted and issued [1]
Weighted average fair market value per share, Forfeited/Cancelled [1]
Weighted average fair market value per share, Vested [1]
Weighted average fair market value per share, Outstanding at ending [1] $ 1.5 $ 1.5
Total unvested restricted shares [Member]    
Schedule of Restricted Stock Activity [Line Items]    
Total unvested restricted shares, Outstanding at beginning [1] 170,792
Total unvested restricted shares, Granted and issued [1]
Total unvested restricted shares, Forfeited/Cancelled [1]
Total unvested restricted shares, Vested [1] (170,792)
Total unvested restricted shares, Outstanding at ending [1]
Unvested restricted Weighted average fair market value per share [Member]    
Schedule of Restricted Stock Activity [Line Items]    
Weighted average fair market value per share, Outstanding at beginning [1] $ 1.47
Weighted average fair market value per share, Granted and issued [1]
Weighted average fair market value per share, Forfeited/Cancelled [1]
Weighted average fair market value per share, Vested [1] (1.47)
Weighted average fair market value per share, Outstanding at ending [1]
Total vested restricted shares [Member]    
Schedule of Restricted Stock Activity [Line Items]    
Total unvested restricted shares, Outstanding at beginning [1] 783,167 612,375
Total unvested restricted shares, Granted and issued [1]
Total unvested restricted shares, Forfeited/Cancelled [1]
Total unvested restricted shares, Vested [1] 170,792
Total unvested restricted shares, Outstanding at ending [1] 783,167 783,167
Vested restricted Weighted average fair market value per share [Member]    
Schedule of Restricted Stock Activity [Line Items]    
Weighted average fair market value per share, Outstanding at beginning [1] $ 1.5 $ 1.5
Weighted average fair market value per share, Granted and issued [1]
Weighted average fair market value per share, Forfeited/Cancelled [1]
Weighted average fair market value per share, Vested [1] 1.47
Weighted average fair market value per share, Outstanding at ending [1] $ 1.5 $ 1.5
[1] After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
v3.24.1.1.u2
Stockholders’ Equity (Details) - Schedule of Restricted Stock Granted, Issued and Exercisable
3 Months Ended
Mar. 31, 2024
$ / shares
shares
[1]
Schedule of Restricted Stock Granted, Issued and Exercisable [Line Items]  
Restricted stock granted and Vested, number granted | shares 783,167
Restricted stock granted and Vested, weighted average fair value per share (in Dollars per share) | $ / shares $ 1.5
Grant Date Price 1.47 [Member]  
Schedule of Restricted Stock Granted, Issued and Exercisable [Line Items]  
Restricted stock granted and Vested, number granted | shares 683,167
Restricted stock granted and Vested, weighted average fair value per share (in Dollars per share) | $ / shares $ 1.47
Grant Date Price 0.50 [Member]  
Schedule of Restricted Stock Granted, Issued and Exercisable [Line Items]  
Restricted stock granted and Vested, number granted | shares 33,333
Restricted stock granted and Vested, weighted average fair value per share (in Dollars per share) | $ / shares $ 1.5
Grant Date Price 1.65 [Member]  
Schedule of Restricted Stock Granted, Issued and Exercisable [Line Items]  
Restricted stock granted and Vested, number granted | shares 66,667
Restricted stock granted and Vested, weighted average fair value per share (in Dollars per share) | $ / shares $ 1.65
[1] After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
v3.24.1.1.u2
Stockholders’ Equity (Details) - Schedule of Fair Value of the Warrants Granted and Issued - Warrants [Member]
3 Months Ended
Mar. 31, 2024
$ / shares
Schedule of Fair Value of the Warrants Granted and Issued [Line Items]  
Exercise price (in Dollars per share) $ 0.345
Expected life 5 years
Expected dividend rate 0.00%
Minimum [Member]  
Schedule of Fair Value of the Warrants Granted and Issued [Line Items]  
Risk free interest rate 4.15%
Expected volatility of underlying stock 190.72%
Maximum [Member]  
Schedule of Fair Value of the Warrants Granted and Issued [Line Items]  
Risk free interest rate 4.21%
Expected volatility of underlying stock 191.17%
v3.24.1.1.u2
Stockholders’ Equity (Details) - Schedule of Warrant Activity - Warrant [Member] - $ / shares
1 Months Ended 3 Months Ended 12 Months Ended
Feb. 03, 2022
Dec. 28, 2022
Mar. 31, 2024
Dec. 31, 2023
Schedule of Warrant Activity [Line Items]        
Shares Underlying, Outstanding (in Shares) [1]     10,442,093 5,186,376
Weighted average exercise price, Outstanding [1]     $ 0.6265 $ 0.9
Shares Underlying, Outstanding (in Shares) [1]     11,187,530 10,442,093
Weighted average exercise price, Outstanding [1]     $ 0.6077 $ 0.6265
Shares Underlying, Granted (in Shares) [1]     745,437 6,289,051
Exercise price per share, Granted [1]     $ 0.345  
Weighted average exercise price, Granted [1]     $ 0.345 $ 0.3556
Shares Underlying, Forfeited (in Shares) [1]     (33,334)
Exercise price per share, Forfeited [1]     $ 1.5
Weighted average exercise price, Forfeited [1]     $ 1.5
Shares Underlying, Cancelled on disposal of investment in Frictionless and Beyond Fintech (in Shares) [1]     (1,000,000)
Exercise price per share, Cancelled on disposal of investment in Frictionless and Beyond Fintech [1]     $ 0.345
Weighted average exercise price, Cancelled on disposal of investment in Frictionless and Beyond Fintech [1]     $ 0.345
Shares Underlying, Exercised (in Shares) [1]      
Exercise price per share, Exercised [1]    
Weighted average exercise price, Exercised $ 4.5 $ 0.345 [1] [1]
Minimum [Member]        
Schedule of Warrant Activity [Line Items]        
Exercise price per share, Outstanding [1]     0.345 0.345
Exercise price per share, Outstanding [1]     0.345 0.345
Exercise price per share, Granted [1]       0.345
Maximum [Member]        
Schedule of Warrant Activity [Line Items]        
Exercise price per share, Outstanding [1]     5.625 5.625
Exercise price per share, Outstanding [1]     $ 5.625 5.625
Exercise price per share, Granted [1]       $ 1.5
[1] After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
v3.24.1.1.u2
Stockholders’ Equity (Details) - Schedule of Warrants Outstanding and Exercisable - Warrant [Member]
3 Months Ended
Mar. 31, 2024
$ / shares
shares
Schedule of Warrants Outstanding and Exercisable [Line Items]  
Number Outstanding 11,187,530 [1]
Weighted Average Remaining Contractual life in years 3 years 9 months 7 days
Weighted Average Exercise Price (in Dollars per share) | $ / shares $ 0.6077 [1]
Number Exercisable 11,156,280 [1]
Weighted Average Exercise Price (in Dollars per share) | $ / shares $ 0.6065 [1]
Weighted Average Remaining Contractual life in years 3 years 9 months 10 days
Exercise Price 0.345 [Member]  
Schedule of Warrants Outstanding and Exercisable [Line Items]  
Number Outstanding 9,801,079 [1]
Weighted Average Remaining Contractual life in years 3 years 11 months 26 days
Number Exercisable 9,801,079 [1]
Weighted Average Remaining Contractual life in years 3 years 11 months 26 days
Exercise Price 0.450 [Member]  
Schedule of Warrants Outstanding and Exercisable [Line Items]  
Number Outstanding 266,668 [1]
Weighted Average Remaining Contractual life in years 4 years 2 months 23 days
Number Exercisable 266,668 [1]
Weighted Average Remaining Contractual life in years 4 years 2 months 23 days
Exercise Price 1.035 [Member]  
Schedule of Warrants Outstanding and Exercisable [Line Items]  
Number Outstanding 500,000 [1]
Weighted Average Remaining Contractual life in years 1 year 3 months 7 days
Number Exercisable 468,750 [1]
Weighted Average Remaining Contractual life in years 1 year 3 months 7 days
Exercise Price 1.500 [Member]  
Schedule of Warrants Outstanding and Exercisable [Line Items]  
Number Outstanding 33,334 [1]
Weighted Average Remaining Contractual life in years 4 years 4 months 13 days
Number Exercisable 33,334 [1]
Weighted Average Remaining Contractual life in years 4 years 4 months 13 days
Exercise Price 4.50 [Member]  
Schedule of Warrants Outstanding and Exercisable [Line Items]  
Number Outstanding 505,560 [1]
Weighted Average Remaining Contractual life in years 1 year 11 months 15 days
Number Exercisable 505,560 [1]
Weighted Average Remaining Contractual life in years 1 year 11 months 15 days
Exercise Price 5.625 [Member]  
Schedule of Warrants Outstanding and Exercisable [Line Items]  
Number Outstanding 80,889 [1]
Weighted Average Remaining Contractual life in years 1 year 11 months 15 days
Number Exercisable 80,889 [1]
Weighted Average Remaining Contractual life in years 1 year 11 months 15 days
[1] After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
v3.24.1.1.u2
Stockholders’ Equity (Details) - Schedule of Option Activity - Stock Option [Member] - $ / shares
3 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Stockholders’ Equity (Details) - Schedule of Option Activity [Line Items]    
Shares Underlying, Outstanding (in Shares) [1] 1,520,002 1,543,891
Weighted average exercise price, Outstanding [1] $ 4.46 $ 4.47
Shares Underlying, Outstanding (in Shares) [1] 1,520,002 1,520,002
Weighted average exercise price, Outstanding [1] $ 4.46 $ 4.46
Shares Underlying, Granted (in Shares) [1]  
Exercise price per share, Granted [1]  
Weighted average exercise price, Granted [1]  
Shares Underlying, Forfeited/Cancelled (in Shares) [1] (23,889)
Exercise price per share, Forfeited/Cancelled [1]
Weighted average exercise price, Forfeited/Cancelled [1] $ 5.41
Shares Underlying, Exercised (in Shares) [1]
Exercise price per share, Exercised [1]
Weighted average exercise price, Exercised [1]
Minimum [Member]    
Stockholders’ Equity (Details) - Schedule of Option Activity [Line Items]    
Exercise price per share, Outstanding [1] 1.2 1.2
Exercise price per share, Outstanding [1] 1.2 1.2
Exercise price per share, Forfeited/Cancelled [1]   1.2
Maximum [Member]    
Stockholders’ Equity (Details) - Schedule of Option Activity [Line Items]    
Exercise price per share, Outstanding [1] 12 12
Exercise price per share, Outstanding [1] $ 12 12
Exercise price per share, Forfeited/Cancelled [1]   $ 12
[1] After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
v3.24.1.1.u2
Stockholders’ Equity (Details) - Schedule of Options Outstanding and Exercisable - Option [Member]
3 Months Ended
Mar. 31, 2024
$ / shares
shares
Schedule of Options Outstanding and Exercisable [Line Items]  
Number Outstanding 1,520,002
Weighted Average Remaining Contractual life in years 7 years 7 months 28 days
Weighted Average Exercise Price (in Dollars per share) | $ / shares $ 4.46
Number Exercisable 1,450,558
Weighted Average Exercise Price (in Dollars per share) | $ / shares $ 4.45
Weighted Average Remaining Contractual life in years 7 years 8 months 4 days
Exercise Price 1.20 [Member]  
Schedule of Options Outstanding and Exercisable [Line Items]  
Number Outstanding 20,001
Weighted Average Remaining Contractual life in years 5 years 7 months 9 days
Number Exercisable 20,001
Weighted Average Remaining Contractual life in years 5 years 7 months 9 days
Exercise Price 4.50 [Member]  
Schedule of Options Outstanding and Exercisable [Line Items]  
Number Outstanding 1,500,001
Weighted Average Remaining Contractual life in years 7 years 8 months 8 days
Number Exercisable 1,430,557
Weighted Average Remaining Contractual life in years 7 years 8 months 15 days
v3.24.1.1.u2
Loss on Convertible Notes (Details) - USD ($)
3 Months Ended
Mar. 14, 2024
Mar. 31, 2024
Debt Instrument [Line Items]    
Purchased shares 387,673  
Debt extinguishment   $ 66,047
v3.24.1.1.u2
Loss on Convertible Notes (Details) - Schedule of the Loss on Convertible Notes - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Schedule of the Loss on Convertible Notes [Abstract]    
Expense on extension of maturity date of convertible notes $ 66,047
v3.24.1.1.u2
Net Loss Per Share (Details) - Schedule of Anti-dilutive Shares - shares
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Schedule of Anti-dilutive Shares [Line Items]    
Anti-dilutive shares 27,939,817 16,541,389
Convertible debt [Member]    
Schedule of Anti-dilutive Shares [Line Items]    
Anti-dilutive shares 15,232,285 8,293,738
Stock options [Member]    
Schedule of Anti-dilutive Shares [Line Items]    
Anti-dilutive shares 1,520,002 1,543,891
Warrants to purchase shares of common stock [Member]    
Schedule of Anti-dilutive Shares [Line Items]    
Anti-dilutive shares 11,187,530 6,703,760
v3.24.1.1.u2
Related Party Transactions (Details) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
William Corbett [Member]    
Related Party Transaction [Line Items]    
Option vesting $ 66,587 $ 66,587
Richard Rosenblum [Member]    
Related Party Transaction [Line Items]    
Option vesting $ 27,877 $ 27,877
v3.24.1.1.u2
Commitments and Contingencies (Details) - Note Payable [Member]
3 Months Ended
Mar. 31, 2024
Loss Contingencies [Line Items]  
Maturity date Mar. 30, 2024
Convertible Notes Payable [Member]  
Loss Contingencies [Line Items]  
Maturity date Feb. 21, 2025
v3.24.1.1.u2
Subsequent Events (Details) - USD ($)
3 Months Ended
Apr. 01, 2024
Mar. 31, 2024
Jun. 30, 2024
May 04, 2024
Dec. 14, 2023
May 12, 2023
Feb. 16, 2021
Subsequent Event [Line Items]              
Gross proceeds   $ 100,000          
Aggregate purchase of warrants (in Shares)           1,000,000  
Exercise Price (in Dollars per share)   $ 0.45     $ 0.345    
Principal amount         $ 225,000    
Warrants exercisable (in Shares)         292,463    
Securities Purchase Agreements [Member]              
Subsequent Event [Line Items]              
Maturity, description   mature 12 months from the date of issuance          
Interest rate   8.00%          
Subsequent Event [Member]              
Subsequent Event [Line Items]              
Gross proceeds $ 70,000            
Principal amount outstanding $ 88,500            
Bears interest 15.00%            
Interest charge $ 13,275            
Variable conversion rate 65.00%            
Exercise Price (in Dollars per share)       $ 0.345      
Principal amount       $ 25,000      
Extension of maturity date       Jun. 30, 2024      
Warrants exercisable (in Shares)       292,463      
Subsequent Event [Member] | BZWR [Member]              
Subsequent Event [Line Items]              
Ownership percentage 96.00%            
Subsequent Event [Member] | Securities Purchase Agreements [Member]              
Subsequent Event [Line Items]              
Maturity date Dec. 30, 2024            
Principal amount       $ 225,000      
Common Stock [Member]              
Subsequent Event [Line Items]              
Aggregate purchase of warrants (in Shares)   289,856          
Exercise Price (in Dollars per share)   $ 0.345         $ 0.24
Common Stock [Member] | Securities Purchase Agreements [Member]              
Subsequent Event [Line Items]              
Conversion price per share (in Dollars per share)   $ 0.345          
Forecast [Member]              
Subsequent Event [Line Items]              
Principal amount     $ 25,000        

Innovative Payment Solut... (QB) (USOTC:IPSID)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more Innovative Payment Solut... (QB) Charts.
Innovative Payment Solut... (QB) (USOTC:IPSID)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more Innovative Payment Solut... (QB) Charts.